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As an important endogenous source of reactive oxygen species (ROS), NADPH 
oxidase 1 (Nox1) has received tremendous attention in the past few decades. It has been 
identified to play a key role as the initial “kindle,” whose activation is crucial for 
amplifying ROS production through several propagation mechanisms in the vascular 
system. As a consequence, Nox1 has been implicated in the initiation and genesis of many 
cardiovascular diseases and has therefore been the subject of detailed investigations.  
 The literature on experimental studies of the Nox1 system is extensive. 
Numerous investigations have identified essential features of the Nox1 system in 
vasculature and characterized key components, possible regulatory signals and/or 
signaling pathways, potential activation mechanisms, a variety of Nox1 stimuli, and 
its potential physiological and pathophysiological functions. While these 
experimental studies have greatly enhanced our understanding of the Nox1 system, 
many open questions remain regarding the overall functionality and dynamic 
behavior of Nox1 in response to specific stimuli. Such questions include the 
following. What are the main regulatory and/or activation mechanisms of Nox1 
systems in different types of vascular cells? Once Nox1 is activated, how does the 
system return to its original, unstimulated state, and how will its subunits be 
recycled? What are the potential disassembly pathways of Nox1? Are these 
pathways equally important for effectively reutilizing Nox1 subunits? How does 
Nox1 activity change in response to dynamic signals? Are there generic features or 
principles within the Nox1 system that permit optimal performance?  
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These types of questions have not been answered by experiments, and they 
are indeed quite difficult to address with experiments. I demonstrate in this 
dissertation that one can pose such questions and at least partially answer them with 
mathematical and computational methods. Two specific cell types, namely 
endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), are used as 
“templates” to investigate distinct modes of regulation of Nox1 in different vascular 
cells. By using a diverse array of modeling methods and computer simulations, this 
research identifies different types of regulation and their distinct roles in the 
activation process of Nox1. In the first study, I analyze ECs stimulated by 
mechanical stimuli, namely shear stresses of different types. The second study uses 
different analytical and simulation methods to reveal generic features of alternative 
disassembly mechanisms of Nox1 in VSMCs. This study leads to predictions of the 
overall dynamic behavior of the Nox1 system in VSMCs as it responds to 
extracellular stimuli, such as the hormone angiotensin II.  The studies and 
investigations presented here improve our current understanding of the Nox1 
system in the vascular system and might help us to develop potential strategies for 
manipulation and controlling Nox1 activity, which in turn will benefit future 






1.1 Overview  
In the past decades, considerable research efforts have focused on studies of reactive 
oxygen species (ROS) and elucidated various aspects of their dynamics, including their possible 
endogenous sources, consuming pathways, regulatory mechanisms, and potential physiological 
and pathophysiological functions in different types of cells and tissues [1-6] (see detailed 
discussion in section 1.2.1). These studies have greatly broadened our knowledge about ROS, 
their specific properties, and features that are important at the molecular and cellular levels, and 
made us realize the importance of ROS not only as intra- and inter-cellular signaling molecules, 
but also as potentially contributing to a wide range of diseases [7-10]. Particularly prominent 
among these diseases are those of the cardiovascular system, such as hypercholesterolemia, 
cardiac hypertrophy, atherosclerosis, hypertension, heart failure, and, diabetes, which have been 
demonstrated by many experimental and clinical studies to involve ROS functionally in their 
initiation and genesis [5, 7-9, 11-15].  
 Within the healthy cardiovascular system, ROS plays an essential physiological role in 
maintaining cardiac and vascular integrity. Under physiological conditions, they are produced in 
a controlled manner at low concentrations and function as signaling molecules that affect 
specific redox sensitive pathways and genes and coordinate several integrated physiological 
responses [1, 6, 16-18] (see detailed review in [1, 17, 18]). Under pathophysiological conditions, 
increased ROS production leads to an unbalanced intracellular redox state, called “oxidative 
stress” [19] , which triggers deleterious processes that can potentially damage cell structures, 
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including lipids, proteins, and DNA [3, 20, 21]. Thus, ROS become mediators of vascular injury 
and inflammation in many cardiovascular diseases [22-24] (see detailed discussion in section 
1.2.4). Further exploration of this increased ROS production revealed the involvement and 
contributions of several cellular components as potential endogenous sources of ROS, including 
xanthine oxidase, NADPH oxidase, endothelial nitric oxide synthase (eNOS), and damaged 
mitochondria [22, 25]. Among them, NADPH oxidase has been identified to play the key role as 
the initial “kindle,” whose activation is crucial for amplifying ROS production by means of 
several propagation mechanisms [13, 25-28] (see detailed discussion in section 1.2.5).  
 NADPH oxidase (or simply called Nox) constitutes a family of enzymes that use 
NADPH and molecular oxygen as substrates to generate a specific amount of ROS [29]. Nox 
was first found in phagocytes of the innate immune system [30], but later also in other types of 
cells and tissues of vertebrates including humans [31]. To date, seven Nox homologues have 
been identified. Four are found in vasculature, namely, Nox1, Nox2, Nox4, and Nox5 [31-35]. 
These four Nox homologues have different vascular distributions, intracellular locations, subunit 
compositions, activation mechanisms, and thus exert distinct physiological functions [31, 32, 34-
36] (see section 1.2.2 for details). Among them, Nox1 has received the most attention because it 
can be activated and regulated by many physiological and pathological stimuli [34, 37, 38], and 
therefore has been implicated in a number of cardiovascular diseases [27, 31, 34, 39-42].  
 The reported studies of the Nox1 system are extensive. Using modern techniques in 
molecular biology, these studies have identified several essential features of the Nox1 system in 
vasculature, including key molecular components, possible regulatory signals and/or signaling 
pathways, potential activation mechanisms, and a variety of stimuli to which Nox1 responds [31-
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33, 37, 38]. This experimental and clinical information has greatly enhanced our understanding 
of the Nox1 system and enabled us to sketch a coarse picture of how individual Nox1 subunits 
are activated, translocate, and assemble into an active Nox1 enzyme. Nevertheless, although the 
basic components and interactions are known, the overall functionality and dynamic behavior of 
Nox1 in response to specific stimuli are not clear and neither are they easy to grasp intuitively.  
Several reasons contribute to this difficulty. First, the structure of the Nox1 system is 
rather complicated, as it consists of different types of metabolic and signaling pathways, as well 
as several proteins and their interactions. These governing pathways and processes often operate 
at multiple time scales, ranging from seconds up to several hours, or even days, which renders 
the integration and understanding of overall system behaviors difficult. Second, Nox1 activity is 
coordinately regulated by different stimuli through distinct mechanisms. These regulatory 
mechanisms exist and interact with each other at different levels, including transcriptional and 
translational regulation, as well as signal-based modulation. The possibility that different stimuli 
can modulate Nox1 activity via distinct and/or shared regulatory pathways makes intuitive 
interpretations and predictions of the Nox1 dynamics unreliable. Finally, our knowledge about 
the disassembly mechanisms of Nox1 is scarce. However, as I will show in this dissertation, 
these mechanisms are crucial, as they reestablish the normal state of the system, which must 
quickly be ready for new signals. 
To exert its proper function in signal transduction, Nox1 needs to reside, under 
unstimulated condition, in a state that one may call “Ready-to-Respond State” (or “RtRS”). In 
this state, Nox1 is prepared to receive signals and act on the ROS system in an effective and 
appropriate manner. After an input signal has triggered the Nox1 system and the system has 
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served its role as signal transducer, the active complex must be disassembled. , As it turns out 
(see later), the disassembly mechanisms of Nox1 determine how efficiently the Nox1 system can 
return to its RtRS and are therefore much more important than previously thought. One possible 
reason for previously neglecting this important aspect might be due to the limitations of current 
experimental designs and set-ups. Modern biochemical techniques have helped us to identify 
many proteins, and sometimes their intracellular concentrations. However, because experiments 
usually focus on concentration changes after a certain stimulus is added, they usually do not 
detect the dynamics of the material flux through each individual pathway, thus making the 
experimental identification of possible disassembly mechanisms difficult.  
The limitations of experimental studies as well as the complicated structure of the Nox1 
system suggest that we should complement the experimental studies with a different type of 
approach, which is afforded by mathematical modeling and computational analysis (see details 
in section 1.3). These computational and modeling approaches are designed to help us integrate 
and predict dynamic responses of complicated biological systems, propose and identify generic 
principles that are usually difficult to discover by experiments, and analyze and diagnose 
prominent features of ill-characterized model structures. I will show that, with the aid of these 
computational approaches, I will be able to answer some of questions regarding the organization 
of the Nox1 system that have not been answered by experiments and are often difficult to 
address. 
Some unanswered open questions regarding the Nox1 system are the following. How is 
Nox1 activity differently regulated by distinct extracellular stimuli? What are the main 
regulatory and/or activation mechanisms of Nox1 systems in different types of vascular cells?  
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What are the potential disassembly pathways of Nox1? Are these pathways equally important for 
effectively reutilizing Nox1 subunits? How does the importance or role of individual recycling 
pathway change in response to different stimuli? How does the dynamics of Nox1 activity 
change in response to these stimuli? Are there generic features or principles for the Nox1 system 
that lead to optimal performance?  
These types of questions are difficult to address with experiments, but I will 
demonstrate here that one can pose such questions and at least partially answer them with 
mathematical and computational methods. The investigation of these questions with 
computational modeling methods expands our knowledge of the regulatory functions of 
the Nox1 system in different vascular cells, improves our understanding of potential 
disassembly mechanisms of Nox1, characterizes the dynamic features of the Nox1 system 
responding to different extracellular stimuli, and might help us develop strategies of 
manipulating and controlling Nox1 activity, which in turn will benefit future experiments.  
 
1.2 Biological Background 
1.2.1 Reactive Oxygen Species in Vasculature: Introduction and Metabolism 
The term “reactive oxygen species” (ROS) collectively refers to chemically-reactive 
molecules that are formed upon incomplete reduction of oxygen [3]. They are mainly generated 
as by-products of normal aerobic metabolism and exist in all cellular organisms, including both 
prokaryotes and eukaryotes. A term that is closely related to ROS is “free radical.” Although 
these two terms are often interchangeably, they are not truly the same. Free radicals are any 
atoms, molecules, or irons with unpaired electrons on an open shell configuration [21]. Many 
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ROS, possessing unpaired electron, are thus free radicals. These include molecules such as 
superoxide anion (O2·-), hydroxyl radicals (OH·), nitric oxide (NO·), and lipid radicals. By 
contrast, other molecules, such as hydrogen peroxide (H2O2), peroxynitrite (OONO-), and 
hypochlorous acid (HOCl), are not free radicals but ROS with oxidizing effects.  
The cellular production of ROS generally stems from one electron reduction of molecular 
oxygen, which can lead to the consecutive production of other ROS via a free radical chain 
reaction [2]. The step-wise reduction of molecular oxygen via 1-electron transfer, producing a 
derivative ROS associated with this reaction network, is schematically shown in Figure 1.1.  
Most ROS are inherently unstable and can readily react with most non-radical bio-
molecules and, in particular, biological macromolecules, such as lipids, proteins, nucleic acids, 
and carbohydrates. Among the various ROS molecules, some are highly reactive, such as the 
OH· [1], while others are less reactive; examples are O2·- and H2O2, which serve as intracellular 
second messengers under physiological conditions [3]. In vascular systems, the most important 
and widely documented ROS molecules include superoxide, hydrogen peroxide, and nitric oxide. 
These three molecules will be briefly discussed in the following to provide a general overview of 
their biochemical characteristics and intracellular sources.  
Superoxide (anion) is created via one-electron reduction from molecular oxygen; it is 
produced both in the cytosol and in the mitochondria [2, 43, 44]. Specifically, O2·- is formed 
during the process of oxidative phosphorylation in vicinity of the inner mitochondrial membrane. 
This reaction constitutes the final step of cellular respiration, which generates usable energy in 
the form of adenosine triphosphate ATP, especially in electron-rich aerobic environments [2, 3]. 
Due to the escape of electrons from the respiratory chain, molecular oxygen is prematurely and 
incompletely reduced to give O2·-.  
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Figure 1.1. Metabolism of reactive oxygen species (ROS).  
The one-electron reduction of molecular oxygen into the formation of superoxide (O2·-) can be catalyzed by several 
enzymes and enzyme systems, including the mitochondrial electron transport chain, lipoxygenase, cyclooxygenase, 
cytochromeP450, xanthine oxidase, NADPH oxidase, and other hemoproteins. O2·- can be dismutated into hydrogen 
peroxide (H2O2) spontaneously or in a reaction catalyzed by superoxide dismutase (SOD) (at the reaction speed 
2.0×109 mol/L-1s-1). O2·- and nitric oxide (NO·) react with each other at a rate that is near the diffusion-limit (6.7×109 
mol/L-1s-1) to form peroxynitrite (ONOO-), a potent oxidant. Lipid radicals (LO· and LOO·) can also react with NO· 
to form LONO and LOONO, respectively. NO· is synthesized enzymatically from L-arginine by endothelial NO· 
synthase (eNOS) with its cofactor BH4. Oxidation of BH4, primarily by ONOO-, can lead to eNOS uncoupling and 
thereby contributes to O2·- generation. H2O2 can also be directly produced from two-electron reduction of molecular 
oxygen via the reaction catalyzed by xanthine oxidase and glucose oxidase. H2O2 can be enzymatically metabolized 
into water by a number of different enzyme systems, such as catalase (CAT), glutathione peroxidases (GPx), 
peroxiredoxins (Prx), and small molecules like thiols. H2O2 can also be converted to the hydroxyl radical (HO
·), 
which is extremely reactive and potentially damages DNA, protein, and lipids. Mammalian peroxidases such as 
myeloperoxidase (MPO) and the eosinophil peroxidases are activated by H2O2 to form highly reactive radicals that 
can oxidize NO· to NO2. NO2 can, in turn, contribute to the formation of nitrotyrosines. Compiled and adapted from 




Because O2·- is membrane- impermeable (although it can across the cell membrane via anion 
channels), it is mainly enclosed within the mitochondria until it is converted into a membrane-
permeable ROS molecule, namely H2O2. The conversion of O2·- into hydrogen peroxide can take 
place spontaneously, or more rapidly via an enzymatic reaction catalyzed by a member of the 
superoxide dismutase (SOD) enzyme family [2, 46, 47], which includes manganese superoxide 
dismutase in mitochondria and copper and zinc superoxide dismutases in the cytosol of virtually 
all eukaryotic cells. The SOD-catalyzed dismutation is favored when the concentration of 
superoxide is low and the concentration of SOD is high, which occurs under physiological 
conditions. 
 In spite of being a free radical, O2·- is surprisingly not very reactive [2]. Together with its 
inefficiency in penetrating a lipid membrane, superoxide is usually considered a poor signaling 
molecule [3]. Under physiological conditions in aqueous solutions at a neutral pH, the favored 
reaction of O2·- is the dismutation reaction yielding H2O2 [2]. However, when produced in excess, 
a significant amount of O2·- reacts with NO· with an extremely rapid rate (6.7×109 mol/L-1·s-1) 
[48], which is three times faster than the reaction rate for O2·- with SOD. Given this rapid 
reaction rate, it is likely that some O2·- always reacts with NO· within cells as well as in the 
extracellular space, implicating the importance of O2·- in the loss of nitric oxide bioavailability.  
Hydrogen peroxide is a non-radical molecule It is nevertheless highly important because 
of its ability of moving freely between intracellular compartments by penetrating biological 
membranes [3]. By forming radicals, it plays an important intermediate in the production of more 
reactive ROS. As shown in the schematic of Figure 1.1, H2O2 can be further reduced to generate 
the highly reactive OH· (in the so-called Haber-Weiss or Fenton reaction) in the presence of 
molecules containing metals such as Fe2+ and Cu+ [3]. Although the majority of H2O2 stems from 
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the conversion of O2·- in the mitochondria as well as in the cytosol, mammalian cells contain 
other sources to produce endogenous H2O2 independently of O2·- generation [49]. For instance, 
xanthine oxidase and glucose oxidase can directly produce H2O2 by donating two electrons to 
oxygen [50]. A more recent study suggests a specific role of Nox4 to directly release H2O2 
within vascular smooth muscle cells (VSMCs) [51]. Once produced, H2O2 can be removed via 
several antioxidant enzyme systems [2, 3, 6]. These enzymatic antioxidants include, but are not 
limited to, catalases (CAT, predominantly residing within the peroxisome), glutathione 
peroxidases (GPx), and peroxiredoxins (Prx).  
Although hydrogen peroxide is much less reactive than other ROS (e.g., the hydroxyl 
radical), its reactivity with intracellular thiol group is significant [3]. Thiol oxidation of H2O2 has 
been shown to inhibit protein tyrosine phosphatase (PTP) activity [18]. Considering its oxidative 
effect, free moving capability, and relatively long half-life, H2O2 is often believed to be an ideal 
candidate for a signaling molecule.  
Nitric oxide (NO· or, more often, NO) is an odd free radical that does not readily react 
with most biological molecules despite its unpaired electrons [1]. Instead, it easily reacts with 
other free radicals (e.g., peroxyl and alkyl radicals), generating less reactive molecules, thus in 
fact functioning as a free radical scavenger. As mentioned above, however, if superoxide and NO 
are produced in parallel in large amounts, the two react with each other to form peroxynitrite 
(OONO-) [52], which is highly cytotoxic. Under physiological conditions, endogenous 
antioxidant defenses minimize this interaction and maintain what seems to be a tenuous balance 
between them. NO is synthesized enzymatically from L-arginine by NO synthase (NOS) [53-55]. 
There are three main isoforms of this enzyme, i.e., neuronal NOS (nNOS), inducible NOS 
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(iNOS), and endothelial NOS (eNOS), which differ in their respective expression and activity 
[53-56].  
In endothelium, NO is mainly generated within endothelial cells (ECs), and diffuses 
across cell membranes into other cells like smooth muscle cells (SMCs). It generally functions as 
an intracellular messenger stimulating guanylate cyclase and protein kinases, thereby relaxing 
smooth muscle in blood vessels [2]. A loss of NO biological activity is often observed in a 
variety of common pathological conditions, including hypercholesterolemia, hypertension, 
diabetes, and heart failure [22]. Expression of eNOS can be regulated either by H2O2 via 
Ca2+/calmodulin-dependent protein kinase II/janus kinase 2 (JAK2)-dependent pathway [57, 58], 
or by shear stress through cSrc-dependent pathways [59].   
 
1.2.2 NADPH Oxidases and Other Sources of Vascular Reactive Oxygen Species 
Virtually all types of vascular cells produce ROS. In addition to mitochondria, ROS can 
be potentially derived from xanthine oxidase, lipoxygenase, cyclooxygenase, cytochrome P450, 
nitrix oxide synthase, peroxidases, heme oxygenases, hemoproteins such as heme and hematin, 
and NADPH oxidases [22, 60-64]. Over the past twenty years, many investigations have 
demonstrated that the last enzyme family, the membrane-associated NADPH oxidases, are the 
primary producer of physiological ROS in vascular tissue [13, 27, 28], and therefore will be 
introduced in greater details in the following.  
NADPH Oxidase 
NADPH oxidase (Nox) was first described in phagocytes of the innate immune system [30] 
(e.g., neutrophils and macrophages) where it is responsible for generating large bursts of O2·- 
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using NADPH and molecular oxygen as an electron donor and acceptor respectively, during the 
process of phagocytosis. The significance of phagocytic NADPH oxidase in host defense is 
clearly demonstrated in a rare disorder known as chronic granulomatous disease (CGD) [65-67], 
in which genetic defects in essential oxidase components result in an inactive enzyme and a 
predisposition to recurrent life-threatening infections in affected children.  The phagocytic Nox 
(or classic Nox) is a multimeric enzyme that contains a heterodimeric membrane-bound 
cytochrome b558 complex, which consists of gp91phox (renamed Nox2) and p22phox, and three 
cytosolic subunits, namely, p47phox, p67phox, and the small G-protein Rac [68, 69]. Upon agonist 
stimulation, these cytosolic subunits translocate to the cytochrome complex, leading to an 
increase in enzymatic activity.  
It was later found that humans have seven different NADPH oxidase homologues, called 
Nox1 to Nox5, Duox1 and Duox2, as well as two additional homologues of the cytosolic 
subunits, NoxO1 and NoxA1 [31]. Structurally, all members of the Nox family contain at least 
six transmembrane domains and cytosolic FAD and NADPH binding domains [70, 71]. Nox5 
contains specific EF-hand Ca2+-binding domains, and Duox1 and Duox2 have an extracellular 
peroxidases-like domain in addition to the EF-hand domains[71]. Although all Nox enzymes are 
able to increase intracellular ROS, there are important differences regarding their subunit 
composition, localization, tissue distribution, activation mechanisms, and possible physiological 
functions [31, 33].  
Compared to their phagocytic counterparts, vascular Nox have a few specific features of 
importance (see detailed review in [33]). First, vascular Nox has low but constitutive activity. In 
homogenized neutrophils, it is necessary to add a cytosolic fraction of p47phox and p67phox to the 
membrane fraction containing the cytochrome to observe oxidase activity. In contrast, in 
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unstimulated vascular cells, oxidase activity was observed in isolated membrane fraction [72-
75]. This constitutive activity was explained by the detection of p47phox and p67phox proteins in 
the membrane fraction [72, 73, 76]. However, the rate of superoxide production in vascular cells 
is much lower (~1-10%) than that in leukocytes [76-78]. This weak activity of vascular Nox may 
be due to lower expression of oxidase subunits in vascular cells. It is also possible that oxidase 
activity is limited in vascular cells by the cytosolic concentrations of NADH and NADPH.  
Another specific feature of the vascular enzymes is their intracellular release of ROS, which 
was described in a number of reports [79-81]. What’s more important, in contrast to the 
cytotoxic amounts of superoxide generated in phagocytes, most vascular Nox produce low 
amounts of ROS, which usually serve as important signaling molecules and regulate many 
fundamental processes [33].  In addition, unlike phagocyte oxidase that uses NADPH exclusively 
as an electron donor [82], vascular Nox is freer in substrate specificity. Many reports have shown 
that vascular Nox may possibly consume NADH as well as NADPH [83-85].  
Another difference between phagocytic and vascular oxidases is their tissue distribution. In 
phagocytes, only one Nox isoform (Nox2) is predominant. In vascular cells, however, expression 
levels of Nox homologues and their cytosolic subunits vary between different vascular layers, 
and may even differ among species [33]. So far, four Nox enzymes, namely, Nox1, Nox2, Nox4, 
and Nox5, are primarily found in the vasculature, and thereby will be introduced separately in 
greater detail. 
Nox1, the first homologue of Nox2 to be cloned [86, 87], is most highly expressed in colon 
epithelia [88], but is also expressed at lower levels in vascular cells, including VSMCs and ECs 
[31]. Recent studies have suggested that Nox1 mainly locates at the plasma membrane, 
specifically in caveolae on the cell surface in VSMCs [35, 89]. Because Nox1 carries electrons 
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across membranes, it requires charge compensation. Agonist-induced Nox1 activity is VSMC 
endosomes is blocked by the deletion of chloride channel 3 (CLC-3) and rescued by transfection 
with intact channel proteins [90]. By exchanging protons for chloride anions, this CLC-3 
antiporter prevents oxidase-induced cytosol acidification and accumulation of endosomal 
negative charges [91].  
At the protein level, Nox1 associates with the membrane subunit p22phox [92, 93], which is 
necessary for enzymatic activity and protein stabilization. Very similar to its homologue Nox2, 
Nox1 is activated by forming a complex with cytosolic activators, and can interact with 
p47phox[31, 33, 94], p67phox[33], and the small GTPase Rac [95-97]. It is interesting to find that 
p47phox and p67phox have homologues, namely, NoxO1 [94] and NoxA1 [46, 98, 99], which can 
very strongly activate Nox1. In contrast to p47phox, which requires an additional phosphorylation 
step for translocation from cytosol to membrane and association with Nox1 [33], NoxO1 lacks 
the auto-inhibitory region found on p47phox, and thereby is constitutively associated with 
Nox1[71]. The membrane translocation of p67phox and the GTP-bound Rac are also essential for 
Nox1 activation [33]. Interestingly, in VSMCs, Nox1 is complexed with NoxA1 and p47phox 
because p67phox exists in ECs and fibroblasts, but not in VSMCs from large vessels [27, 98-100].   
Nox1 can be activated by a variety of extracellular stimuli [31, 37, 101, 102], including 
cytokines, growth factors, hormones, and mechanical forces. Upon stimulation, Nox1 could 
either be acutely activated within a few seconds or exhibit sustained activity for longer-time 
exposures (e.g., several hours). The former regulation is usually dependent on signaling 
responses induced by extracellular stimuli, whereas the latter activation is often due to the up- or 
down-regulation of Nox1 subunit expression. For example, in VSMCs, the acute activation of 
Nox1 is mainly caused by angiotensin II (AngII)-stimulated protein kinase C (PKC) [38], and 
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subsequent ROS-sensitive, Src-mediated epidermal growth factor receptor (EGFR) 
transactivation [38]. By contrast, the sustained activation of Nox1 is preceded by up-regulation 
of Nox1 mRNA [37, 103], p22phox mRNA and protein [104, 105], and p47phox protein [105, 106]. 
In addition, recent a study has identified a novel mechano-sensitive pathway through which both 
Nox1 mRNA and protein expression are up-regulated upon stimulation by oscillatory shear stress 
(OSS)[101].  
Although Nox1 has a low basal expression in VSMCs, it has been extensively studied, 
because many experimental and clinical studies have revealed evidence that Nox1 can regulate 
smooth muscle cell growth, proliferation, contraction, and migration, and therefore has been 
implicated in AngII-induced hypertension and hypertrophy, vascular inflammation, endothelial 
dysfunction, and even atherosclerosis [34, 102].  
Nox2, the first discovered Nox in leukocytes [30], is expressed in both phagocytic [68, 107, 
108] and non-phagocytic cells including all vascular wall cells, except VSMCs from large 
arteries. It is localized in the membrane of phagosomes in neutrophils, in caveolae on the leading 
edge of lamellipodia in ECs [109] as well as in endosomes [69, 110] of other non-phagocytic 
cells.  
Very similar to Nox1, activation of Nox2 is a highly controlled process that requires three 
different elements, including the cytoplamic subunit p67phox[111], active Rac [112], and at least 
in vivo free fatty acids.  The direct interaction between p67phox and Nox2 is not steadily stable, 
but instead facilitated by p47phox, which acts as an “organizer” [113]. In resting cells, non-
phosphorylated p47phox does not interact with the membrane, and other oxidase subunits like its 
SH3 and PX domains, are governed by an autoinhibitory loop [114]. Serine phosphorylation of 
p47phox results in its conformational change and the exposure of the interacting domain. In 
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addition, Nox2 has been found to complex with p40phox, but the functional consequences of this 
interaction are controversial [33].  
In vascular cells, Nox2 is activated by angiopoietin-1 [115], endothelin-1 [116], vascular 
endothelial growth factor (VEGF) [117], thrombin [118], and mechanical forces [34]. For 
example, Nox2 mRNA is increased by oscillatory shear stress (OSS) in ECs [101]. Because O2·- 
produced by Nox2 can rapidly neutralize vasodilator NO, Nox2 is expected to induce 
contraction, and Nox2 expression was shown to correlate well with hypertension [119]. 
Moreover, Nox2 promotes EC proliferation by p38MAPK and Akt stimulation [34]. Besides, 
accumulating evidence suggests Nox2 promotes inflammation and atherosclerosis in resident 
ECs, adventitial fibroblasts, as well as recruited macrophages [34].  
Nox4 is highly expressed in the kidney [120], but has been found to be expressed and 
functionally important in many other cell types including all vascular cells [27, 34, 121]. In 
general, Nox4 is highly expressed compared to other Nox homologues [121]. In VSMCs, Nox4 
has been identified in focal adhesions [35], the nucleus [122], and the endoplasmic reticulum 
[93]. Nuclear and endoplasmic reticular localizations have been confirmed in other cell types.  
Unlike other Nox homologues, Nox4 only requires the membrane subunit p22phox for 
enzymatic activity, and appears to be constitutively active [123]. This observation has led to the 
proposal that Nox4 is an inducible Nox with an activity proportional to protein expression. A 
recent paper identified a p22phox-interacting protein, polymerase delta-interacting protein 
(Poldip2), which increases the activity of Nox4 and participates in its regulation of cytoskeleton 
in VSMCs [124]. At the mRNA level, Nox4 is up-regulated by serum withdrawal in VSMCs and 
ECs [33, 125], but down-regulated by growth-promoting agents such as AngII, platelet-derived 
growth factor (PDGF), interleukin-1 beta (IL-1β), transforming growth factor-β (TGF-β), and 
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thrombin in VSMCs and fibroblasts [33, 123, 126]. However, these results may need to be re-
evaluated since a recent study showed that Nox4 mRNA and protein expression are not always 
correlated [127]. In addition, Nox4 in ECs is upregulated by physiological shear stress and 
down-regulated by pathological stress (e.g., high intensity laminar shear stress) and oscillatory 
shear stress [128].  
The physiological function of Nox4 is often cell-specific. For example, Nox4 is required to 
maintain the quiescent VSMCs phenotype and tumor necrosis factor-α (TNF-α) induced 
apoptosis in ECs [129-131]. In contrast, proliferation induced by urotensin or hypoxia in 
pulmonary VSMCs requires Nox4 [132, 133]. Nox4-derived ROS have been implicated in a 
variety of physiological processes, including cellular senescence, apoptosis, survival, insulin 
signaling, migration, the unfolded protein response, and differentiation [34].  
Nox5 is expressed in lymphatic tissue [134], testis [135], VSMCs [136], ECs [134], spleen, 
uterus [137], and prostate cancer cells [138]. However, little information is available about the 
subcellular localization of endogenous Nox5. Recent studies detected that over-expressed Nox5 
locates at the plasma membrane in HEK293 cells, and phosphatidylinositol 4, 5-bisphosphate 
(PIP2) causes Nox5 to localize in this region [139, 140].  Nox5 has several isoforms, including 
Nox5-L (α, β, δ, and γ) and a short form, Nox5-S. Nox5-L contains specific EF-hand Ca2+-
binding domains, which is absent for Nox1 to Nox4 [141, 142]. Nox5-S lacks EF-hand motifs at 
the N-terminus [134].  
Nox5 differs from other Nox enzymes in its molecular composition as well we its activation 
by calcium and possibly calmodulin-based mechanisms. Phosphorylation of Nox5 at residues 
Thr494 and Ser498 can increase the sensitivity of Nox5 to calcium, and result in activation of Nox5 
at lower calcium concentrations [143]. Nox5 is not found in rodents, a model that has been 
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commonly used to study other Nox proteins, thereby presenting a severe limitation for 
physiological and pathophysiological studies of Nox5.  
 
Other Sources of Reactive Oxygen Species 
In addition to NADPH oxidase, xanthine oxidase and endothelial nitric oxide synthase, 
although contributing less to vascular ROS formation, have also been extensively studied, and 
therefore will be briefly introduced in the following paragraphs. 
Xanthine oxidase (XO), an enzyme found in abundant amounts mainly in ECs and 
epithelial cells [144] but absent from SMCs, is a molybdoenzyme that uses xanthine and 
hypoxanthine as reducing substrates and yields both superoxide and hydrogen via 1- and 2-
eletron reduction of molecular oxygen [145]. XO and xanthine dehydrogenase (XDH) are often 
collectively referred to as xanthine oxidoreductase (XOR). XDH is initially synthesized as a 150-
kDa protein from which XO is derived, either reversibly by conformational changes or 
irreversibly by proteolysis [146]. Under basal conditions, the majority of 150-kDa protein 
contains XDH activity. Reversible formation of XO from XDH is achieved by the oxidation of 
cysteine 535 and 992, a process that changes enzymatic function but not molecular weight [147]. 
The irreversible proteolysis of XDH occurs at a specific site, leading to the formation of a 130-
kDa form of XO, which can be further proteolyzed into smaller proteins with XO activity. 
However, the mechanisms responsible for either the irreversible or the reversible conversions of 
XDH to XO remain incompletely understood. A recent study shows that hydrogen peroxide may 
modulate the irreversible conversion of XDH to XO in a calcium-dependent manner, suggesting 
that stimulation of XDH to XO may represent a feed-forward mechanism for ROS self-
propagation [144].  
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The second source of vascular ROS production that has received substantial attention is 
endothelial nitric oxide synthase (eNOS), which is the enzyme primarily responsible for NO 
production.  eNOS is a cytochrome p450 reductase-like enzyme that requires tetrahydrobiopterin 
(BH4) as cofactor to transfer an electron to L-arginine to generate NO under normal 
physiological conditions [22]. However, in the absence of either L-arginine or BH4, eNOS can 
produce superoxide and hydrogen peroxide [148]. This phenomenon has been referred to as 
“NOS uncoupling”, and has been demonstrated in several studies with the purified enzyme as 
well as in vivo experiments [149-151]. The mechanisms of eNOS uncoupling in vivo remain 
unclear. One possibility is via peroxynitrite, the product of the reaction between nitric oxide and 
superoxide, since peroxynitrite has been shown to be able to oxidize BH4, thus leading to 
uncoupling of eNOS in vivo [152]. 
 
1.2.3 Oxidative Stress and Vascular Diseases 
Oxidative stress is a condition characterized by an imbalance in redox state where pro-
oxidants overwhelm anti-oxidant capability [19]. Overproduction of ROS (arising either from 
mitochondria or excessive stimulation of NADPH oxidase) can result in oxidative stress, a 
deleterious process that can damage cell structures, including lipids, proteins, and DNA [3, 20, 
22]. An increasing body of evidence suggests that oxidative stress and associated oxidative 
damage are mediators of vascular injury and inflammation in many cardiovascular diseases [22-
24], including hypertension, hypercholesterolemia, atherosclerosis, and heart failure. Two of 
them, namely, hypertension and atherosclerosis, are discussed in greater detail as examples in the 
following.  
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Hypertension is a chronic cardiac  condition in which the systemic arterial blood 
pressure is elevated [153].  Persistent hypertension is a leading risk factor for stroke, myocardial 
infarction, heart failure and arterial aneurysms, and a significant cause of chronic kidney failure. 
Evidence in animal models suggests that oxidative stress is increased in hypertension and that 
treatment with antioxidants or agents that inhibit NADPH oxidase-driven generation of ROS 
reduces, and may even prevent, blood pressure elevation in hypertensive animals [26, 154, 155]. 
A characteristic of hypertension is hypertrophy of large vessels [153]. Several studies have 
demonstrated that AngII-induced hypertrophy of SMCs is dependent on intracellularly produced 
H2O2, which is derived, at least partially, from a Nox enzyme [84, 156, 157]. AngII-induced 
hypertrophy can be inhibited by diphenyleneiodonium (DPI), a NADPH oxidase inhibitor [84], 
attenuation of Nox activity by transfection of antisense p22phox [156], and catalase over-
expression [157].  
Atherosclerosis is a chronic inflammatory syndrome of large- and medium-sized arteries 
that is characterized by a formation of atherosclerotic plaques consisting of necrotic cores, 
calcified regions, accumulated modified lipids, inflamed SMCs, ECs, leukocytes, and foam cells 
[158, 159].  These features of atherosclerotic plaques illustrate that atherosclerosis is a complex 
disease, and many components of the vascular, metabolic, and immune systems are involved in 
this process. Experiments and clinical studies have shown accumulated evidence for the fact that 
many aspects of this process are known to be redox sensitive; examples include endothelial 
activation, oxidative modification of lipids, the recruitment of leukocyte, macrophage and 
VSMCs into atherosclerotic plaques, and VSMCs proliferation. In humans, higher expression of 
NADPH oxidase subunit proteins is associated with increased superoxide production and 
severity of atherosclerosis [24].  
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Disturbed blood flow dynamics is believed to be one of the pertinent factors determining 
the localization of developing plaques, which preferentially occur in the branched or curved 
regions of arteries [160]. Emerging evidence suggests that oscillatory shear stress (OSS), which 
is usually generated on ECs in these branched or curved regions of arteries, is an essential 
regulator [158, 161, 162]. OSS, as a potent pro-atherogenic factor, can stimulate monocyte 
adhesion by inducing one of the earliest measurable markers of atherogenesis, namely, 
intercellular adhesion molecule 1 (ICAM-1). Both in vitro and in vivo experiments have 
suggested the same underlying mechanism with which OSS induces inflammation, namely by 
activating endothelial NADPH oxidase and enhancing endothelial ROS production [101, 163]. 
This mechanism points to the specific and important role of OSS in leading to rapid and robust 
atherosclerosis development.  
Based on experimental evidence and clinical studies that oxidative stress plays a key role 
in vascular damage, there has been great interest in developing strategies that target ROS in the 
treatment of hypertension and other cardiovascular diseases. However, although treatment with 
antioxidants has been found to be effective in experimental models of hypertension as well as in 
small clinical studies [164, 165], data from large clinical trials have been disappointing [166, 
167]. One possible reason for this poor response to antioxidant vitamins may be related to the 
low doses of the compounds reaching the sites in which they are needed at the appropriate 
moment. An alternative potential therapeutic target to ROS is its primary vascular source - 
NADPH oxidase. Although interesting studies of using peptide-based inhibitors (like PR-39) of 
NADPH oxidase have shown to be useful for experimental interventions [168, 169], utilization 
of these peptides as clinical therapeutics still has a long way to go because the peptides cannot be 
effectively administered orally, and therefore, may have limited efficacy.  
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1.2.4 Regulatory Mechanisms of Vascular Reactive Oxygen Species and Implications 
Under normal physiological condition, ROS molecules operate at low, but measurable 
concentrations in the cell [1]. Their steady-state concentrations are determined by the balance 
between their production rates and the rates of removal by various antioxidants. In recent years, 
the term “redox state” has not only been used to describe the state of a redox pair, e.g., 
glutathione disulfide (GSSG)/2 glutathione (GSH), but also to describe more generally the redox 
environment of a cell [170, 171]. Usually, the redox state of a cell is kept within a narrow range 
under normal conditions. Any significant disturbance of the current “redox balance” may lead to 
small and temporary “oxidative bursts,” which in turn may activate intracellular redox sensitive 
signaling cascades [21]. This disturbance can be caused either by an increase in ROS formation 
upon stimulation of extracellular cytokines, growth factors, and hormones, or by a decrease in 
the activity of antioxidant systems. The literature concerning the latter mechanisms is outside the 
scope of this dissertation and has been reviewed by others in detail [1-3]. The aim of the 
following brief review is to provide insights into the mechanisms associated with regulating ROS 
production.  
Regulation of endogenous ROS formation occurs in multiple levels and through different 
mechanisms. First, NADPH oxidase, a primary source of endogenous ROS, is itself subject to 
feedforward and feedback regulation. In VSMCs, NADPH oxidase-derived H2O2 is capable of 
activating NADPH oxidase via a cSrc-dependent signaling pathway, thereby amplifying ROS 
production and contributing to its long-lasting pathological effects [38]. In contrast, Rac1-
dependent NADPH oxidase activation and subsequent O2·- production in ECs mediates a negative 
feedback loop leading to increased proteosomal degradation of Rac1, which may then down-
regulate Nox enzyme activity [172].  
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Except for signaling-based regulatory mechanisms, ROS can also amplify its production 
via modulating protein expression on a longer time scale. In endothelial cells, H2O2 was found 
capable of up-regulating p22phox expression, an essential component for NADPH oxidase 
activation [173]. In VSMCs, AngII-induced ROS increases occur in two phases. The first phase 
is transient and due to an acute activation of NADPH oxidase by AngII, while the second 
depends on the initial burst and is a consequence of upregulation of different NADPH oxidase 
subunits. For example, in VSMC, the sustained phase of ROS production is preceded by 
upregulation of Nox1 mRNA [37, 103], p22phoxmRNA and protein [104, 105], and p47phox 
protein. 	  
NADPH oxidase-derived ROS can also promote their own production from other sources, 
thereby further amplifying total production. First, several studies have found that NADPH 
oxidase-derived ROS can promote the oxidative degradation of the essential eNOS cofactor BH4, 
thus leading to eNOS uncoupling and superoxide (rather than NO) generation [174]. The 
potential role of eNOS uncoupling has been supported by in vitro BH4 restoration experiments, 
as well as in human studies with BH4 precursor treatment [152, 175]. Second, in ECs, oscillatory 
shear stress (OSS) induced activation of NADPH oxidase lies upstream of xanthine oxidase-
dependent production of H2O2, which has been shown to modulate the irreversible conversion 
(oxidative conversion) of XDH to XO [60]. Third, extra-mitochondrial H2O2 can induce 
mitochondrial DNA damage, destroying respiratory enzymes to produce ROS [176]. Finally, 
transferrin receptor-dependent endothelial iron uptake is augmentable by H2O2, amplifying 
intracellular H2O2 formation to induce apoptosis [177]. Mitochondrial iron uptake can also be 
upregulated by H2O2 [178].  
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Thus, ROS, originally generated by vascular NADPH oxidase, can propagate their own 
production via enhanced NADPH oxidase activity and subunit protein expression, intracellular 
iron uptake, formation of xanthine oxidase, uncoupled eNOS, and damaged mitochondria; the 
mechanisms are schematically depicted in Figure 1.2. These feedforward mechanisms form a 
vicious cycle that amplifies and sustains endogenous ROS production in large quantities, 
contributing to pathological signaling. All these mechanisms together render the generation of 
any initial burst of ROS, mainly due to vascular NAPHD oxidase activation upon extracellular 
stimuli, extremely important and worthy of further investigation.  
 
Figure 1.2 Schematic representations of regulatory mechanisms affecting vascular ROS. 
Regulation of vascular ROS formation occurs in multiple levels and through different mechanisms. M1: NADPH 
oxidase self-regulation through either signaling-based mechanisms or modulation of gene or protein expression; M2: 
NADPH oxidase-based ROS propagation through eNOS uncoupling; M3: NADPH oxidase-based ROS propagation 
through XO formation; M4: NADPH oxidase-based ROS propagation through mitochondrial damage; M5: NADPH 
oxidase-based ROS propagation through iron uptake. 
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1.3 Modeling Approaches 
Modern techniques in molecular biology have enabled the generation of comprehensive 
data sets that have greatly benefited the field of computational system biology. With the 
availability of various kinds of experimental data, qualitative or quantitative, static or dynamic, 
at multiple time and organizational scales, numerous computational and mathematical modeling 
approaches have been proposed, developed, and applied to a variety of aspects of biological 
systems. Some of these have proved to be very successful and thus been widely utilized to 
different biological systems.  These approaches include stoichiometric models [179-182], which 
describe metabolic pathway systems with a focus on their time-invariant stoichiometry and are 
frequently used to determine the flux rates throughout a network. Among these approaches, flux 
balance analysis (FBA) uses the property of stoichiometry but adds constraints that permit the 
identification of feasible or optimal flux distributions [182].  
Another class of successful models contains kinetic models. In contrast to stoichiometric 
representations, these kinetic models require detailed information about the biochemical features 
of the metabolic reactions of interest. The best-known representative models in this category 
include the Michaelis-Menten and Hill rate laws and the mass action rate law.  
Between stoichiometric and kinetic models, canonical models are a good compromise, 
especially as a default for setting up models for ill-characterized systems. Canonical models 
capture the system dynamics with sufficient kinetic information while keeping the mathematics 
simple. Therefore, it is often beneficial, especially at the beginning of a modeling effort, to 
search for a canonical nonlinear model whose structure is fixed and whose individuality comes 
from its parameter values. Arguably the most promising canonical nonlinear models in 
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computational system biology are S-systems and Generalized Mass Action (GMA) systems 
within the Biochemical Systems Theory (BST) [183-187], which will be introduced in detail in 
the following.  
1.3.1 Biochemical Systems Theory (BST) 
Biochemical Systems Theory (BST) was originally designed for studying the dynamics 
and other features of biochemical and gene regulatory systems, but is not restricted to these 
application areas in terms of its mathematical foundation. The basic tenets of BST are quite 
simple. In a nutshell, the dynamics of each dependent variable is given by an ordinary 
differential equation (ODE), which describes the change over time as it is governed by processes 
that affect this variable. The mathematical descriptions of these processes are constructed by 
approximating their associated fluxes with products of power-law functions. In the S-system 
formalism, each ODE has a particularly simple format: The change in a dependent variable is 
given as one set of influxes (called α-term) minus one set of effluxes (called β-term), and each 
set is collectively written as one production of power-law function. As the result, the ODE for a 
specific dependent variable Xi is given as follows: 
.                                                (1.1) 
Here, Xi is the dependent system variable, and  is its derivative. The products generically run 
to n+m. The first n variables refer to dependent variables, whereas the remaining m variables are 
independent variables, which have an effect on the system but are not affected by the system. A 
typical example is a constant enzyme activity. The non-negative number αi  and βi are rate 
constants, which quantify the turnover rate of the production or degradation, respectively. The 










real-valued numbers gij, and hij are kinetic orders that reflect the strengths of the effects that the 
corresponding variable Xj have on a given flux term. A positive value signifies an activating or 
augmenting effect exerted by Xj, a negative value indicates an inhibitory effect, and a zero value 
implies that the corresponding variable Xj has no effect on a given flux.  
In the GMA format, instead of aggregating all influxes and all effluxes into one term, 
each flux is approximated individually with one power-law term such that the derivative of a 
specific dependent variable Xi is given as follows: 
.     (1.2) 
Here, the rate constants γik are non-negative and the kinetic orders fijk are real-valued as in the S-
system format. It should be noted that differences between these two formulations only exist at 
branch points, whereas all other steps are represented identically.  
BST models have a number of important advantages that have been discussed in detail 
[183-186]. Among the beneficial features, four particularly useful properties are summarized 
here: First, BST models are rich enough in structure to capture any nonlinearity including 
complex oscillations and chaos. Second, the highly structured format of BST models facilitates 
mathematical, computational, and simulation-aided analyses. These analyses include 
computations associated with steady states, sensitivity, stability, as well as dynamic features. 
Third, BST models are characterized by a one-to-one relationship between parameters and 
structural features. Thus, the interpretation of identified parameters is explicit and immediate. 
Finally, the homogenous structures of BST models are more or less size independent, and 
therefore allow the same type of analyses and diagnostics. These models have been shown to be 
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successfully applicable not only in the context of metabolic pathways, but also in modeling 
numerous other kinds of biological systems, including genetic networks, multi-level systems, and 
cell signaling [188-190].  
 
1.4 Dissertation Overview 
In spite of the considerable amount of experimental studies that have been conducted in 
the field, the exploration of the underlying regulatory mechanisms of the Nox1 system and its 
subsequent ROS formation in vascular cells is incomplete and unclear. Many open questions 
remain that have not been addressed, and it will be hard to answer them with purely experimental 
methods. Therefore, in order to improve our understanding, the objective of this research is to 
investigate how Nox1 activity and its subsequent reactive oxygen species (ROS) production are 
differently and dynamically regulated by distinct extracellular stimuli in vascular system by 
using computational and modeling methods. Two specific cell types, namely endothelial cells 
(ECs) and vascular smooth muscle cells (VSMCs), are used as “templates” to demonstrate and 
compare the differences in Nox1 regulatory mechanisms. Furthermore, two distinct extracellular 
stimuli, namely mechanical shear stresses and hormones like angiotensin II (AngII), are 
respectively treated as representative Nox1 activators in each cell. In Chapter 2, the shear stress-
induced and Nox1-mediated mechanotransduction system in ECs is investigated in detail (as 
proposed in Specific Aim 1). In Chapter 3, the function and design of the Nox1 system in 
VSMCs is explored and four potential disassembly mechanisms of Nox1 are proposed and 
analyzed according to different user-defined criteria (as proposed in Specific Aim 2). In Chapter 
4, the AngII-stimulated Nox1 activation and its subsequent ROS production in VSMCs are 
studied and the features of Nox1 disassembly mechanisms in stimulated cells and overall system 
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dynamic responses are discussed (as proposed in Specific Aim 3). An overview of chapters and 
appendixes is shown in Table 1.1. Chapter 5 contains conclusions and suggestions for future 
work. 
 
Table 1.1 Dissertation overview. 
Chapter Content Related Appendixes 
2i System Analysis of the Role of Bone Morphogenic 
Protein 4 in Endothelial Inflammation 
APPENDIX A 
3ii Function and Design of the Nox1 System in Vascular 
Smooth Muscle Cells 
APPENDIX B 
4iii Dynamic Analysis of Angiotensin II-Induced Nox1 
Activation in Vascular Smooth Muscle Cells 
APPENDIX C 
5 Conclusions and Future Work  
i.  Adapted from: Yin, W., Jo, H., Voit, E.O. “Systems Analysis of the Role of Bone Morphogenic Protein 4 in 
Endothelial Inflammation”, Annals of Biomedical Engineering, 38:2, 291-307, 2010.  
ii. Adapted from: Yin, W., Voit, E.O. “Function and Design of the Nox1 System in Vascular Smooth Muscle Cells”, 
(submitted), 2012.  
iii. Adapted from: Yin, W., Voit, E.O. “Dynamic Analysis of Angiotensin II-Induced Nox1 Activation in Vascular 




SYSTEMS ANALYSIS OF THE ROLE OF BONE MORPHOGENIC 
PROTEIN 4 IN ENDOTHELIAL INFLAMMATION1 
 
2.1 Introduction  
Atherosclerosis is a chronic inflammatory response that is characterized by the hardening 
of arteries and loss of their elasticity [158, 159]. Its hallmark is the formation of atheromatous 
plaques consisting of macrophages, smooth muscle cells, cholesterol crystals and calcification 
within vascular smooth muscle cells.  Disturbed blood flow dynamics is believed to be one of the 
pertinent factors determining the localization of developing plaques, which preferentially occur 
in the branched or curved regions of arteries[160]. When blood flows through an artery, 
endothelial cells are subjected to several mechanical forces. Among these, shear stress is 
believed to be the most important. This tangential frictional force is caused by blood flowing 
along the walls of the vessel and constitutes an important signal to the endothelial cells lining the 
arterial wall [191, 192]. Straight sections of the arteries are exposed to relatively unidirectional, 
high-level laminar shear stress (ULS) and are typically lesion-free. By contrast, the complex 
arterial geometry and pulsatile blood flow during the cardiac cycle cause disturbed, turbulent 
flow conditions with low shear in branched and curved regions of the arteries, and these tend to 
be lesion-prone [191, 192]. For investigations in vitro, these complicated flow patterns at arterial 
                                                
 
 
1 Adapted from: Yin, W., Jo, H., Voit, E.O. “Systems Analysis of the Role of Bone Morphogenic Protein 4 in 
Endothelial Inflammation”, Annals of Biomedical Engineering, 38:2, 291-307, 2010. 
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branches are mimicked with experimental set-ups that repeatedly change the direction of blood 
flow, thus yielding oscillatory shear stress (OSS) [193-195].  
 Emerging evidence suggests that shear stress is an essential regulator of inflammatory 
responses in endothelial cells, and thus in the critical early phase of atherogenesis [158, 161, 
162]. OSS is a potent pro-atherogenic factor that can stimulate monocyte adhesion by inducing 
one of the earliest measurable markers of atherogenesis, namely expression of the Inter-Cellular 
Adhesion Molecule-1 (ICAM1) [162, 196].  In contrast, ULS is atheroprotective and has been 
shown to suppress ICAM1 as well as Vascular Cell Adhesion Molecule-1 (VCAM1) expression. 
The mechanisms with which OSS and ULS exert opposite roles in inflammation and 
atherosclerosis have so far remained unclear, even though they have received intense attention. 
Some studies suggest that the opposite effects of OSS and ULS are likely mediated through 
differential expression of several specific genes and proteins in each condition [193, 195, 197, 
198]. Among these, DNA microarray studies and subsequent functional studies have identified 
the recently discovered mechanosensitive gene product Bone Morphogenic Protein 4 (BMP4) as 
a potent inflammatory cytokine[195].  
The role of BMP4 in mechanosensing is complicated, as the protein acts in concert with 
numerous other known components of the inflammatory response, including reactive oxygen 
species, NADPH oxidase, and the signaling molecule NFĸB. These components interact in a 
complicated fashion and on different time scales, which renders intuitive cause-and-effect 
argumentation problematic. To shed light on the systemic nature of the mechanosensitive 
response to different stresses, we have in the present work developed a dynamic mathematical 
model that allows us to merge all pertinent information into a computational structure that 
permits easy interrogation, analysis, diagnostics, scenario simulations, and analyses that are 
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different and complementary to experimental approaches. The model is the first of its kind. It is 
mainly constructed within the framework of Biochemical System Theory (BST) [184-186, 199], 
but extended to permit the account for time delays. At this point, the model is obviously not 
complete but captures experimental findings quite well qualitatively and semi-quantitatively. 
 
2.2 Materials and Methods 
2.2.1 Overview of Model Structure  
The shear stress response system consists of numerous genes, proteins and biochemical 
molecules. Those believed to be most important are reviewed in this section.  
BMP4 
Bone morphogenic protein 4 (BMP4) is a potent inflammatory cytokine that is 
synthesized from a 408 amino acid precursor, proteolytically cleaved in the Golgi apparatus, and 
secreted as active protein [200]. Its activity is counterbalanced by secreted antagonists, such as 
noggin, follistatin and matrix Gla protein (MGP), which have been found to be co-expressed 
with BMP4 in cultured endothelial cells [201, 202]. Binding of BMP4 to its antagonists prevents 
it from binding to the cognate receptor and thus blocks BMP4 induced signaling. Cell culture 
studies have shown that BMP4 expression is stimulated by OSS and inhibited by ULS [101, 
195]. Treatment of cultured endothelial cells with BMP4 alone leads to similar responses as 
OSS, including increased ICAM1 expression and monocyte adhesion [195]. Furthermore, OSS-
induced endothelial inflammatory responses can be completely blocked by treating the cell with 
sufficient amounts of the BMP4 antagonist noggin or upon administration of BMP4-siRNA 
[195]. Opposite to our initial expectation, however, ULS tends to decrease BMP4 antagonist 
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expression, while OSS up-regulates it [201]. This up-regulation may be accomplished through 
both BMP4–dependent and –independent mechanisms, which would reveal a novel negative 
feedback regulation of the action of BMP4 under shear stress. These and other studies strongly 
indicate the important, essential, and specific role of BMP4 in shear-dependent inflammation, 
which is a key feature of atherosclerosis.   
Reactive Oxygen Species 
Reactive oxygen species (ROS) have been implicated in many cardiovascular diseases including 
atherosclerosis and hypertension and play an essential role in many intracellular signaling 
pathways that ultimately lead to changes in gene transcription, protein synthesis and, 
consequently, cell function [5, 11, 12, 203]. Under physiological conditions, ambient production 
of ROS occurs at low concentrations, which are necessary for endothelial cell growth and 
proliferation [18, 204]. However, under pathological conditions, large quantities of ROS are 
produced, resulting in a mismatch between ROS formation and the ability of antioxidants to 
degrade them, which subsequently leads to a state of oxidative stress [11]. ROS were discussed 
in Chapter 1 of this dissertation.  
NADPH Oxidase 
NADPH oxidase has been identified as an important player in the shear-induced inflammation in 
endothelial cells [42, 80, 196]. Its chemical and function features were already discussed in 
Chapter 1 of this dissertation. 
 Of note here is that, in addition to humoral factors, which were discussed before, 
physical factors like shear stress and pulsatile stretch can stimulate NADPH oxidase activation as 
well [42, 80].  
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Specifically, shear stress has been shown to be able to stimulate endothelial NADPH 
oxidase activation by quickly enhancing the amount of phosphorylated p47phox through a PKC-
dependent pathway [205]. A recent study in vitro furthermore suggests that shear stress can 
regulate the activity of NADPH oxidase via a BMP4-dependent mechanism [101, 196]. Short-
term (1h) and long-term (18~24h) exposures to OSS have been shown to increase O2- production 
in cultured endothelial cells to a similar level. Compared with OSS, ULS induces a similar 
transient increase in the short term but the opposite long-term effect in terms of superoxide 
production. While both Nox1 and Nox2 are activated by OSS, only Nox1 expression was shown 
to be induced by BMP4[101, 128], suggesting that Nox1 may be the NADPH oxidase that 
mediates the OSS- and BMP4-dependent response.  
NFκB 
As a downstream signaling target and very important transcription factor, Nuclear Factor ĸB 
(NFĸB) has been suggested to participate and play an essential role in OSS-induced monocyte 
adhesion [195, 206]. Although the mechanism is not completely clear, hydrogen peroxide is 
believed to be the upstream molecule that initiates the signal to degrade the inhibitors of NFĸB 
(IκB) and release active NFĸB, which can then translocate to the nucleus to mediate expression 
of a wide array of genes that participate in inflammation and immune processes[101]. ICAM1 
has been shown to be one of these targets[207].  
Interactions within the Mechanosensitive Response System 
The collection and interpretation of numerous results and observations, obtained with extensive 
series of experiments, have suggested the following mechanism for BMP4-triggered 
mechanotransduction [42, 80, 101, 195, 196]. OSS induces inflammation and early markers of 
atherosclerosis in endothelial cells by triggering mechanisms that involve the stimulation of 
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BMP4 expression, which in turn enhances the activity and expression of p47phox-dependent 
NADPH oxidases, including Nox1, in an autocrine-like manner. The OSS induced activation of 
NADPH oxidase enhances the production of reactive oxygen species (ROS), up-regulates 
ICAM1 expression and activation of the transcription factor NFĸB, and strengthens monocyte 
adhesion to endothelial cells, a critical step in atherogenesis. In contrast to OSS, ULS was shown 
to inhibit BMP4 expression, thus inducing the opposite effect. Intriguingly, both types of shear 
stress are able to induce an acute increase in superoxide production during an exposure of one 
hour, but induce opposite effects on superoxide production for much longer exposure [196]. The 
processes constituting BMP4-triggered mechanotransduction are schematically presented in 
Figure 2.1.  
Although this pathway has been well characterized and tested experimentally [101, 195], 
several questions remain unanswered. For instance, why do OSS and ULS induce similar short-
term effects but different long-term effects with regard to superoxide production? How does the 
activity of NADPH oxidase dynamically change in response to a specific external stimulus such 
as shear stress? And how do the various regulatory mechanisms, which govern the expression of 
all subunits, dynamically cooperate to effect the overall changes in NADPH oxidase activity and 
the subsequent production of ROS? These types of questions are difficult to answer solely with 






Figure 2.1 Simplified schematic representation of the BMP4-triggered system of shear-dependent 
inflammation in endothelial cells. 
 
2.2.2 Modeling Framework 
The work presented here consists purely of mathematical and computational modeling. 
The primary goal of the modeling effort is to translate the BMP4-dependent inflammatory 
pathway (Figure 2.1), triggered by shear stress, into a mathematical structure that permits 
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diagnoses and analyses and yields insights into the cooperation among the different components 
of the system. 
Very few, if any, of the processes governing the mechanotransduction system in Figure 
2.1 are known in sufficient depth to allow the formulation of mechanistic, mathematical 
representations. This situation is quite typical for biological phenomena that include gene 
expression, signaling, and metabolic conversion and suggests the use of concept modeling [208] 
with canonical models that are well suited as default representations of systems composed of ill-
characterized components. Specifically, we use the modeling framework of Biochemical Systems 
Theory (BST; [184-187, 199]), which was discussed in Chapter 1 of this dissertation. A 
particular advantage of BST is a set of guidelines for setting up models for diagrams as the one 
shown in Figure 2.1. Namely, a differential equation is formulated for each component 
(dependent variable) that varies over time. This equation consists of all processes or fluxes 
producing or degrading this component. The processes are modeled as products of power-law 
functions, which are based on the rigorous foundation provided by Taylor’s theory of numerical 
analysis [209].  
 While the translation of a diagram such as Figure 2.1 into model equations is 
straightforward, the severe difficulty of the model design step is the identification of appropriate 
numerical values for all rate constants and kinetic orders. This parameter identification heavily 
depends on the availability and quality of the supporting data, other biological information, and 
on educated assumptions. Particularly useful for these estimation purposes are time series data, 




2.2.3 Available Data and Model Assumptions 
Data 
Few of the data are available as time-series or even truly quantitative. Instead, most are given as 
singular values or extents that are relative to a control level, which is usually assumed to be 
measured under static no-flow conditions. Much information is semi-qualitative and of the type 
“24 hours after onset of OSS variable X increases several fold over control.” Variables like 
mature BMP4, Nox1, active NFĸB and ICAM1 have been characterized through these types of 
data [101, 195]. Measurements of superoxide and hydrogen peroxide are given by their specific 
product concentrations, which can be recalculated into ratios over control [60, 101, 196]. 
Additional information extracted from p47phox knockout experiments [196] and treatments with 
BMP4 or BMP4 antagonist [195] is qualitative and of the type “variable X significantly 
increases/decreases in comparison with the control under this specific treatment”. Shear stresses 
with different patterns and intensities are added to the system as external stimuli. Among these, 
ULS typically has a range of 5~15 dyn/cm2, while OSS has been investigated at only one 
intensity of 5 dyn/cm2.  
Accounting for the primarily semi-qualitative nature of the available data, most model 
variables are assumed to have their steady state at the “normal” numerical value of 1 (100%). 
Phosphorylated p47phox is assumed to have a steady state of 0.2, which corresponds to one fifth 
of the available Nox1 at steady state under control conditions. Obviously, these numerical values 
are quite crude. However, since essentially all model results are expressed as relative results, the 





By design, the proposed GMA model of the diagram in Figure 2.1, which was constructed under 
the guidelines of BST [210], includes the following key components: BMP4-mRNA, BMP4-
precursor, mature BMP4 protein, BMP4 antagonist, BMP4 and BMP4 receptor (BMP4/R) 
complex, Nox1-mRNA, Nox1-protein, the free phosphorylated form of p47phox, active NADPH 
oxidase, superoxide, hydrogen peroxide, nitric oxide, active NFĸB and ICAM1 expression. Shear 
stress is treated as an independent variable; i.e., it affects the system but is not affected by it. 
Interactions and connections between variables are entered into the model equations according to 
the biological observations as they are diagrammed in Figure 2.1. Thus, two major assumptions 
for this prototype model are that Figure 2.1 is sufficiently comprehensive to gain interesting 
insights and that the power-law representation is sufficiently adequate for semi-quantitative 
explanations and predictions. 
As an initial simplification, we do not consider all known subunits of NADPH oxidase 
individually, but focus on the two most pertinent subunits, namely Nox1 as the representative of 
the transmembrane form and p47phox as the representative of the cytosolic form. This assumption 
appears to be reasonable because other subunits are either not significantly regulated by shear 
stress or do not strongly affect the pathways of interest here [101]. Furthermore, the total amount 
of free unphosphorylated and phosphorylated forms of p47phox is assumed to be constant due the 
fact that the amount of the cytosolic component should be of the same or similar magnitude as 
the amount of the transmembrane component under normal conditions (without external 
stimulus).  
NADPH oxidase and xanthine oxidase are considered to be the only representatives of 
sources for superoxide production. This assumption ignores the contributions of other sources 
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that were discussed in Chapter 1 [5, 11], like mitochondrial, cytochrome P450 and uncoupled 
eNOS, presuming their expression and contribution to superoxide production to remain 
unchanged or to change only insignificantly in response to shear stress. Furthermore, we 
presume that the substrate NADPH is not limiting the enzymatic reaction rate and that the 
concentration of NADPH is about the same under different shear stress conditions. As a 
consequence, NADPH can be treated as a constant, independent variable that can be merged 
mathematically with the appropriate rate constants.   
Some experiments have suggested that long exposure of endothelial cells to shear stress 
could possibly affect the expression of relevant enzymes [80, 197, 211-214], including the 
enzymes catalyzing the conversion of superoxide to hydrogen peroxide (e.g., SOD) and the 
degradation of hydrogen peroxide (e.g., catalase, glutathione peroxidase, thiol peroxidase). In 
this initial phase of model development, we assume that the expression and activities of all 
enzymes in the corresponding reactions remain constant. We plan to consider their effect and 
regulation by shear stress in the future (see Discussion in section 2.4).  
The system under investigation contains several organizational levels, including gene 
transcription, translation into protein, and enzyme-catalyzed biochemical reactions. These 
processes operate at distinct time scales, which are at the order of minutes, seconds or even less 
for biochemical reactions, but hours for gene transcription and protein synthesis. As an 
indication of these differences, the level of BMP4-mRNA was significantly decreased after ~2h 
exposure to ULS, but protein expression of BMP4 was first observed ~10h after oscillatory shear 
stress applied [195], thus suggesting a significant time delay during protein synthesis. At the 
other end of the spectrum, the reaction rate of nitric oxide and superoxide has been measured to 
be approaching the diffusion limit [7]. Since we are primarily interested in the activity of the 
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system as a whole, which occurs at a relatively slow time scale of hours, we initially ignore 
dynamic changes happening at much faster time scales (of minutes, seconds, or faster). This 
separation of time scales is a common strategy in modeling [215] and allows us to consider fast 
reactions, like conversions between superoxide and nitric oxide, and between superoxide and 
hydrogen peroxide, always to be in a steady state and therefore constant. To address the 
relatively slow generation of new proteins, the de novo appearance of BMP4 precursor, BMP4 
antagonist, Nox1, and ICAM1 is modeled with appropriate time delays. 
 As indicated in the system diagram (Figure 2.1), shear stress affects the system 
simultaneously through two distinct pathways. One is mediated through the delayed BMP4- and 
BMP4 antagonist-associated pathway, while the other is hypothesized to occur through 
phosphorylation of p47phox. Details and specifics of the signaling pathway with which shear 
stress regulates BMP4-mRNA and BMP4 antagonist are still unclear. Therefore, we simply use a 
power law function with the format  to represent the strength of the signal. S represents the 
shear stress intensity and fi = 1, 2 represents the effects of shear stress on BMP4 mRNA and 
BMP4 antagonist expression separately, namely:  
  .         (2.2) 
Moreover, in order to indicate the protein synthesis of BMP4 antagonist, one time delay is 
artificially added to the corresponding pathway.   
 The effect of the signal for the second pathway is assumed to decay exponentially, 
because of two reasons. One is that the amount of phosphorylated p47phox was detected to 
increase significantly at time t=2 min (2 min can be ignored in our slow time-scale system) after 
















functions (constant, exponentially decaying function, burst signal function) that we explored in 
simulations (results not shown), the simulation results for an exponentially decaying function 
best matched the experimental observations.  Therefore, an exponentially decaying function is 
used in the current simulations until more experimental measurements are available.  
2.2.4 Model Design 
Model Equations 
Based on Figure 2.1 and incorporating the assumptions outlined above, we constructed a set of 
ordinary differential equations in GMA format and extended it by accounting for four time 
delays (τ1, τ2, τ3 andτ4)  associated with the synthesis of BMP4 precursor, BMP4 antagonist,  
Nox1 and ICAM1. The time delays were modeled as shown in [216]. The resulting equations are 
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42 
Here, S and P represent the intensity of shear stress and the signal of shear stress acting on the 
phosphorylation of p47phox, respectively. The constant C represents the total amount of free 
unphosphorylated and phosphorylated forms of p47phox. The parameters γi and gi are rate 
constants and kinetic orders, respectively.  The ultimate output of the system is formulated in the 
following equation: 
,            (2.4) 
where is a constant coefficient, representing the binding ratio of free monocyte to ICAM1.  
Parameter Estimation 
Many methods have been developed for the estimation of parameters in BST systems [217-219]. 
Some of them are based on computing kinetic orders and rate constants from information on 
traditional Michaelis–Menten functions while others use techniques of estimation from time-
series data.  In our case, neither mechanistic information nor time series data are available, thus 
forcing us to develop ad hoc methods of parameter estimation. 
We are primarily interested in system behaviors on a time scale of hours, rather than 
questions of what exactly happen in the system within seconds or minutes.  This strategy implies 
that most fast processes will be in a steady state, which permits the exploitation of genuine 
benefits of the BST format. As an example, consider variable , which is modeled with the 
equation 
                    (2.5)  
in which the quantities , , and are the parameters that need to be estimated. If the 
variable is in a steady state, its derivative on the left-hand side of the equation is equal to zero by 
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                    (2.6) 
Logarithmic transformation of this nonlinear equation yields a linear equation in terms of the 
parameters: 
                  (2.7) 
Suppose three scenarios have been assessed experimentally. The first may be a control condition 
with no stimulus, while conditions and  refer to external stimuli 1 and 2. If so,  may 
assume three distinct (or similar) steady states, each of which is characterized by the same linear 
Eq. (2.7). These three equations 
                            (2.8) 
form a linear system where , and  represent the steady-state values of variable  
under the Static control, Oscillatory (OSS) and Laminar (ULS) stress conditions. These equations 
may be converted into the condition 
                             (2.9) 
where , i = 3, 4 and j = O, L represents the ratio of the steady-state values under OSS 
and ULS in relation to the control condition. Thus, even if we do not know the absolute values at 
the steady states, we can still derive a linear relationship between g4 and g7 if we have 
information on how the steady-state value of this variable changes for different stimuli. 
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Consequently, given some positive value for either g4 or g7, we can easily calculate the value of 
the other kinetic order to satisfy all three scenarios. Therefore, for all equations with only two 
terms, we can derive constraint equations (like Eq. (2.9)), assign experience-based default values 
of some parameters [186], and then infer the values of the others through linear constraints. 
Similarly, Eq. (2.7) involves a relationship between γ5 and γ7, which is deduced secondarily from 
g4 and g7. All constraint equations for rate constants and kinetic orders are presented in the 
APPENDIX A. The free choice of a kinetic order may seem to insert undue degrees of freedom, 
but experience with BST systems severely limits the likely values of kinetic orders, which are 
usually in ranges of [0, 2] if they are positive, or [-1, 0] if they are negative [186].  Equations 
with more than two terms or several modulators require similar, but more extensive effort of 
tuning and validating parameter values.  
 
2.3 Results 
The results fall into two categories. The first group describes simulations representing 
observed scenarios. These simulations functionally connect known inputs and outputs and have 
explanatory character by allowing the detailed tracing of events between stress and response. By 
contrast, the second group of simulations consists of analyses that do not directly correspond to 
existing experimental data and characterize the roles of some of the model components on the 
dynamics of the system. These simulations lead to predictions regarding not yet observed 
scenarios and to novel hypotheses. 
 Due to the paucity of quantitative data, all results are presented in relative units, which 
measure the ratio of each variable under different stimulus conditions in comparison to a control 
scenario. This type of assessment is actually directly in line with most observations.   
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All simulations and diagnoses were executed in MATLABR2007a. Parameter values, 
including , and , constants and initial conditions (see details in APPENDIX A) are always 
the same except if indicated differently in the corresponding text or figure legend.  
2.3.1 Simulation of Three Experimentally Investigated Scenarios 
In order to elucidate the distinct roles of OSS and ULS, we implemented three scenarios 
that had been investigated experimentally. The general starting point for the simulations was the 
mechanosensitive response system at its control steady state, characterized by static blood 
overlay without shear, and the simulations consisted of applying ULS (15 dyn/cm2 ) and OSS (
5 dyn/cm2), which caused the system to assume different (quasi) steady states. The results are 
shown in the Figure 2.2. The panels in the two top rows show model results (lines) for which 
corresponding experimental data (circles) are available, except for the BMP4/R complex. The 
panels in the bottom row show model results for which no data are available.  
The levels of BMP4 mRNA, BMP4 precursor, mature BMP4, BMP4 antagonist, and 
Nox1-mRNA increase under OSS and decrease under ULS.  Simulations are well consistent with 
time series measurements for mature BMP4 under ULS and for other measurements at t=24h 
[101, 195, 196, 201]. An exception is Nox1-mRNA under ULS: The experimental result 
indicates a non-significant increase of Nox1-mRNA level when ULS is applied, compared with 
the static control level, while the simulation shows a noticeable decrease. The logic of the model 





Figure 2.2. Simulation results of three scenarios. 
Blue Line: static control; Red line: OSS ( 5 dyn/cm2); Green line: ULS (15 dyn/cm2). Lines indicate simulation 
results; dots are experimental measurements. 
 
The processes leading to the production of superoxide appear to be adequately simulated 
as well. Although we have no experimental data for direct comparisons, we can infer their 
performance by investigating the intriguing dynamics of superoxide. After shear stress was 
applied at time t = 0, the amount of superoxide was observed to increase to a similar level for a 
short-time exposure (~1.7 fold of the static level at time  [196]) under both shear stresses, 
but to reach quite different levels for a longer exposures (~1.7 fold under OSS and about one 
third under ULS at time  [196]). The simulation results of superoxide clearly reflect the 
observed similarity in short-term effect and the subsequent discrepancy in long-term effect for 
the two shear stresses. The amounts of superoxide between 1h and 18h were not experimentally 





suggesting a quick drop of superoxide after the initial peak, which may be interpreted as the 
result of fast depletion of the available Nox1 protein. The subsequent climb of superoxide is then 
caused by the increased amount of Nox1 protein, which is induced by OSS through a delayed 
BMP4-dependent pathway. As a consequence, the relative ratio of the initial condition of Nox1 
to p47phox has an effect on the systemic response, and especially on the dynamics of superoxide 
production. Opposite to the OSS situation, superoxide production under ULS drops below the 
control level, although the amount of phosphorylated p47phox stays high. This finding is primarily 
due to the suppression of Nox1 protein by ULS through the same pathway. By varying the 
corresponding parameter values, we could easily change the shape of the dynamic transient to 
some extent. These simulations are, however, futile until more biological observations at 
intermediate time points become available that would allow us to determine parameter values 
with greater precision and reliability.  
The second ROS, H2O2, is also simulated well. As discussed in the Materials and 
Methods section, we assume no self-propagation or complex signaling mechanisms to be 
involved in the model. Instead, the activity of H2O2 is mainly affected by its precursor, 
superoxide, and its own degradation. The kinetics of H2O2 elimination has been investigated in 
endothelial cells of the human umbilical vein in culture [220], where it was shown to be 
composed of two different types of reactions exhibiting a linear and nonlinear dependence on the 
H2O2 concentration. In our simulation, one single degradation term is used instead of two, and 
the corresponding model parameter (g21=1.615) is set between 1 and 2 as a compromise between 
linearity and second-order non-linearity. Similar to superoxide, hydrogen peroxide in the 
simulation is up-regulated roughly two-fold under OSS, but greatly down-regulated under ULS. 
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Nitric oxide, an important antioxidant component, is regulated by shear stress in the opposite 
direction compared with superoxide and hydrogen peroxide.  
 As the downstream signal receiver and target gene respectively, NFĸB activity and 
ICAM1 are also simulated well. Consistent with experimental observations [195], a long-term 
(~24h) simulation reflects an increasing trend for both variables under OSS and a decreasing 
trend under ULS. Experiments seem to indicate no change in ICAM1 expression for the first few 
hours, while the corresponding simulation result suggests an immediate increase in ICAM1. The 
reason for this inconsistency can be traced back to the dynamics of hydrogen peroxide. The 
current model simplifies both the production and degradation processes of hydrogen peroxide, in 
line with the primary purposes of this preliminary model. Therefore, the level of hydrogen 
peroxide increases right after superoxide is increased at the very beginning.  As a consequence, 
the quick increase of hydrogen peroxide leads to the increase of NFKB activity and ICAM1 
expression. 
No quantitative data are available for comparisons of results of the BMP4/R complex and 
the variables in the bottom row of Figure 2.2. Active NADPH oxidase and Nox1 protein appear 
to be reasonable, at least at later times. The simulated concentrations of nitric oxide (NO) also 
reach reasonable levels after some while, although the initial dynamics may not be correct. 
Experimental results [221] seem to indicate that NO production begins to increases quickly upon 
ULS and remains elevated as long as the stress is maintained, whereas the simulation exhibits a 
temporary undershoot. The reason for this initial discrepancy is that the current model assumes 
constant NO production and only a single degradation reaction with superoxide. In reality, NO 
production is subject to genetic and metabolic regulation, as well as various signaling events, 
which are presently not modeled due to the lack of specific data. As a consequence of the 
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simplifications, NO initially decreases in the model under ULS, because ULS induces acute O2- 
production, which consumes more NO than under static control. In a similar fashion, the 
phosphorylated form of p47phox remains high under ULS, because Nox1 is depleted by ULS in 
the model.  
The number of monocytes bound is simulated as the overall output of the system 
according to Eq. (2.4). As shown in the right lower corner in Figure 2.2, long exposure to shear 
stress (for about one day) increases the number of bound monocytes to ~3 fold over control 
during OSS (~3 fold according to experimental measurements[196]) and decreases the number to 
~10% of control during ULS (~50% according to experimental measurements [195]). Given the 
preliminary nature of the model, these results can be considered both qualitatively and semi-
quantitatively consistent with the experimental findings.  
To elucidate the relevance of the shear stress and the BMP4-depdendant mechanosensing 
system further, we applied external shear stress with different intensities and patterns to the 
targeting system.  As Figure 2.3 shows, the simulation results for BMP4 mRNA, BMP4 
precursor, mature BMP4 and Nox1 mRNA are well consistent with both the available time series 
and experimental measurements at one time point (t=24h) [101, 195, 222]. Although the 
simulated results for mature BMP4 under ULS with different intensities are a little bit higher 
than the experimental measurements (comparing the model results and experimental 
measurements for ULS at 5 dyn/cm2 and 15 dyn/cm2), we still can clearly see the trend that ULS 




Figure 2.3. Simulation results of shear stress with different intensities and modalities. 
Lines indicate simulation results; dots are experimental measurements. Black: static control; Red: ULS (5 dyn/cm2); 




2.3.2 Validation Simulations Characterizing the Role of BMP4 under OSS 
Experiments in vitro [195] have shown that BMP4 alone stimulates monocyte binding in 
a dose-dependent manner with a maximal activation of 4 to 7 fold over control. In order to test 
our model by investigating the role of BMP4, we added at time  a bolus of BMP4 to the 
system, which was initiated at the static control steady state. In a series of simulation 
experiments, the size of the BMP4 bolus was varied. The combined results are shown in Figure 
2.4. They suggest that the number of bound monocytes increases in a dose-dependent manner 




fold, which is somewhat smaller than indicated by the experiments. Nonetheless, the qualitative 
trend in this positive correlation is consistent and supports the hypothesis of a strong effect of 
BMP4 on the regulation of monocyte adhesion in endothelial cells. Retro-fitting of the model 
parameter values would make the numerical values more similar, but it is not pursued here in 
light of the preliminary nature of the model and the scarcity of data. 
To elucidate the role of BMP4 in OSS-induced monocyte adhesion further, we added at 
time t=0 a bolus of BMP4 antagonist to the system, which was initiated under static or OSS 
condition. Experimental results [195] have shown that treating cells with a sufficient amount of 
noggin (as a BMP4 antagonist) will completely block OSS-induced monocyte adhesion. As 
shown in Figure 2.5, BMP4 antagonist treatment in the model simulation with OSS greatly 
reduces the number of monocytes bound at time t=24h. Even in the static control scenario, 
treating the system with enough BMP4 antagonist reduces monocyte adhesion, which from a 
different angle illustrates the important role of BMP4 in OSS-induced monocyte adhesion. 
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Figure 2.4. Simulated number of bound monocytes under different BMP4 treatments.  
Solid black line: static control; solid red line: OSS ( 5 dyn/cm2); dashed red line: treatment with BMP4 bolus of 1 
at time t = 0; dashed green line: treatment with BMP4 bolus of 2 at time t = 0; dashed blue line: treatment with 
BMP4 bolus of 4 at time t = 0; dashed magenta line: treatment with BMP4 bolus of 9 at time t = 0; dashed cyan line: 
treatment with BMP4 bolus of 19 at time t = 0; dashed black line: experimentally measured maximum increase (in 
relation to control with BMP4 treatment).  
 
2.3.3 Role of p47phox in the Regulation of NADPH Oxidase Activation by Shear Stress 
As a requisite subunit for Nox1- and Nox2-based NADPH oxidase activation, p47phox plays an 
important role in the regulation of enzyme activity in response to various agonists[205, 223]. In 
order to clarify the specific role of p47phox in shear stress-induced NADPH oxidase activation, 
we artificially blocked the signaling pathway through which shear stress stimulates the 
phosphorylation of p47phox and compared superoxide production with the control case. As shown 
in Figure 2.6 (dashed lines), the normally quick increase of superoxide production during the 




Figure 2.5. Simulated number of bound monocytes with and without BMP4 antagonist treatment.  
Solid black line: static control; solid read line: OSS (±5 dyn/cm2); dashed black line: static control with a BMP4 
antagonist bolus of 2 at time t = 0; dashed red line: OSS (±5 dyn/cm2) with a BMP4 antagonist bolus of 9 at time t = 
0. 
 
longer time horizon remains similar. This finding indicates the potential role of p47phox in the 
quick increase of superoxide production for the first few hours and also provides a possible 
explanation for why both shear stresses seem capable of stimulating superoxide production 
during acute exposure. 
Finally, the system model represents a p47phox knockout quite well. When the p47phox 
gene is knocked out, the amount of its corresponding protein becomes extremely small and 
undetectable by experimental measurements [196]. Obviously, if the available p47phox is entirely 
depleted, the amount of active p47phox -dependent NADPH oxidase approaches zero, and all 
subsequent reactions will stop. However, if the amount of p47phox is not completely zero, but 
drastically reduced (e.g., 30% of the control case), the simulation demonstrates that both 
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superoxide production and monocyte adhesion become very low with an indistinguishable 
amount for OSS, ULS and static control conditions (shown in Figure 2.7), even for exactly the 
same set of parameters. Although OSS and ULS can respectively up-regulate or down-regulate 
the Nox1 subunit through the BMP4-dependent pathway, the integrative effect of shear stress 
acting on the activity of NADPH oxidase is limited, or even blocked, if not enough p47phox is 
available, and this strongly implies the mandatory role of p47phox in the activation of NADPH 
oxidase. Experimental observations [196] indicate that superoxide produced in endothelial cells 
obtained from p47phox-deficient mouse aortas (p47-/- system) is about 50% or less of the amount 
produced by the corresponding p47+/+ system under static condition. Our simulation results 
(Figure 2.7 left panel) point in the same direction but indicate a greater reduction (~20% or less 
of the amount produced by the p47+/+ system) in superoxide. This difference in extent is possibly 
due to the omission of other contributing sources for superoxide production in the current model.   
2.4 Discussion 
Shear stress has been identified as one of the most important factors for the location of 
inflammation and subsequent atherosclerosis [42, 158, 161, 162]. In vitro experiments have 
identified an important cytokine, BMP4, which is involved in shear-induced inflammation in 
endothelial cells and capable of activating endothelial NADPH oxidase, and thus inducing 
ICAM1 expression [42, 101, 195]. In order to investigate the role of BMP4 in the 
mechanotransduction system in greater detail, we have in the present work developed a prototype 
mathematical model. The model was constructed in the GMA format of Biochemical Systems 




Figure 2.6. Simulated superoxide production under different conditions.  
Lines indicate simulation results; dots are experimental measurements. Black line: static control; solid red line: OSS 
(±dyn/cm2); dashed red line: OSS (±5 dyn/cm2) with blocked signal pathway through which OSS otherwise 
stimulates the phosphorylation rate of p47phox; solid green line: ULS (15 dyn/cm2); dashed green line: ULS (15 
dyn/cm2) with blocked signal pathway through which OSS otherwise stimulates the phosphorylation rate of p47phox.  
 
As an important initial step, we focused on the key components and processes of the 
targeted pathway as they are described in Figure 2.1. Due to the paucity (or entire lack) of 
available time-series data and kinetic characterizations of the processes within the system, we 
resorted to a novel ad hoc method of identifying suitable parameter values that was consistent 
with the nature of most of the available data, which report responses in relation to a “normal” 
state.  A few assumptions and simplifications (see details in Materials and Methods section) were 
made to permit a first grasp of the complexity of the mechanosensing system and to allow 
numerical implementation. Time delays accounting for protein synthesis were added to the GMA 
model as a means of handling different time scales. Indeed, it turned out that these delays  
56 
 
Figure 2.7. Comparison of selected simulation results investigating the p47+/+ and p47-/- systems under 
different shear stress conditions.  
In the p47+/+ system, C = 1 and initial condition of p47phosphorylated = 0.2; in the p47-/- system, C = 0.3 and initial 
condition of p47phosphorylated = 0.06.  
 
were crucial because their removal led to irreconcilable inconsistencies between model and data 
(results not shown).  
Three scenarios, namely static control, OSS and ULS, were simulated with the model. 
Most simulation results were found to be consistent with experimental measurements and 
permitted additional dynamical predictions that have not yet been assessed experimentally. The 
analysis led to two slight discrepancies between simulation results and experimental 
observations. One is associated with the steady-state level of Nox1-mRNA under ULS condition, 
which seemed not to change significantly over static control in experiments, but exhibited a 
significant reduction in the simulation. A possible explanation may be that the static flow control 
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is not a physiologically relevant condition for comparison, because the complete lack of blood 
flow only occurs in extreme pathological conditions. Excluding the static condition, one could 
simply compare Nox1 mRNA levels under ULS and OSS. In this comparison, the simulation 
result indicates a significant decrease, which is consistent with the experimental observation. A 
second discrepancy is the increased ICAM1 expression in the first few hours under ULS, which 
was not observed in vitro. One possible reason for this difference may be that the degradation 
processes of hydrogen peroxide are extremely simplified at this step, which leads to a direct 
correlation between the concentration of hydrogen peroxide and ICAM expression. Besides, it is 
possible that ICAM1 increases as a part of the adaptation response to a sudden change from 
static to shear conditions (either ULS or OSS).  However, it is important to note that ULS 
inhibits, whereas OSS stimulates, monocyte adhesion to endothelial cells [101, 195], suggesting 
that there are additional shear-sensitive changes, including an increase in ROS, that regulate the 
inflammatory response.  
Although it is generally agreed that OSS is a critical pro-inflammatory factor that 
increases ROS production during long exposure (~ one day), different research groups generated 
distinct transient dynamics and quantitative measurements. For example, studies conducted by 
Griendling and her colleagues [80] suggested that endothelial cells gradually increase their 
superoxide production in response to OSS, which is different from our experimental findings 
[101]. This discrepancy in short-time effect may be caused by the different experimental set-up 
between the two groups. The model is presently too coarse to identify the “correct” response 
because changes in parameter values permit reproducing both types of observations (results not 
shown).  
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In order to illustrate the specific roles of BMP4 and p47phox, additional simulations were 
implemented to mimic special experimental treatments, like BMP4/BMP4-antagonist treatments 
and a p47phox knockout model. The results of these simulations unequivocally pointed to the 
necessity of BMP4 and p47phox in OSS-induced inflammation, suggesting that BMP4 might 
indeed be a crucial and potent component in the regulation of distinct long-term effects of OSS 
and ULS, and that p47phox might be a critical factor inducing similar short-effects for OSS and 
ULS.  
Of course, the mechanosensing system in vivo is much more complicated than our current 
model.  It consists not only of the single pathway targeted here, but is tied to uncounted other 
pathways that could have direct or indirect, weak or strong influences on its genomic or 
metabolic regulation, on important intra- or extra-cellular signals, and on the production or 
degradation of some of the key compounds that govern our coarse model system. For instance, a 
recent study suggests that a cAMP/PKA-dependent pathway plays an essential role in the down-
regulation of BMP4 under ULS [222]. Furthermore, as stated in the Materials and Methods 
section, the activities and expressions of some critical antioxidant enzymes, like superoxide 
dismutase, endothelial nitric oxide synthase and peroxiredoxin 1, have been shown to be 
regulated by long exposure (~one day) to shear stress, thereby providing a cellular defense 
mechanism counteracting oxidative stress [211, 213, 214]. These regulations were not 
incorporated in current model. However, we performed sensitivity analyses of the corresponding 
parameters (like ), which pointed towards reduced quantities of ROS and increased 
availability of nitric oxide (data not shown). These results may be interpreted as a self-regulatory 
defense, which further supports the reasonableness of the current model structure.  
202119 ,, gγγ
59 
To grasp the overall response of endothelial cells to shear stress, these potentially 
important pathways and mechanisms must ultimately be integrated into a single conceptual 
framework. It is clear that the increasing scope of such extensions and their explorations will 
overwhelm the linear cause-and-effect thinking that our human mind likes best, and that the only 
possible remedy will be a sequence of ever more detailed and fine tuned systematic 
computational representations. As it stands, the model proposed here is coarse and quite 
primitive. However, once this prototype model is validated, it can be expanded toward the 
investigation of other external stimuli like angiotensin II and TNF-α, which also stimulate 
NADPH oxidase activation and mediate endothelial function in inflammation [13, 224]. The 
step-wise extension of the model will permit investigations of a growing network of reactions 
and processes, which might eventually cover the entire dynamic stress response of the 




FUNCTION AND DESIGN OF THE NOX1 SYSTEM IN VASCULAR 
SMOOTH MUSCLE CELLS2  
3.1 Introduction  
Reactive oxygen species (ROS) play crucial roles as signaling molecules in vascular 
physiology [16, 17], and aberrations in their profiles or function can lead to a wide spectrum of 
diseases [5, 9-12, 45]. Under normal physiological conditions, ROS are produced in a controlled 
manner and found in low concentrations [1]. They exert much of their signaling functions by 
influencing the activities of specific redox-sensitive genes, proteins, and pathways [1, 16]. Under 
pathological conditions, ROS production is often increased. This increase leads to an unbalanced 
redox state, which is generically referred to as “oxidative stress” [19] and often involves 
deleterious processes that can damage cell structures and negatively alter lipids, proteins, and 
DNA [3, 20, 21]. Indeed, extended periods of oxidative stress have been shown, both with 
experimental and clinical evidence, to associate with a wide variety of cardiovascular and 
metabolic diseases [24, 225], including hypertension, endothelial inflammation, diabetes, and 
atherosclerosis.  
Elevated levels of ROS in the vascular system are often the result of several contributing 
factors at the production and removal side, but they are generally associated with the activation 
of vascular NADPH oxidase (Nox) [13, 27, 28], which responds to extracellular stimuli [32, 33]. 
Once the production of ROS is initially triggered through reactions catalyzed by Nox, ROS can 
                                                
 
 
2 Adapted from: Yin, W., Voit, E.O. “Function and Design of the Nox1 System in Vascular Smooth Muscle Cells”, 
(submitted), 2012.  
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propagate their own production by enhancing activities of other ROS sources [25, 29, 226], 
including intracellular iron uptake, xanthine oxidase, uncoupled endothelial nitric oxide synthase 
(eNOS), and damaged mitochondria. This type of propagation constitutes a feedforward 
mechanism that can lead to a vicious cycle of amplification and the maintenance of endogenous 
ROS in large quantities, which in turn contribute to pathological signaling. Because vascular 
NADPH oxidase is at the center of this deleterious process, it has become the subject of 
extensive investigation.  
NADPH oxidase is a member of a family of enzymes that transfer electrons from 
NADPH to molecular oxygen [29], thus producing specific amounts of superoxide (O2.-), one of 
the major ROS in vessel walls. The Nox family consists of seven catalytic homologues, four of 
which (Nox1, Nox2, Nox4, and Nox5) are found in the vasculature [34]. These Nox subtypes 
present in distinct subcellular compartments, respond to different agonists, and often mediate 
specific cellular functions [32-36]. Among them, Nox1 has received the most attention mainly 
because it can be triggered by many physiological or pathological stimuli [34], such as 
angiotensin II (AngII), a hormone that activates Nox1 in vascular smooth muscle cells (VSMCs) 
[37, 38], and platelet derived growth factor (PDGF) [37]. Many experimental studies have 
pointed out that Nox1 is clearly implicated in vascular pathologies [27, 34], including AngII-
induced hypertension and hypertrophy [39], serum-induced proliferation and PDGF-induced 
migration in VSMCs [40, 41], abnormal vascular growth and inflammation [34], and 
atherosclerosis [28, 42].  
Under normal physiological condition, Nox1 serves several beneficial purposes. 
Importantly, it is a crucial component in several signal transduction pathways [31], and 
extracellular activators, such as AngII [17] and PDGF [17], typically use Nox1-catalyzed ROS as 
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specific intracellular signaling molecules to transduce information to downstream signals [227]. 
If Nox1 does not respond to these extracellular activators efficiently, the ROS it generates are 
unable to exert their proper signaling function. As a consequence, extracellular signaling 
information may be lost, along with the intracellular processes or events that were to be 
triggered. Thus, for proper functioning, Nox1 needs to be maintained in an optimal state, where 
it is ready to respond appropriately to upstream signals by producing enough ROS to transduce 
the signal. By the same token, as soon as the input signal disappears, Nox1 must quickly return 
to its optimal state, where ROS production is low and the machinery for generating new ROS is 
ready for new upstream signals. In this sense, one may define the optimal state and dynamics for 
Nox1 under normal physiological condition by two demands. First, Nox1 needs be responsive to 
input signals. And second, once an input signal ceases, Nox1 must return to its normal state as 
soon as possible. 
The control of Nox1 activity is quite complex, as it is associated with the assembly and 
disassembly of several components, and in order to understand Nox1 and its regulatory function, 
it is necessary to discuss its components in some detail. Owing to the large body of experimental 
studies, we have substantial information about Nox1’s molecular composition, intracellular 
compartmentalization, activation mechanisms, and possible physiological functions [31, 33, 34]. 
Generally, Nox1 becomes functionally active when it is complexed with several cytosolic 
subunits and regulators, including an “organizer” [33], an “activator” [33], and the small GTPase 
Rac [95]. Both the organizer and the activator exist in two homologues, namely, p47phox or 
NoxO1 [94, 228], and p67phox or NoxA1 [94, 228], respectively. These homologues have 
different, cell-specific spatial distributions, and their regulatory mechanisms are somewhat 
different [229]. The specific identity of the Nox1 regulatory subunits is not completely known in 
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all vascular cells. A notable exception is the case of VSMCs, where Nox1 is complexed with the 
activator NoxA1 [98, 99] and the organizer p47phox [27, 99, 100]. In this paper, we focus 
specifically on this very pertinent cell type.   
While we have learned much about the assembly and activation of Nox1, the equally 
important disassembly and recovery of subunits have received much less attentions. One possible 
reason for neglecting this important aspect might be due to the limitations of current 
experimental set-ups. Modern biochemical techniques have helped us to identify many proteins, 
and sometimes their intracellular concentrations. However, because experiments often focus on 
their concentration changes after a certain stimulus is added, they usually cannot detect the 
dynamics of material flowing through each individual pathway, thus making the identification of 
possible disassembly mechanisms difficult. For instance, it is still unclear whether the active 
Nox1 complex will disassociate into individual subunits or directly degrade via proteolysis once 
it is no longer needed. It is also unknown in which fashion the disassociation happens and, in 
fact, whether the order of disassembly is of any importance.   
Given the key role of active and inactive Nox1 in normal physiology and in 
pathophysiology, it is necessary to improve our understanding of Nox1 regulation with respect to 
both, assembly and disassembly. However, developing deeper insights poses a problem, as subtle 
differences in the rates of the various assembly and disassembly steps can have consequences 
that we are unable to quantify and interpret with intuition alone. We are therefore proposing in 
this work a computational modeling approach that allows us to answer questions about the 
complex dynamics of Nox1 under normal and pathological conditions. 
The model we propose is directly based on the current understanding of the topology of 
the different, potentially simultaneous activation and disassembly pathways for Nox1 in VSMCs, 
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as they are shown in Figure 3.1. The disassembly dynamics of the Nox1 system contains four 
pathways, namely, one direct degradation pathway via proteolysis (marked with f14 in Figure 3.1) 
and three independent recovery pathways (marked as f2, f3, and f4), which differ in a subtle 
manner: f2 is the only pathway that directly recoups the subunit NoxA1p; f3 is the only pathway 
that directly recoups p47phox; and f4 is the only pathway that directly leads to Rac1GDP.   
We allow for the flexibility that these disassembly and recovery pathways may be 
triggered separately or concomitantly by different signals that lead to Nox1 disassembly via 
dephosphorylation of p47phox, via phosphorylation of NoxA1, or via deactivation of Rac1. While 
these individual pathways have not been experimentally verified specifically in VSMCs, they 
have been reported to play important roles in the disassembly of Nox1 [230] or its closest 
homologue, Nox2, in other types of cells [231, 232]. They are therefore reasonable candidates 
for the so-far ill-characterized disassembly of Nox1.    
The proposed system of recovery pathways raises several questions, which have not been 
answered experimentally, and which are in fact difficult to assess with purely experimental 
means. Such questions include the following: Are all four pathways active? Are they active 
simultaneously? Are they all equally important for the effective reestablishment of an 
appropriate profile of Nox1 subunits? Is one, or are several of the pathways, more effective than 
others? Do any of them dominate the disassembly process? Does the importance of each pathway 
change with particular cellular demands? Are the role and importance of each pathway driven by 
external or intracellular factors, such as initial protein concentrations, necessary response speeds, 
and the net directions of some of the involved reactions? 
These types of questions are difficult to address with experiments, but we will 
demonstrate here that we can pose such questions and at least partially answer them with 
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mathematical and computational methods. Indeed, the mathematical model we develop here not 
only integrates all available biological information and addresses specific questions, but also 
answers a number of generic questions that target the principles governing the natural design of 
the Nox1 system. They are of the type “why is this system organized in the fashion we see it, and 
not in an alternative fashion that appears to be just as reasonable”? To achieve this level of 
generality, we will construct models in a fashion that is only very mildly dependent on parameter 
values. Expressed differently, we will develop an entire ensemble of models and distill those 
with superior features. The initial target is the special case of Nox1 in VSMCs, but features of 
this representative template are likely to have relevance for other members of the Nox family as 
well. The model will offer new insights into the possible deactivation mechanisms of Nox1 
under normal physiological conditions and allow us to explore generic features that make the 
observed design superior to imaginable alternatives.  
3.2 Materials and Methods 
3.2.1 Features of Nox1 in VSMCs 
NADPH oxidase 1 (Nox1) is expressed at the plasma membrane [35, 89] and in 
endosomes [90] of VSMCs of large vessels. For protein stabilization and enzymatic activity, 
Nox1 needs to associate with the membrane subunit p22phox [92, 93], thereby forming a 
transmembrane complex. Nox1 is activated when it is complexed with the cytosolic regulators 
p47phox [31, 94] and NoxA1[98, 99], and the small GTPase Rac1[95-97]; the process is denoted 
with f1 in Figure 3.1.  Activation of Nox1 is usually preceded by the activation of its cytosolic 
regulators. Activation of p47phox and Rac1 by certain upstream signals is essential for obtaining 
full enzymatic activity of Nox1 in VSMCs. In unstimulated cells, p47phox mainly resides in the 
cytosol [100, 233]. It requires additional phosphorylation in several positions to open its auto-  
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Figure 3.1. Schematic representation of the Nox1 activation-disassembly system in VSMCs.  
Note the subtle differences among the three recycling fluxes, which lead to differently phosphorylated or 
unphosphorylated products. For instance, only the pathway marked f3 directly produces the unphosphorylated form 
of p47phox and only f4 leads directly to Rac1GDP. 
  
inhibitory region and to turn it into its active form [33, 70], which then enables it to translocate 
from the cytosol to the membrane where it associates with the Nox1/p22phox complex. The 
translocation of phosphorylated p47phox often occurs together with the activator subunit NoxA1 
[33, 99]. This phosphorylation of p47phox is mainly catalyzed by protein kinase C (PKC) [38, 
105] (marked f5 in Figure 3.1), which may be stimulated by AngII, typically in association with 
three different phospholipases [234-236]. However, there are exceptions. For instance, the strong 
PKC activator phorbol-12-myristate-13-acetate (PMA) alone was shown to increase Nox1 
activity in VSMCs [27].  Similar to the activation of p47phox, the small GTPase Rac1 also 
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requires activation by certain upstream signals. Also like p47phox, Rac1 can exist in two inter-
convertible forms: GTP-bound (active) and GDP-bound (inactive). Activation of Rac1from its 
inactive form is facilitated by a family of enzymes called Guanine Exchange Factors (GEFs) 
[112] (associated with f7 in Figure 3.1). GEFs render Rac1 capable of associating with the 
Nox1/p22phox complex, which is another indispensable step for achieving enzymatic activity in 
Nox1 [95]. Interestingly, the action of GEFs on Rac1 is usually independent of the translocation 
of p47phox [112]. As an alternative, recent studies suggest that the second cytosolic subunit 
NoxA1 can be phosphorylated by protein kinase A (PKA) [230, 237] (process f9 in Figure 3.1). 
The phosphorylation of NoxA1 greatly enhances its binding affinity to 14-3-3 proteins, thus 
preventing its association with other Nox1 subunits. Although this mechanism has not directly 
been verified in VSMCs, it has been suggested as a possible negative regulatory mechanism of 
Nox1 since both the signal (PKA) and the substrate (NoxA1) co-exist in this type of cell.  
Many experimental studies have investigated Nox1-induced ROS production in different 
cells and under various conditions. By comparing the system responses to certain stimuli with 
the control system, several Nox1 activators and regulators have been identified. For instance, 
Nox1 can be directly activated by PDGF [37], AngII [37, 38], thrombin [33], tumor necrosis 
factor-alpha (TNF-α) [90], and many others (for details see [31, 34]). In these experiments, the 
measured output variables are usually intra- or extra-cellular ROS concentrations or production 
rates under different conditions. For example, AngII (100nmol/L) has been shown to increase 
Nox1-catalyzed ROS significantly [38, 235] and is therefore considered an effective activator of 
Nox1 enzyme. However, due to differences in experimental settings, the measured ROS 
concentration or production might be found in different magnitudes, and it is possible to 
encounter slightly different transient behaviors even in response to the same stimulus. As an 
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example, two experimental groups treated cells with AngII and measured the response over a 
period of 30 minutes. In both cases, the ROS concentration eventually reached a higher plateau 
(~2 fold), but in one case the transient was found to be biphasic [38], whereas the other group 
indicated a continuous and gradual increase in ROS concentration to the same plateau [235]. In 
both cases, the plateau was sustained for a long time indicating that the levels of ROS and of the 
corresponding active Nox1 complex assume an up-regulated steady state in response to AngII 
treatment that is higher than in controls. Western blot analysis did not show any significant effect 
of AngII on the total Nox1 protein level over 4 hours after AngII treatment [36], which implies 
that ROS production is likely due to AngII-induced signal activation of Nox1 activity rather than 
to an increase in the Nox1 protein level.   
 
3.2.2 Variables, Assumptions, Simplifications, and Model Settings 
The Nox1 activation-deactivation system has been investigated in numerous studies, and 
the pathway structure, key components, and a variety of other biological data are available in the 
literature. The model we propose is based on this information and directly reflects the pathway 
structure shown in Figure 3.1. The most pertinent information about the model is summarized in 
Table 3.1. The dependent variables, whose concentrations are affected by the system, include 
active Nox1 complex (Nox1active), Nox1/p22phox, p47phox, phosphorylated p47phox ( ), 
GDP-bound Rac1 (Rac1GDP), GTP-bound Rac1 (Rac1GTP), NoxA1, and phosphorylated NoxA1 
(NoxA1P). Input signals, including those leading to p47phox phosphorylation, those effecting 
Rac1 activation, and those responsible for NoxA1 phosphorylation, are represented by S1, S2, and 




control conditions and are changed to a value above “1” when a relevant extracellular stimulus is 
applied.  
In a VSMC system residing in its control state and exposed to basal input signals, one 
detects a continuous, low production of ROS [33, 36]. This ROS production does not 
significantly decrease even if Nox4, a Nox homologue, is significantly knocked down [36]. 
Combining these two observations suggests the sustained existence of Nox1active even if it might 
have a low concentration. It also indicates that the target system at the ready-to-respond state 
(RtRS) dynamically maintains a fine-tuned balance of fluxes. As an illustration, consider 
Nox1active (X1). Basal signals enable continuous formation of X1 by depleting the pool of 
Nox1/p22phox, , Rac1GTP, and NoxA1P. This formation continues to exist as long as the 
basal signals are present and the pool of free subunits is not depleted. Thus, in order to maintain 
X1 at a stable level, there must be additional pathways (generically referred to as disassembly 
pathways) that disassociate X1.   
Four alleged disassembly pathways are incorporated in the current model. They include 
one direct degradation pathway via proteolysis (associated with f14 in Figure 3.1) and three 
independent recycling pathways that recoup subunits of Nox1 (associated with f2, f3, and f4 in 
Figure 3.1). Because the exact enzymes that catalyze these disassembly reactions of Nox1active 
have not been clearly identified in VSMCs, and their responses to extracellular stimuli are ill 
characterized, these enzymes are modeled with a nominal activity level of 1. The same strategy 
is applied to partial or more complicated disassociation mechanisms of Nox1active, which might 





              Table 3.1. System variables 
Variable Biological Component 
X1 active Nox1 complex (Nox1active) 
X2 Nox1/p22phox 
X3 p47phox 
X4 phosphorylated p47phox ( ) 
X5 GDP-bound Rac1 (Rac1GDP) 
X6 GTP-bound Rac1 (Rac1GTP) 
X7 NoxA1 
X8 phosphorylated NoxA1 (NoxA1P) 
S1* Signals that phosphorylate p47phox (such as PKC) 
S2* Signals that activate Rac1 
S3* Signals that phosphorylate NoxA1 (such as PKA) 
                       * indicates independent variable; others are dependent variables. 
 
3.2.3 Model Structure  
Based on the model assumptions and the simplifications described above, we propose a 
model structure, which directly corresponds to the scheme in Figure 3.1, to represent the 
dynamics of Nox1 in VSMCs. In order to balance the loss of material leaving the system via the 
proteolytic pathway of Nox1active, the model accounts for several processes entering the system, 
including the influxes of Nox1/p22phox, p47phox, Rac1GDP, and NoxA1 (blue arrows marked f11, 
f12, f13, and f15 in Figure 3.1, respectively). Because the PKA-phosphorylated NoxA1 (NoxA1P) 
has been shown to bind with 14-3-3 protein to form a complex [237], which could be directly 
degraded, one additional degradation pathway of NoxA1P (associated with f16 in Figure 3.1) is 




(marked f6, f8, and f10 in Figure 3.1), such as dephosphorylation of p47phox and NoxA1, 
association of GDP to inactivate Rac1, are considered to be reversible, which is supported by 
experimental observations [33, 112, 230]. By accounting for these various influxes and effluxes, 
the pathway constitutes an open system that operates at a dynamic steady state, with small 
amounts of material continuously flowing in and out of the system. 
3.2.4 Mathematical Description 
The first and arguably most critical step of model design is the translation of the 
biological system diagram into an appropriate mathematical structure that permits analytical or 
simulation-supported diagnosis [238]. We use here ordinary differential equations in mass action 
format that describe how each component in the system varies over time.  
The Nox1 system represented in Figure 3.1 can be expressed succinctly in matrix format:  
          (3.1) 
where is the dependent variable vector,  denotes its derivative, is the flux vector, and
is the stoichiometric matrix, which quantifies the relationships between dependent variables 
and corresponding fluxes (see details of N in APPENDIX B.1). The fluxes are given in mass 
action format as 
          






















3.2.5 Parameter Estimation 
Model simulations and system diagnosis require the specification of numerical values for 
all parameters from experimental observations. This step is often challenging, for a wide variety 
of reasons (e.g., see [217]). In the present case, the Nox1 system is at first assumed to operate at 
its nominal, stable steady state (RtRS), which corresponds to unstimulated control conditions.  
The concentrations of all dependent variables remain unchanged in this state, which allows the 
formulation of linear constraints that the fluxes must satisfy Eq. (3.3).  
              
        (3.3) 
This set of constraints has an eight-dimensional basis, indicating that only eight linearly 
independent fluxes need to be characterized from data instead of sixteen.  In addition, the fluxes 
are naturally non-negative, which imposes a set of inequality constraints that confine the search 
space for feasible parameter values further. 
Linear algebra assures us that it ultimately does not matter which basis of flux vectors in 
Eq. (3.3) is chosen. For reasons of practicality, we select fluxes f2SS, f3SS, f4SS, f6SS, f8SS, f14SS, and 
f16SS, as independent fluxes. As the eighth independent flux, we choose f9SS or f10SS, depending on 
the relative sizes of f2SS and f16SS. Two reasons support this particular selection. First, f2SS, f3SS, 















































of particular interest. Their characterization will enable us to identify the most effective 
strategies of degrading Nox1active. Second, once these selected fluxes are numerically quantified 
by their rate constants, the remaining fluxes are guaranteed to be non-negative because of their 
relatively larger magnitudes.   
Since little experimental information is available regarding any of the fluxes or their 
corresponding rate constants, we use Monte Carlo methods, which permit the exploration of 
large search spaces with reasonable effort. Specifically, the targeted fluxes are randomly sampled 
from a uniform distribution over an appropriate non-negative domain. The performance of each 
sampled set is then evaluated by a series of user-defined criteria.  
3.2.6 Criteria for Proper Functioning 
The criteria used here consist of two types. The first characterizes how efficiently the 
system responds to signals and how fast this response can be mounted. The rationale for this 
criterion is the likely advantage for Nox1 to reside in its “optimal state” as much as possible, 
while ensuring maximal responsiveness to input signals with a minimal response time. The 
combination of these two aspects becomes particularly important when the system receives 
several signals within a relatively short time span: If the system is optimized to be launched most 
effectively from its nominal state, than the system should return to this state as quickly as 
possible after a signal has been transduced. 
The second criterion reflects experimental measurements and qualitative observations. 
Based on experimental observation of ROS production at and after 30 minutes in AngII [36, 38, 
235] and PMA stimulated VSMCs [27], the following three qualitative conditions constitute of 
the second criterion: (1) At 4 hours of AngII treatment, the total protein of Nox1 subunit, 
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including both Nox1/p22phox (X2) and Nox1active(X1), is not significantly changed [36]; (2) After 
30 minutes of AngII treatment, the system reaches a steady state or a quasi-steady state with up-
regulated Nox1active (X1) [38, 235]; (3) At 30 minutes of PMA treatment, Nox1active (X1) activity 
is up-regulated since ROS production is increased [27]. 
 
3.3 Results 
3.3.1 Importance of Fine-Tuned Availability of Nox1 Subunits 
Before we discuss the details of our modelling results, it is beneficial to confirm, at least 
conceptually, that a well-controlled disassembly of Nox1 is indeed important and not at all 
random. In order to respond to extracellular activators like AngII and PDGF effectively, Nox1 
needs to reside in a state that is prepared to receive signals and act on the ROS system in an 
effective and appropriate manner. As discussed in Chapter 1, we call this state the “Ready-to-
Respond State” or “RtRS.” As soon as an input signal has been processed, Nox1 must quickly 
return to RtRS, where ROS production is low and the machinery for generating new ROS is 
ready for new upstream signals. Thus, RtRS and the dynamics with which Nox1 returns to this 
state must satisfy two demands, as discussed before. Nox1 needs to be maximally responsive to 
input signals, and, once these cease, return to RtRS as soon as possible. 
 While many factors affect Nox1’s performance, the availability of its subunits in specific 
proportions is of particular importance for RtRS to be effective. The impact of such a profile can 
be demonstrated most clearly with a few extreme thought experiments. As an example, suppose 
that only two subunits (p47phox and Rac1) are involved in the activity of Nox1 and that they are 
either totally absent (coded as “0”) or maximally available and active (coded as “1”), which 
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simplifies the discussion to four possible states (Table 3.2). Let’s furthermore assume that Nox1 
must respond to two possible signals (S1 and S2) and assess its responsiveness to arbitrary 
combinations of incoming signal trains of S1, S2, or S1 & S2. It is not difficult to see that the 
responsiveness of the Nox1 system is severely limited, no matter in what state Nox1 resides. In 
reality, the states are somewhere between 0 and 1, but the very much simplified examples 
already indicate that their distribution is important. Similar thought experiments may be 
constructed if three subunits are involved in the Nox1 dynamics.  
 A second factor influencing the responsiveness of Nox1 at RtRS is the relative speed of 
the rates in reversible reactions, namely the phosphorylation and dephosphorylation of p47phox, 
the activation and deactivation of Rac1GDP, and the phosphorylation and dephosphorylation of 
NoxA1. Again, a thought experiment demonstrates the effects of such rates most easily. Suppose 
the phosphorylation of p47phox is extremely slow, while dephosphorylation is very fast in 
comparison, so that p47phox will essentially always be dephosphorylated. An immediate 
consequence is that no signals of type S1 have the capacity to trigger the system, because any 
newly formed phosphorylated p47phox is rapidly deactivated and essentially no additional active 
p47phox is formed (see Figure 3.1). In the opposite case, if the phosphorylation of p47phox is fast, 
while dephosphorylation is very slow in comparison, any free p47phox is immediately activated. 
Thus, even without incoming signals of type S1, any further addition of S1 will have little effect 
on this process, and the Nox1 system is again not responsive to S1. Similar arguments hold for 
the other two reversible reactions.  
As a conclusion from these thought experiments, optimality of Nox1’s RtRS critically 
depends on the material distribution of subunits and on a fine-tuned balance between the rates in 
the reversible reactions of the system. In fact, it is not difficult to realize that these two aspects 
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are correlated with each other. Thus, to maintain or regain an effective RtRS, the Nox1 system 
must finely tune the balance of fluxes, and the control of this fine-tuning must be dynamic and 
adaptive.  
Table 3.2. Simplified examples illustrating the need for a proper distribution of Nox1 subunits. 
Subunit Distribution in RtRs Responsiveness to Representative Signals 
 
[p47phox] = 0; [Rac1GDP] = 0; 
 
No response to S1, S2, or S1 & S2 
[p47phox] = 0; [Rac1GDP] = 1; Response to S2, and S1&S2, but no response to S1 
[p47phox] = 1; [Rac1GDP] = 0; Response to S1, and S1&S2, but no response to S2 
[p47phox] = 1; [Rac1GDP] = 1; Response only to S1&S2, but not to S1 or S2  
 
 The computational results fall into two categories. The first category evaluates the four 
disassembly mechanisms of Nox1 against different, objective criteria of functional effectiveness, 
which are described in detail in the section 3.2 (Materials and Methods). The second category 
explores the functional importance of the relevant disassembly and recovery pathways, and their 
relationships to details of the intracellular milieu, such as initial protein concentrations, the 
relative magnitudes of different pathway rates, and balances between forward and reverse 
reactions. 
 
3.3.2 Assessment of Nox1 Disassembly Mechanisms According to the First Criterion 
In order to evaluate the system’s responsiveness to different signals and signal 
combinations, we investigate four distinct sets of input signals, namely strong individual signals 
S1, S2, or S3, as well as simultaneous S1 and S2 signals. Among these, three signal sets have been 
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experimentally shown to possess the capacity of activating Nox1 in VSMCs [27, 38]. The 
exception, and thus a prediction of the model, is the response to an individual S3 signal, which is 
likely to inhibit Nox1 activity, although this has not been directly verified yet in VSMCs.  
 A factor that could possibly affect the system’s responsiveness is the set of initial 
concentrations of the system components, especially for the cytosolic subunits p47phox, Rac1, and 
NoxA1. Indeed, two questions that need to be investigated are whether their active or inactive 
forms are dominant under control conditions and how different distributions between these states 
affect the system’s responsiveness to input signals. Because no experimental information is 
available to address these questions, we explore a large space of possible combinations for initial 
distributions of the cytosolic components. In order to facilitate this comparative analysis, we 
assume that the sum of each quantity in its active plus its inactive form is constant, with an 
arbitrary default value of 100. The initial quantity of a component in active form is assigned by 
sampling a truncated Gaussian distribution with either a higher mean or a lower mean, as 
formulated in Eq. (3.4).  
;  
     
  (3.4)       
Here, “0” and “1” represent truncated Gaussian distributions with a lower and higher means, 
respectively.  This strategy yields a total of 8 combinations of initial condition (Table 3.3). For 
instance, index 4 in Table 3.3 codes for the vector [0 1 1] and represents the specific situation 












































Once the initial conditions and input signals are specified, the independent fluxes f2SS, 
f3SS, f4SS, f6SS, f8SS, f9SS (or f10SS), f14SS, and f16SS are randomly sampled between 1 and 100 with the 
same uniform distribution U(0, 2) in log10 space, which ensures an appropriate spread of 
probabilities, and the system’s response is evaluated by the new steady state of Nox1active (X1) 
under different input signals. Intriguingly, the averages of the new steady state of X1 are 
essentially unchanged among any of the four sets of input signals and for all initial condition 
combinations (Figure 3.2(a)).  
Table 3.3. Combinations of initial conditions for the three cytosolic subunits contributing to Nox1 assembly. 
Index  (X4) Rac1GTP  (X6) NoxA1P (X8) 
1 0* 0 0 
2 0 0 1 
3 0 1 0 
4 0 1 1 
5 1 0 0 
6 1 0 1 
7 1 1 0 
8 1 1 1 
*: “0” represents a truncated Gaussian distribution with a lower mean, while “1” represents a truncated Gaussian 
distribution with a higher mean, as described in the Text. 
The situation is different for the flux representing the amount of Nox1active that is being 
degraded via direct proteolysis pathway (f14SS). If the numerical sampling range for this flux is 
gradually decreased, the system responses to input signals, given as the averages of new steady 
states of X1, gradually increase or decrease under different input signals. An illustration is given 
in Figure 3.2 (b). Here, all independent fluxes are sampled with the same distribution U(0, 2) in 
log10 space, except for f14SS, which is sampled between 0.001 and 0.1 from U(-3, -1) in log10 




steady state of X1 is enabled to increase or decrease greatly in response to different input signals. 
Expressed differently, a low flux f14SS “sensitizes” X1. For the extreme case of f14SS = 0 (Figure 
3.2 (c)), the system has the most effective responses, and it behaves quite similarly when f14SS is 
very small. This result clearly shows that a relative low magnitude of f14SS is important for the 
system’s responsiveness to input signals.  
 
Figure 3.2. Monte-Carlo simulation results for evaluating the performance of the system against the first 
criterion.  
(a) All independent fluxes are sampled from U(0, 2) in log10 space; (b) All independent fluxes are sampled from 
U(0, 2) except that f14SS is sampled  from U(-3, -1) in log10 space; (c) All independent fluxes are sampled from U(0, 
2) in log10 space except for f14SS, which equals zero. Colors indicate different input signals. Dark Blue: S1 signal; 
Light Blue: S2 signal; Yellow: S3 signal; Brown: Combined S1 and S2 signal. Numbers indicate index in Table 3.2 for 
representing different initial distributions. The sampling size for each bar is 2,000 points. Details of simulation 
settings are given in the APPENDIX B Table B.1.  
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 The same simulation results demonstrate that different combinations of initial conditions 
affect system performance and can lead to distinct responding patterns. For instance, consider the 
situation where p47phox and Rac1 are dominant in their active forms. The system readily responds 
to S3 signals, but exhibits the most inefficient responses to input signals S1, S2 and their 
combination (Figure 3.2 (c; bars 7 and 8)). Thus, maintaining both p47phox and Rac1 dominant in 
their active states appears to be an inferior strategy. By contrast, if both p47phox and Rac1 are 
dominant in their inactive forms, the system is most responsive among all the simulations 
(Figure 3.2 (c; bars 1 and 2)), suggesting that this state is to be preferred for effective responses. 
Other sets of initial distributions (Figure 3.2 (c; bars 3 through 6)) are either not responsive to S1 
or S2 signals, respectively. This computational result correlates well with the previous, and so far 
unexplained, observation that a system with components in their active forms is generally less 
responsive than if the components are in their inactive forms.  
3.3.3 Assessment of Nox1 Disassembly Mechanisms According to the Second Criterion 
Similar to the analysis in the previous section, input signals and initial conditions need to 
be specified before simulations can be performed. Here the situation is slightly different, because 
the second criterion is associated with quantitative experimental observations, which allows us to 
replace the sampling scheme with direct experimental information about input signals and initial 
conditions. Details of the correspondence between the experimental, extracellular treatments and 
the numerical characteristics of the input signals and initial conditions for the model are 
summarized in APPENDIX B.3 and Table B.2.   
While valuable, the data are not sufficient to determine specific parameter values and it is 
still necessary to sample the independent fluxes. They are randomly selected between 0.01 and 
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100 from the uniform distribution U(-2, 2) in log10 space, and each sampled set is screened 
against three qualitative criteria as described in the  section Materials and Methods. The wide 
range is expected to cover all pertinent combinations of fluxes, and therefore appears to be 
adequate for the initial sampling. Ratios beyond this range would result in either very fast or very 
small reactions, which would ultimately render a dependent variable static.  
With these settings, we can now examine combinations of fluxes of the proteolytic 
pathway (f14SS) and the total recycling pathways (summations of f2SS,  f3SS, and f4SS) by screening 
preliminarily sampled points (APPENDIX B Figure B.1) against different criteria (Figure 3.3). 
We begin by testing flux combinations against our first criterion of a Nox1 protein level that is 
sustained for 4 hours of AngII treatment. Interestingly, forcing all admissible flux combinations 
to match this criterion filters out almost all sampling points located in the lower-right region of 
the plot, where the proteolytic flux is large and the recycling flux is small. In other words, the 
combination of a large proteolytic flux and a small recycling flux is inefficient, and this finding 
directly and independently confirms the results presented before. Next we screen the flux 
combinations against the second criterion of an up-regulated (quasi-) steady state of Nox1active 
(X1) at 30 minutes of AngII treatment. This screen filters out different combinations of fluxes, 
and the remaining, successful combinations locate mainly in the upper-left region  of the plot 
where the proteolytic flux is smaller than 1 while the recycling flux is larger than 1. Finally, 
filtering the flux combinations against the third criterion, namely up-regulated Nox1active (X1) 
under phorbol-12-myristate-13-acetate (PMA) treatment, effectively excludes essentially all 
combinations that are located to the very right, where the numerical value of the proteolytic flux 
is usually larger than ~ 3, which corresponds to about 0.5 in log10 space.  
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Valid combinations of flux magnitudes should satisfy all three criteria. Thus, when we 
sequentially screen against all three criteria, we obtain the result in the lower-right panel of 
Figure 3.3: the remaining flux combinations are compactly located in a well-defined region 
where the numerical value of the proteolytic flux is less than ~0.3 (corresponding to about -0.5 in 
log10 space) while the recycling flux is larger than 1. An extended flux distribution analysis 
(discussed below; see Figure 3.4) of these remaining points confirms this result.  To summarize  
 
Figure 3.3. Results of a Monte-Carlo simulation with an initial sample of 20,000 points, used to evaluate the 
performance of the Nox1 system.  
Top-left: 7,040 points (combinations of proteolytic and recycling flux magnitudes) are retained after screening 
against the first criterion. Top-right: 1,473 points are retained after screening against the second criterion; Bottom-
left: 6,471 points are retained after screening against the third criterion; Bottom-right: 843 points are retained after 
screening against all three criteria. 
 
this section, the fluxes were originally sampled with the same probability distribution.  Filtering 
according to the three criteria discussed before yields proteolytic and recycling fluxes that have 
distinctly separated distributions, with the average recycling flux exceeding the average 
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proteolytic flux by almost 3 magnitudes in log space, which corresponds to a ratio of about ~ 500 
fold.  
The combined criteria-driven identification of suitable parameter ranges clearly suggests 
that the admissible flux candidates satisfying all three criteria tend to reside in the region where 
much more flux runs through the recycling pathway than through proteolysis.  In other words, 
we can say that under control conditions (unstimulated cells) the dissociation of Nox1active into 
recycled subunits plays a dominant role in lowering enzyme activity, thus serving as the primary 
disassembly mechanism.  Beyond this conclusion, the flux distribution analysis of the recycling 
pathways f2SS, f3SS, and f4SS does not reveal a clear activity pattern (lower panels in Figure 3.4). 
The identification and analysis of such patterns are discussed below.    
 
Figure 3.4. Distributions of flux magnitudes in samples filtered with the second criterion.  
Upper panel: flux distributions of proteolytic and recycling fluxes. Lower panel: distributions of magnitudes of 
individual recycling fluxes.  
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3.3.4 Patterns of Nox1 Recycling Mechanisms  
As suggested by the results in previous sections, the three recycling pathways appear to 
play more important roles for the disassembly of Nox1active than proteolysis. In fact, the fluxes 
going through these pathways are at least 2 magnitudes (~100 fold) larger, a conclusion that is 
consistent no matter which of the criteria are used. It is now of interest to explore whether any of 
the recycling fluxes is more effective than the others. For this analysis, we temporarily ignore the 
small contribution of proteolysis and set its flux f14SS equal to zero. To balance this missing 
efflux from the system, the alleged input influxes f11SS,  f12SS, and f13SS are also set to zero, so that 
the constraints in Eq. (3.3) of the Materials and Methods section are again satisfied.  
The steady-state fluxes through the three recycling pathways of Nox1active are f2SS, f3SS, 
and f4SS. A priori we do not have any information regarding the relative importance of each of 
these fluxes or their combinations. Accounting for all possibilities, seven disassembling modules 
are considered (Figure 3.5). In order to explore the effectiveness of these distinct modules, we 
again use Monte-Carlo simulations, which allow us to screen for very many combinations of flux 
magnitudes and to examine their responsiveness and response times to treatment with AngII 
(represented by a combined S1 and S2 signal).  
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Figure 3.5. Schematic representation of seven possible Nox1 recycling modules.  
The proteolytic flux f14SS is assumed to be negligible, as suggested by simulation results in previous sections.  
 
We begin with a closed Nox1 system (for the model structure see APPENDIX B Figure 
B.2), where the efflux f16SS has a very small magnitude and can be omitted. We analyze the 
system’s response to the pertinent input signal (combined S1 and S2) and also track how the 
active Nox1 complex behaves when the input signal is removed.  
 In order to keep the initial flux distribution consistent with observations in AngII 
treatment experiments, we set the control condition such that free p47phox, GDP-bound Rac1, and 
NoxA1 are dominant; in earlier notation, this setting corresponds to the index [0 0 0] in Table 
3.3. For fair comparisons among the different flux modules, we always set the flux of active 
Nox1 production (f1SS) constant (at the numerical value of 100), which ensures that differences in 
system performance are due to the module structure at hand, rather than differences in flux 
magnitudes in a given Monte Carlo sample. Within this constraint, the remaining independent 
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fluxes (f6SS, f8SS, and f9SS) are calculated from (uniformly) randomly sampled rate constants γ6, γ8, 
and γ9. Sampling rate constants rather than fluxes allows us to inspect the effect of the different 
reaction rates, especially those associated with reversible reactions, on the performance of the 
system.  
The rate constants, which represent the reversible reactions for activation and deactivation of 
subunits p47phox, Rac1, and NoxA1, respectively, are either sampled as “slow” from the uniform 
distribution U(0, 1), or as “fast” from the uniform distribution U(10, 100).  The simulation 
results (Figure 3.6 (a)) indicate that when the reversible reaction rates are “slow”, all seven 
deactivation modules tend to exhibit similar behaviors in response to the input signal. Namely, 
the steady state value of X1 (in the “on” response) is up-regulated to about the same level 
between 2.5 ~ 3 fold in all simulations. When the input signal is removed (in the “off” response), 
X1 returns to the control level for all seven modules. However, the response times for the “on” 
and “off” responses are quite different among the modules. Module 1, which has only one 
recycling pathway specifically associated with f2SS, has the longest response time in both the 
“on” and “off” responses. In contrast, modules 6 and 7, which contain both recycling pathways 
(f3SS and f4SS) have much shorter response times (less than half of other response times). The 
response time is an important feature of a signaling system, because it determines its refractory 
period. Thus, the latter modules are to be considered more efficient than the former. By the same 
token, the differences in response times have to be significant to allow the identification of 
superior and inferior designs. In the present case, the differences among all seven modules are 
insignificant in terms of responsiveness and response times, as long as the reversible reaction 
rates are fast in both directions (Figure 3.6 (b)). Thus, these simulations clearly demonstrate how 






Figure 3.6. Results of Monte-Carlo simulations evaluating the responsiveness and response time of a closed 
Nox1 activation-deactivation system (f16SS = 0).  
(a) Slow rates for reversible reactions with γi ∈ U(0, 1), i = 6, 8, 9. (b) Fast rates for reversible reactions with γi ∈ 
U(10, 100), i = 6, 8, 9. Integer numbers indicate the index of the deactivation module. The sampling size for each 
bar is 2,000 points. Note different y-axes. 
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In reality, the system is open, and the efflux f16SS may affect the disassembly of Nox1. 
The analysis of this case is complicated by the fact that we have no information regarding the 
relative magnitudes of the input fluxes and only know that the constraint 
 must be true. We study two scenarios. In the first, f9SS is larger than 
f10SS, which tips the balance from NoxA1 to NoxA1p, while in the second scenario the opposite is 
true.  
 Intriguingly, the system performance is strongly affected by the transition from a closed 
to an open system, even though the efflux f16SS is not substantial (compare Figures 3.6 and 3.7). 
In particular, the magnitudes of the reversible reaction rates affect the performance of the system 
differently for the various deactivation modules. When the reversible reaction rates are slow 
(Figure panels 3.7(a) and (b)), different disassembly modules exhibit distinct responses, 
depending on the direction of the net flux between f9SS and f10SS.  For instance, in modules 2, 3, 
and 6, which do not contain the recycling pathway f2SS, the steady states of X1 in the “on” 
response are up-regulated to above 3 fold. By contrast, the steady state of X1 for the other 
modules (1, 4, 5, and 7) is only modestly up-regulated (less than 2 fold). Moreover, the stronger 
responders (modules 2, 3, and 6) exhibit much shorter response times. In particular, module 6 
has a response time that is almost one third of the other response times, as long as f9SS < f10SS 
(Figure 3.7(b)). By contrast, if f9SS > f10SS, the differences in response times for the various 










Figure 3.7. Results of Monte-Carlo simulations evaluating the responsiveness and response times of an open 
Nox1 activation-deactivation systems (f16SS ≠ 0) with slow reversible reaction rates (γi ∈  U(0, 1), i = 6, 8, 9).  
(a) Scenario 1: f9SS > f10SS;  (b) Scenario 2: f9SS ≤ f10SS.  Integer numbers indicate the index of the deactivation 
module. The sample size for each bar is 2,000 points.   
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 When all reversible reaction rates are fast, the seven disassembly modules tend to 
perform similarly in terms of responsiveness as well as response time (Figure panels 3.8 (a) and 
(b)). However, the response times of modules 2, 3, and 6 are much shorter than the others if f9SS 




Although Nox1 exhibits relatively low basal expression in VSMCs [37], it has been 
extensively studied. Nox1-induced ROS often serve as important intracellular signaling 
molecules, transducing extracellular signals into intracellular targets. This process can be 
activated by numerous physiological and pathological stimuli [37, 38, 239] and has therefore 
been implicated in a variety of cardiovascular diseases [31, 34]. As a consequence, Nox1 must 
function properly and efficiently. It must be able to respond quickly and strongly. It is similarly 
important for Nox1 to return to its normal state fast, lest it is unable to respond to further stimuli.  
The activation and disassembly processes of Nox1 in VSMCs constitute a system of 
pathways whose components have been identified and characterized to some degree over the past 
decades [33, 37, 38, 93, 95, 99]. In particular, the scientific community has assembled quite a 
detailed picture of how individual subunits of Nox1 are organized to form an active enzyme 
complex. While the components and basic interactions are known, the overall functionality of the 
Nox1 system is not easy to intuit. For instance, the balance between phosphorylated and 
dephosphorylated states under nominal, unstimulated conditions, as well as the reaction rates of 






Figure 3.8. Results of Monte-Carlo simulations evaluating the responsiveness and response times for an open 
Nox1 activation-deactivation system (f16SS ≠ 0) with fast reversible reaction rates (γi ∈  U(10, 100), i = 6, 8, 9). 
(a) Scenario 1: f9SS > f10SS;  (b) Scenario 2: f9SS ≤ f10SS.  Integer numbers indicate the index of the deactivation 
module. The sample size for each bar is 2,000 points.   
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should it matter in which order the Nox1 complex is disassembled? As we have shown with our 
computational analysis here, specific routes of disassembly and proper characteristics of the 
unstimulated RtRS are crucial for optimal performance. To arrive at this insight, we set up a 
rather generic pathway model and analyzed it in a fashion that is only minimally affected by the 
choice of particular parameter values.  
The model accounts for four potential Nox1 disassembly pathways, which include one 
direct degradation pathway of Nox1active via proteolysis and three independent recovery pathways 
for subunits (see fluxes f14, f2, f3, and f4 in Figure 3.1).  Investigations of these fluxes at a 
nominal, unstimulated steady state were performed with Monte-Carlo simulations. For these 
analyses, the magnitudes of fluxes were classified as fast or slow, and the relatively effectiveness 
of the four disassembly pathways was assessed in terms of different criteria, namely, the strength 
and speed of system responses to input signals, and their consistency with experimental and 
clinical data.  
 Assessments with respect to the different criteria led to similar results. First, for effective 
functioning, the flux associated with proteolysis (f14SS) must be much smaller (by at least two 
orders of magnitude) than the fluxes associated with recycling pathways (Figures 3.2 – 3.4), 
indicating the relative inefficiency of proteolysis for the disassembly of Nox1active under normal 
physiological conditions.  Expressed differently, the disassociation of the active Nox1 complex 
and recycling into subunits plays the dominant role, which is seen in the relatively large 
magnitudes of these fluxes. This result is not too surprising, because proteolysis requires total de 
novo assembly of Nox1 before new signals can be transduced. 
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 Less predictable, the optimal unstimulated state (RtRS) is characterized by specific 
balances between phosphorylated and dephosphorylated forms of the subunits. These proper 
balances are critical for efficiency. As consistently shown by the results of different scenario 
simulations (Figures 3.2 (b) and (c)), the initial states with indices [0 0 0] and [0 0 1] exhibit the 
most effective responses to external signals, while systems with indices [1 1 0] and [1 1 1] are 
the least efficient. These results imply that both p47phox and Rac1 should reside in their inactive 
forms when the system is at rest. This inference from the computational analysis, while difficult 
to predict from the topology of the pathway, is well consistent with experimental observations 
[100, 112, 233] and offers an unbiased rationale and explanation. As an interesting side effect, 
this state equips the Nox1 system with a certain degree of noise tolerance: Residing in the 
inactive forms, any spurious formation of Nox1 in the absence of true signals, followed by an 
erroneous signal transduction, is much less likely than if the system maintained the active forms, 
which are the direct precursors of the active Nox1 enzyme. Thus, to avoid spurious signaling 
events, the system is “parked” in its inactive form and requires external stimuli to trigger a signal 
transduction event. In contrast to p47phox and Rac1, the unphosphorylated form of the Nox1 
activator unit NoxA1 is the direct precursor component of active Nox1, and the current analysis 
has not revealed whether the balance is tilted toward the precursor or its complement.   
 One should note that although the three disassociation and recycling pathways apparently 
play interchangeable roles in disassembling Nox1active, they actually guide the system to different 
states. It is instructive to perform another thought experiment to study the resulting 
consequences. Suppose the system receives a strong signal S1. Depending on the different 
combinations or flux distribution patterns among the three recycling pathways f2, f3 and f4, the 
enzymatic profiles of Nox1active generation can vary substantially. Let’s first consider the extreme 
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case where only f3 is present as the recycling pathway (cf. Figure 3.1). In the presence of S1, 
p47phox becomes depleted, and formation of active Nox1 subsequently depletes the other active 
precursors Rac1GTP and NoxA1. Disassociation of the Nox1 complex through pathway f3 restores 
p47phox and, more importantly, Rac1GTP and NoxA1, which enable sustained formation of new 
active Nox1 as long as S1 is present. In other words, if S1 is persistent and f3 is the only recycling 
pathway, Nox1 will be highly and continuously activated. By contrast, if S1 is persistent and the 
system does not use f3, but instead f2 or f4, the situation is very different. Because f2 and f4 
respectively restore NoxA1p and Rac1GDP, but not NoxA1 and Rac1GTP, the restoration of these 
two active precursors depends mainly on the reverse reactions f7 and f10. As a consequence, the 
formation of new active Nox1 is now limited by the availability of NoxA1 or Rac1GTP even if 
there are significant residual amounts of phosphorylated p47phox. Thus, the refraction period of 
the Nox1 system is driven by the slower rates of f7 and f10. As a result, one should expect a much 
lower activity of Nox1, compared to the previous case, even under the same input signal S1. In 
other words, in the presence of all three pathways, the system can lower Nox1 activity by either 
inhibiting f3 or decreasing its flux distribution ratio in the presence of input signal S1.  
The analogous arguments hold for an input signal of type S2. By contrast, signal S3 is a 
“negative” signal that effectively shuts down the entire system as it decreases the availability of 
NoxA1. The presence of pathway f2 can further exacerbate this situation, while the presence of f3 
or f4 may counteract this negative effect by releasing more active NoxA1. However, the situation 
under this scenario is more complicated because f3 or f4 also restore the inactive form of p47phox 
or Rac1GDP, which might need additional activation signals.  
Nothing is truly known about the internal regulation of the Nox1 system, but our analysis 
implies that the three disassembly and recycling pathways may not just be redundant variants, 
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but that they may permit specific control mechanisms that allow the system to habituate, adjust 
to persistent signals, and control its refractory period under repeated signals of the same or 
different types. An example is given by a system exposed to a persistent signal S1, and 
comparative simulation results for three distinct scenarios with only one recycling pathway each 
are presented in Figure B.3 (for details, see APPENDIX B.4). Although the responsiveness of the 
Nox1 system is affected by a number of factors, such as the relative rates of the reversible 
reactions and the magnitude of efflux, recycling via dephosphorylation of p47phox consistently 
tends to lead to as high, and usually higher, a steady state of X1 than the other two recycling 
mechanisms. Therefore, to achieve enhanced responsiveness to persistent signals of type S1, the 
most efficient regulatory mechanism would appear to be the activation of the corresponding 
recycling pathway via dephosphorylation of p47phox. This activation could be triggered directly 
by signals of type S1 or by an indirect mechanism. Particular responsiveness to other signals 
would require different control strategies. 
 In order to explore the relative effectiveness of the three recycling pathways, we used 
Monte-Carlo simulations to test the performance of seven distinct disassembly modules. These 
modules accounted for scenarios with only one, two or all three recycling pathways.  Initially, we 
tested the case where the basal flux through the proteolytic pathway (f14) is so small that it can be 
omitted. Several cases were explored. When the independent efflux f16 is also small enough to be 
ignored, the simulation results (Figure 3.6) are strongly affected by the relationships between the 
rate constants for the reversible reactions. When the reversible reactions are slow, modules 6 and 
7 (see Figure 3.5), have the shortest response time. These modules contain both disassociation 
pathways f3 and f4, which directly restore inactive p47phox and Rac1. In contrast, if the reversible 
reactions are fast, all modules exhibit a similar performance in terms of responsiveness as well as 
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response time. These results are consistent with the arguments from the thought experiment 
above. They strongly indicate that it is efficient to replenish the subunit pools as quickly as 
possible. However, this is only possible up to a point. In this case, the distributed disassembly via 
f3 and f4 is a preferred strategy. Recycling through f2 is particularly effective if the system is to be 
shut down. 
 If the efflux f16 cannot be ignored, the system performance is strongly influenced by the 
net balance between the fluxes converting NoxA1 and NoxA1P into each other. Clearly, tipping 
the balance toward the phosphorylated form supplies substrate for f16, thereby leading to a 
depletion of this subunit. This effect is exacerbated by a large apportionment of the deactivation 
flux toward f2, which is the only recycling flux generating NoxA1P. Indeed, supporting this 
assessment, our model analysis pointed to the importance of a suitable balance between f9 and 
f10. Given the potentially detrimental outcome of this scenario, it will be useful to study the 
magnitudes and regulation of both f16 and f2 experimentally.  
          We have employed computational methods to investigate the effectiveness of alternative 
strategies for Nox1 disassembly and the recycling of subunits in VSMCs. The results of the 
Monte-Carlo simulations, which by and large are independent of specific parameter values, 
strongly indicate that disassembly through recycling is much more effective than proteolysis. 
Furthermore, the relative performance of each recycling pathway is affected by the rates and 
balances of the reversible reactions in the system, and also by quantitative features of the system, 
such as the magnitude of the efflux of phosphorylated NoxA1 (f16) and the direction of the net 
flux between NoxA1 and NoxA1P. These balances are natural targets for internal control 
mechanisms of Nox1 dynamics, which at this point are unknown. Finally, the analysis revealed 
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information regarding the refractory period of the signaling system, which is determined by the 
relative magnitudes of several flux rates. 
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CHAPTER 4 
DYNAMIC ANALYSIS OF ANGIOTENSIN II-INDUCED NOX1 
ACTIVATION IN VASCULAR SMOOTH MUSCLE CELLS3 
 
4.1 Introduction  
  All cell types in vasculature have the ability to produce reactive oxygen species (ROS). 
More and more experimental and clinical evidence indicates that ROS, serving as important 
inter- and intra-cellular second messengers [3, 16], are involved in numerous fundamental 
biological processes [5, 10, 17, 45], including growth, proliferation, migration, and apoptosis. By 
the same token, ROS have been implicated in the genesis of a variety of vascular diseases [1, 7, 
11, 12], including atherosclerosis, hypertension, angiogenesis, and heart failure. Given their 
widespread importance, it becomes imperative to gain a better understanding of the potential 
endogenous sources of ROS and their regulatory mechanisms in vascular wall.  
The physiological generation of ROS often occurs as a by-product of other cellular 
processes [25]. Prominently, NADPH oxidase (Nox) has been identified as a main source of 
ROS, when it responds to various extracellular stimuli [13, 27, 28, 33], such as growth factors, 
hormones, and mechanical forces. Four distinct Nox homologues are found in vasculature, 
including Nox1, Nox2, Nox4, and Nox5 [33, 34]. The cellular distributions of these different 
homologues are rather complicated; they may exist in different types of vascular cells, and may 
also co-express in the same type of cells. For instance, in vascular smooth muscle cells (VSMCs) 
                                                
 
 
3 Adapted from: Yin, W., Voit, E.O. “The Dynamic Analysis of Angiotensin II-Induced Nox1 Activation in Vascular 
Smooth Muscle Cells”, (in the process of being submitted), 2012.  
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of large vessels, which have been extensively used to study the activation and regulation of Nox 
enzymes, two distinct homologues, namely Nox1 and Nox4, are found to co-exist [35].  
Compared to Nox4, which primarily maintains the basal level of ROS under unstimulated 
cells and is proposed to have enzymatic activity proportional to its protein expression  [31, 34], 
Nox1 is much more active and capable of responding to many extracellular stimuli. It is also 
regulated through a number of different signaling pathways[31]. Indeed, uncounted experiments 
have been devoted to exploring the underlying activation and regulatory mechanisms of Nox1 in 
different types of cells, as well as the responses to different stimuli. Among these stimuli, 
angiotensin II (AngII)-induced Nox1 activation in VSMCs has received the most attention [36-
38]. This system is thus as a good template to explore further details of the dynamics of Nox1.  
Regulation of Nox1 occurs at multiple levels, including transcription and translation, as 
well as through signal-based modulation. The former mechanisms are mainly associated with the 
long-term, sustained effects of Nox1 activity, while the latter is tightly related to the dynamic 
and transient responses of the Nox1 system. The signaling molecules that could directly affect 
Nox1 activity and subsequent ROS production include protein kinase C (PKC) [33], protein 
kinase A (PKA)[230], and cSrc together with its downstream signaling molecules [38, 233]. The 
involvement and regulatory functions of these signaling molecules have been identified and 
validated through various kinds of experiments, such as experiments that add pertinent activators 
and inhibitors to both unstimulated and stimulated cells [38], and knocked-down or silencing 
experiments of specific signaling molecules [38]. These carefully designed experiments have 
greatly enhanced our understanding of Nox1 regulation, and particularly its activating process, 
and have revealed the important and distinct roles of the involved signaling molecule. For 
instance, PKC has been shown to be involved in regulating the initial release of ROS in AngII-
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induced Nox1 activation in VSMCs; while the cSrc-dependent signaling cascade appears to be 
more involved with the sustained ROS increase over longer time horizons [38].  
Many studies have found that signal-based regulation often operates in a complicated 
fashion. On the one hand, distinct signals may simultaneously regulate the same process.  For the 
Nox1 system in VSMCs, both PKC [33] and cSrc [233] signals have been reported to be able to 
enhance the phosphorylation of p47phox, an essential step for initiating Nox1 activation. On the 
other hand, the same signaling molecule may be involved in multiple processes but exert 
opposite effects. For instance, PKC is not only involved in p47phox phosphorylation [33], but also 
capable of facilitating the phosphorylation of the subunit NoxA1[230]. The former mechanism 
tends to activate the Nox1 system, while the latter has the opposite effect of inhibiting Nox1 
activity by reducing the availability of active subunit NoxA1. As a consequence of these 
complex signaling regulation mechanisms, intuition is insufficient for deducing or predicting the 
ultimate effect or function of a pertinent signal that can potentially play two opposite roles. It is 
also not easy to infer the dominant signaling player for each pertinent process when multiple 
signals are involved.  
Compared to the activation process, the disassembly mechanisms of Nox1 have received 
much less attention, and many open questions remain that need to be answered. Some of these 
questions have already been posed and partially answered in Chapter 3, where we discussed four 
possible Nox1 disassembly mechanisms, namely one direct degradation pathway via proteolysis 
and three independent recycling pathways. By using different types of criteria, we inferred that 
the direct degradation pathway via proteolysis is most inefficient in disassembling the active 
Nox1 complex under nominal physiological condition, that is, in unstimulated cells. Moreover, 
we found that the relative importance and performance of each recycling pathway are affected by 
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the rates and balances of the reversible reactions in the system, and also by other quantitative 
features of the system (see detailed discussion in section 3.4).  
All analyses in Chapter 3 were based on the considerations of constant signals and 
steady-state values of the Nox1 system under both unstimulated and stimulated conditions. This 
restriction to the steady state is not sufficient for interpreting the function of the Nox1 system 
when it is exposed to the dynamic signals whose values continuously change over time. For 
instance, when the cell is treated with certain doses of Ang II , the Nox1 system is actually 
regulated by AngII-induced, dynamic signals, rather than constant signals. Dynamic scenarios of 
this type raise additional questions, including the following. Are the previously proposed 
disassembly pathways active simultaneously in the presence of dynamic signals? Are they 
equally important in disassembling Nox1 in stimulated cells? Does the role and importance of 
each disassembly pathway change in response to AngII-induced dynamic signals? How do 
AngII-induced signals dynamically regulate Nox1 activity?  
These types of questions are difficult to address with experiments, but we demonstrated 
here that we can at least partially answer and explore them with mathematical and computational 
methods. Indeed, the mathematical models we propose here not only integrate all available 
biological information and answer specific questions, but are also capable of reproducing most 
experimental observations regardless of whether they are static or dynamic, qualitative or 
quantitative. In fact, these mathematical models help us understand the overall dynamic behavior 
of the target system and its complicated structure, and enable us to analyze and predict the 
effects of time-varying responses in all system components.   
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The design of such models is complicated by the fact that good data are still scarce. 
Currently, many experiments exclusively measure input-output relationships of some select 
system components, without however characterizing the intermediate dynamics of the system. 
While these experiments have offered us many invaluable insights into the target system, 
including its key components, activators, and inhibitors, they seldom reveal detailed and specific 
information of each pertinent reaction or process, such as its reaction rate, kinetic properties of 
enzymes, or flux information. The question thus arises whether sophisticated computational 
approaches might be able to extract additional insights out of the given body of data, This 
chapter shows that this is possible, at least to some degree. It uses computational simulation 
methods to characterize dynamic features of the AngII-induced Nox1 activation system in 
VSMCs.  
4.2 Materials and Methods 
4.2.1 Overview of Model Structure 
Angiotensin II (AngII)-stimulated ROS production in VSMCs is mediated via Nox1 
activation [37]. Typically, this activation occurs in two distinct phases [240]: the first is rapid 
and transient (with a time scale ranging from seconds up to minutes), whereas the second phase 
is delayed and sustained (with a time scale ranging between 1 hour and several hours). The early 
phase of ROS production is due to an acute activation of Nox1 by AngII through different signal 
regulatory pathways [38], while the second phase is thought to depend mainly on the initial burst 
and is a consequence of up-regulation of mRNA and/or protein expressions of different Nox 
subunits, including Nox1 [37, 103], p22phox [104, 105], and p47phox [105, 106]. In order to 
investigate the regulatory mechanisms of Nox1 activation, we will mainly focus on the first 
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phase of ROS production with the targeted time interval ranging from the beginning of an AngII 
stimulus experiment up to 30 minutes.  
In the first phase, rapid ROS release requires p47phox phosphorylation by PKC and its 
subsequent translocation to the membrane [38, 105, 241]. PKC activity is regulated by AngII 
through three different phospholipases (PLs): PLC [234], PLA2 [236], and PLD [235]. An 
additional potential regulator of p47phox phosphorylation is cSrc [233, 242], although its function 
remains to be determined biochemically. Another indispensible step for Nox1 activation by 
AngII requires Rac1 [95, 96, 243], whose activation is regulated by some guanine nucleotide 
exchange factor (GEF), which has not be unambiguously identified in VSMCs. Of importance, 
the sustained stimulation of Rac1 by AngII depends on the initial burst of Nox1-catalyzed H2O2, 
which in turn activates cSrc and its downstream signaling molecules EGFR and PI3K [38]. As a 
result, this H2O2-induced cSrc activation creates an amplification of oxidase activity by imposing 
a positive feedback on the system, thereby maintaining the sustained increase of ROS production 
in cells stimulated with AngII. Moreover, recent studies suggest that the cytosolic subunit 
NoxA1 can be phosphorylated by some protein kinases, including protein kinase A (PKA) and 
PKC [230, 237]. This phosphorylation of NoxA1 greatly enhances its binding affinity to 14-3-3 
proteins [237], thus preventing its association with other Nox1 subunits. However, compared to 
other signaling molecules like PKC, AngII-induced PKA activation in VSMCs appears to be 
negligible (K. Griendling, pers. comm.). Therefore, we temporally ignore the regulatory effect of 
PKA on the process of NoxA1 phosphorylation in the current model and only consider the PKC-
mediated NoxA1 phosphorylation.  
 Based on our current understanding of the activation pathway, its topology, key 
components, pertinent regulatory signals, and the different, potentially simultaneous disassembly 
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pathways which have been proposed and discussed in Chapter 3, we propose here a model 
structure describing AngII-induced Nox1 activation and its subsequent ROS production in 
VSMCs. The key processes are shown schematically in Figure 4.1. In order to represent the Nox-
catalyzed ROS production in VSMCs as faithfully as possible, we consider not only Nox1, but 
also its homologue Nox4. However, because the enzymatic activity of Nox4 is not acutely 
affected by AngII treatment within the time interval 0~30 minutes, Nox4 is simply considered as 
an independent input with constant enzymatic activity under both unstimulated and stimulated 
conditions.  
 
Figure 4.1 Schematic representation of the model structure for AngII-induced Nox1 activation and 
subsequent ROS production in VSMCs.  
Components within the blue ellipse govern the Nox1 activation-disassembly system, while components within the 
yellow ellipse show a simplified representation of ROS metabolism. Orange ellipses represent two Nox1 
homologues that co-exist in VSMCs; the activity of Nox4 is considered constant. Red fonts represent signaling 




4.2.2 Two-Phase Modeling Strategy 
 The first step toward the computational analysis is to design a pathway model of the 
system in Figure 4.1. However, it seems not feasible to estimate parameters and deal with 
uncertainties regarding the ill-characterized pathway structure in one stroke. Instead, we apply a 
two-phased strategy: In the first phase, the target system is decomposed into four distinct 
modules. These modules include: the AngII-induced PKC activation module (shown in red font 
in Figure 4.1; the detailed structure of this module is given in Figure 4.2); the cSrc/EGFR/PI3K 
signaling cascade module (also shown in red font in Figure 4.1; the detailed structure of this 
module is given in Figure 4.3); the module of ROS metabolism (shown in the yellow ellipse in 
Figure 4.1); and the Nox1 activation-disassembly module (shown in the blue ellipse in Figure 
4.1).  Each module is separately constructed, and parameters are estimated correspondingly, as 
far as it is feasible. In the second phase, all individually constructed modules are integrated and 
the composite model is further modified and analyzed.  
Phase I: Model Decomposition 
 The pathway system depicted in Figure 4.1 is decomposed into four distinct modules, as 
discussed above, and each individual module is briefly and separately described in the following.  
AngII-induced PKC activation module: Protein kinase C (PKC) is a family of protein kinases 
that are involved in controlling the function of other proteins through the phosphorylation of 
hydroxyl groups of serine and threonine amino acid residues on these proteins [244, 245]. The 
PKC family contains fifteen isoforms in human, which can be divided into three subfamilies 
based on their second messenger requirements [244]. The term “protein kinase C” usually refers 
to the entire family of isoforms. The PKC enzymes are activated by signals such as increases in 
the concentration of diacylglycerol (DAG) [244, 246], calcium ions (Ca2+) [244], or arachidonic 
acid (AA) [247], and therefore play important roles in several signal transduction cascades.  
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 In cultured VSMCs, PKC can be activated by many extracellular stimuli. Among them, 
the best-studied example is probably AngII [248, 249]. Treatment of VSMCs with AngII induces 
a series of biochemical events, including sequential phospholipase C (PLC)-mediated hydrolysis 
of phosphotidylinositol (PI) and polyphosphoinositides (including PIP and PIP2) [250-252], 
phospholipase D (PLD)-mediated hydrolysis of phosphatidylcholine (PC) [253, 254], and 
cytosolic phospholipase A 2 (cPLA2)-mediated hydrolysis of PC and phosphatidylserine (PE) 
[255].  These coordinated events result in a transient formation of inositol trisphosphate (IP3) that 
is associated with calcium (Ca2+) mobilization [256, 257], a biphasic formation of diacylglycerol 
(DAG) [250, 251], and a rapid and time-dependent release of arachidonic acid (AA) [255]. 
Through these mechanisms, AngII leads to an increase in the concentrations of Ca2+, DAG, and 
AA, and thus up-regulates PKC enzymatic activity in VSMCs.  
 Although several studies have documented that AngII can induce a sustained PKC 
activation in VSMCs, there few published records directly describe to which level PKC activity 
is upregulated, let alone its responsive dynamics. Therefore, in order to mimic the dynamic 
activity of PKC in response to extracellular AngII treatment in VSMCs, we use here 
computational simulation methods.   
 The PKC activation system has been investigated in numerous studies, and the pathway 
structure, key components, and a variety of other biological data are available in the literature. 
The model we propose is based on this information and directly reflects the pathway structure 
shown in Figure 4.2. The most pertinent information for the model is summarized in Table 4.1. 
The dependent variables, whose concentrations are affected by the system, include inactive PKC, 
active PKC in six distinct forms (PKC alone, AA·PKC complex, Ca2+·PKC complex, 
AA·Ca2+·PKC complex, Ca2+·PKC·DAG complex, and AA·PKC·DAG complex), and inactive 
intermediate complexes in four different forms (Ca2+·PKC complex, Ca2+·PKC·DAG complex, 
DAG·PKC complex, and AA·PKC·DAG complex). The independent variables, whose 
concentrations are not affected by the system, include DAG, AA, and Ca2+. All biochemical 
reactions tend to be reversible (denoted by double-headed arrows in Figure 4.2), including 
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reactions in both “forward” (denoted by the arrow pointing to the right) and “backward” 
(denoted by the arrow pointing to the left) directions.  Since AngII indirectly regulates PKC 
activity through these three independent variables, it is feasible and reasonable to use their 
dynamic profiles under AngII treatment as “offline inputs” to the PKC activation system to 




Figure 4.2 Schematic representation of the AngII-induced PKC activation in VSMCs.  
Pink boxes represent active PKC in distinct formats; Grey boxes represent inactive PKC in distinct formats. Black 







Table 4.1 System variables in PKC activation module. 
Variable Index Variable Name 
X1 PKCinactive (inactive PKC alone) 
X2 PKCactive1 (active PKC alone) 
X3 PKCactive2 (active AA·PKC complex) 
X4 PKCactive3 (active Ca2+·PKC complex) 
X5 PKCactive4 (active AA·Ca2+·PKC complex) 
X6 PKCactive5 (active Ca2+·PKC·DAG complex) 
X7 PKCactive6 (active AA·PKC·DAG complex) 
X8 Inactive Ca2+·PKC complex 
X9 Inactive Ca2+·PKC·DAG complex 
X10 Inactive DAG·PKC complex 





Symbols with * indicate independent variables; other symbols indicate dependent variables.  
 
 To translate the targeted biological system diagram into an appropriate mathematical 
structure that permits analytical and simulation-supported diagnosis, we use ordinary differential 
equations in mass action format. The module thus can be expressed as shown in Eq. (4.1): 
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  (4.1) 
Here, each Xi, i =1, 2, ···, 11, is a dependent variable, while each Xi, i =12, ···, 14, is an 
independent variable (see Table 4.2). The parameters and  are rate constants of the 
corresponding reactions in forward and backward directions, respectively.  
 
cSrc/EGFR/PI3K signaling cascade module: Although experimental studies have revealed that 
AngII increases ROS levels in VSMCs via a Nox1-mediated mechanism [37], the upstream 
signaling mechanisms through which AngII stimulates Nox1 activity are still not completely 
known. It has been suggested that they might include several signaling molecules, including 
PKC [38, 241], epidermal growth factor receptor (EGFR) [38], cSrc[38, 233], and 
phosphatidylinositol-3-kinase (PI3K) [38]. These signaling molecules are involved in different 
phases of ROS production, and thus have distinct functions in regulating Nox1 activity. The 
suggested mechanism is shown in Figure 4.3 and summarized as ollows. AngII binds to the 
AngII type 1 receptor (AT1R), leading to acute Nox1 activation, mainly through PKC-regulated 
p47phox phosphorylation and the release of an initial burst of ROS. This initial increase in ROS 
(specifically, H2O2) then activates the redox-sensitive signaling molecule cSrc, a process which 
results in the subsequent activation of its down-stream signals, including EGFR and PI3K. The 
X1 = −k f (1)*X1 − k f (2)*X1 *X12 − k f (7)*X1 *X13 − k f (9)*X1 *X14 + kb(1)*X2 + kb(2)*X3 + kb(7)*X8 + kb(9)*X10
X2 = k f (1)*X1 − kb(1)*X2
X3 = k f (2)*X1 *X12 − kb(2)*X3
X4 = k f (3)*X8 − kb(3)*X4
X5 = k f (4)*X8 *X12 − kb(4)*X5
X6 = k f (5)*X9 − kb(5)*X6
X7 = k f (6)*X11 − kb(6)*X7
X8 = −k f (3)*X8 − k f (4)*X8 *X12 + k f (7)*X1 *X13 − k f (8)*X8 *X14 + kb(3)*X4 + kb(4)*X5 − kb(7)*X8 + kb(8)*X9
X9 = −k f (5)*X9 + k f (8)*X8 *X14 + kb(5)*X6 − kb(8)*X9
X10 = k f (9)*X1 *X14 − k f (10)*X10 *X12 − kb(9)*X10 + kb(10)X11
X11 = k f (10)*X10 *X12 − k f (6)*X11 + kb(6)*X7 − kb(10)X11
fk bk
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activation of PI3K enhances the productivity of phosphatidylinositol (3,4,5)-triphosphate (PIP3), 
which potentially stimulates Rac1 activation, an essential and indispensable step for gaining 
Nox1 enzymatic activity. As a result, Nox1 is continuously activated and the increase of ROS 
continues. Although the regulatory mechanism of PIP3 on Rac1 activation is not completely 
understood, it has been suggested that PIP3 may regulate Rac activation by binding with several 
Rac-guanine nucleotide exchange factors (Rac-GEF) including Vav and Sos, which enhances 
their activity [38].  
 The proposed model structure for the cSrc/EGFR/PI3K signaling cascade is 
schematically shown in Figure 4.3. All signaling molecules can exist in two interconvertible 
forms, namely active form (marked with an asterisk in Figure 4.3) and inactive (without 
asterisk). The levels of all active signaling molecules are defined as “1” (100%) in unstimulated 
condition, but may increase above “1” (by activation) or decrease below “1” (by inhibition) as 
their up-stream signals vary. Two further metabolites of the module, phosphatidylinositol (4,5)-
bisphosphate (PIP2) and PIP3 (denoted with green boxes), are also interconvertible into each 
other; the reaction from PIP2 to PIP3 is regulated by the level of active PI3K.  
 In order to understand how the Nox1 system is dynamically activated and regulated by 
the cSrc-dependent signaling cascade, we first need to determine the dynamic response of PIP3. 
Unfortunately, this profile cannot be directly found in literature, but needs to be estimated 
through simulation methods. By contrast, records of the active signaling molecules for cSrc, 
EGFR, and PI3K under the same experimental condition can be found in literature (see details in 
section 4.2.3). As a result, the availability of multiple experimental data sets for the same 
signaling cascade offers several options as we set up the corresponding module to predict the 
dynamic profile of PIP3.  
 For instance, we can use the PI3K data as the only external input and directly predict PIP3 
dynamics, while ignoring the effects of upstream EGFR and cSrc signals. Alternatively, we can 
use EGFR data as the only external input to predict the dynamics of both PI3K and PIP3. Finally, 
we can also use cSrc data as the system input to predict the entire signaling cascade 
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simultaneously. These options raise several questions: Are the data characterizing different 
aspects of the same signaling cascade consistent with each other? Do these data have equivalent 
information content or is one or are several of them more useful for our task?    
 In order to explore possible answers to these questions, we use three candidate modules 
by using different data as the external input; the module structures are shown in Figure 4.4, 
panels (a) to (c). Due to the different input variables, the three candidate modules have distinct 
structures, and different numbers of system variables and parameters. The most pertinent 
information of the three module candidates is summarized in Table 4.2. Specifically, the first 
candidate (Figure 4.4a) uses active PI3K as an input, and contains only one dependent variable, 
PIP3. The second candidate (Figure 4.4b) uses active EGFR as input, and contains two dependent 
variables, namely PIP3 and PI3K. The last module (Figure 4.4c), takes active cSrc as input and 
represents the entire signaling cascade; it therefore has the most dependent variables, namely 
PIP3, PI3K and EGFR.  
 The mathematical representation of the pathway structures again uses ordinary 
differential equations in mass action format, which is extended toward the GMA format (see 
Chapter 1) in some places to permit the modeling of different signal strengths. Specifically, a 
real-valued kinetic order gi is assigned to each regulatory signal. A positive value indicates 
activation, while a negative value indicates inhibition. Thus, models of the three module 




Figure 4.3 Schematic representation of the cSrc/EGFR/PI3K signaling cascade.  
Orange boxes with an asterisk represent active signaling molecules. Light blue boxes without an asterisk represent 
inactive signaling molecules. Green boxes represent metabolites.  
 
 
Figure 4.4 Three candidate modules for the cSrc/EGFR/PI3K signaling cascade that use different data as 
external input.  
(a) Active PI3K serves as input signal; (b) Active EGFR serves as input signal; (c) Active cSrc serves as input 
signal. Orange boxes with asterisk represent active signaling molecules. Light blue boxes without asterisk represent 




  Table 4.2 System variables in three candidate modules of the cSrc/EGFR/PI3K signaling cascade. 











    Active EGFR 
X1 PIP3 
X2 Active PI3K 
X3* PIP2 








X2 Active PI3K 
X3 Active EGFR 
X4* PIP2 
X5* Active cSrc 
        Symbols with * indicate the independent variables; Symbols without * indicate the dependent variables.  
 
Candidate Module 1:       (4.2) 
Candidate Module 2:     (4.3) 
Candidate Module 3:     (4.4) 
In these representations, the parameters γi, i = 1, ···, 6, represent rate constants, while gi, i = 1, 2, 
3, are kinetic orders. These two parameters, whose numerical values need to be estimated, 
characterize the dynamics of the system. TPI3K and TEGFR respectively represent the total amount 
of PI3K and EGFR, including both active and inactive forms.  
 
Module of ROS metabolism: VSMCs possess mainly two types of reactive oxygen species 
(ROS), namely superoxide ( ) and hydrogen peroxide (H2O2). As stated in the section 1.2.1 


























































(also see Figure 1.1), these two ROS molecules can be generated from a variety of intracellular 
sources, and also be consumed by different mechanisms. Due to the existence of multiple 
production and degradation pathways for ROS, the pathway structure of ROS metabolism is 
complicated, and the experimental identification of ROS from specific sources difficult. A recent 
study used membrane fractions extracted from cultured rat aortic smooth muscle cells 
(RASMCs) to measure ROS production [36]. In this study, sources other than Nox1 and Nox4 
were excluded, and thus had no measurable contributions to ROS production. Based on this 
experimental investigation, we limit our analysis here on ROS produced from Nox1- and Nox4-
catalyzed biochemical reactions.  
 Although the main product of Nox is commonly considered to be superoxide (see 
discussion in section 1.2.2), some Nox is believed to be capable of producing other types of 
ROS. For instance, in VSMCs, Nox4 is thought to directly release hydrogen peroxide rather than 
superoxide [36]. Therefore, it is reasonable for the model to consider Nox4 as a constant supply 
for both superoxide and hydrogen peroxide.  
 Compared to their production process, the degradation pathways of ROS are more 
complicated. As a free radical species, superoxide has a surprisingly limited reactivity with 
intracellular components [3]. As a result, the dominant pathway for superoxide depletion is its 
conversion to hydrogen peroxide, either spontaneously or enzymatically via superoxide 
dismutase (SOD) [1, 11, 21]. The fact that the amount of SOD in VSMCs is sufficient to 
dismutase increased superoxide production rapidly into H2O2 further confirms the effectiveness 
of this pathway. Besides, superoxide can also be consumed by its reactions with other molecules 
[11], such as NO, although the involved amount might be very limited. With respect to depletion 
mechanisms, H2O2 is far more diverse and complicated than superoxide, because H2O2 is more 
reactive, especially when it reacts with intracellular thiol groups [2, 3]. Once produced, H2O2 can 
be removed via several antioxidant enzyme systems [2], including catalases (CAT), glutathione 
peroxidases (GPx), and peroxiredoxins (Prx). Since the details of H2O2 degradation are not of 
premier interest here (see the comprehensive and detailed model for H2O2 elimination in [258]), 
115 
we combine for simplification all H2O2 degradation pathways into one pathway. By doing so, we 
do not necessarily need to know detailed profiles of each involved antioxidant system that could 
potentially react with H2O2, which thus greatly reduces the modeling and computational 
complexity.  
 After collecting all available biological information regarding Nox-mediated ROS 
production and degradation in VSMCs, we propose a simplified model structure for ROS 
metabolism that is schematically represented in Figure 4.5. The most pertinent information about 
this module is summarized in Table 4.3. The model contains two dependent variables, namely 
superoxide and hydrogen peroxide. The active Nox1 enzyme is temporarily considered as an 
independent variable in this module, although its activity may dynamically change over time in 
other modules. The active Nox4 enzyme serves as another independent variable, whose value is 
kept constant for both unstimulated and stimulated conditions (except for Nox4 knock-outs). The 
concentrations of other involved substrates, such as NADPH and molecular oxygen, are 
considered to be abundant enough to become constant. Thus, they can ultimately be combined 
with system parameters, such as rate constants.  
 
                    Figure 4.5 Schematic representation of ROS metabolism in VSMCs.  
 
 To translate the pathway structure in Figure 4.5 into a model, we again utilize ordinary 
differential equations in GMA format. Specifically, the targeted module is mathematically 
represented by Eq. (4.5) in the following manner: 
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 .          (4.5) 
Here, is th vector of dependent variables, is the flux vector, and 
 is the stoichiometric matrix, which describes the quantitative 
relationships between dependent variables and corresponding fluxes. The explicit expression of 
each individual flux is given in Eq. (4.6). Most fluxes are mathematically expressed with the 
mass action rate law except for the degradation of H2O2, which is modeled in GMA format with 
a corresponding kinetic order equal to 0.5. This modification is adjusted according to a later 
parameter estimation process to obtain satisfactory model fits.  
         (4.6) 
          
Table 4.3 System variables in the ROS metabolism module. 
Variable Index Variable Name 
X1 Superoxide (O2.-) 
X2 Hydrogen Peroxide (H2O2) 
X3* Active Nox1 (Nox1active) 
X4* Active Nox4 (Nox4active) 
Symbols with * indicate independent variables; Symbols without * indicate the dependent variables. 
 
 
Nox1 activation-disassembly module: To capture all potential activating and disassembly 
pathways of Nox1 in VSMCs, we already proposed a generic pathway structure and described it 
in great detail in Chapter 3 (see Figure 3.1). In this Chapter, we will keep the generic pathway 
X = N ⋅F
X2×1 F6×1
N2×6 = [
1 1 −1 −1 0 0
0 0 0 0.5 1 −1
]
f1 = γ1 *X3
f2 = γ2 *X4
f3 = γ3 *X1
f4 = γ4 *X1
2
f5 = γ5 *X4













structure that has been proposed before, and only change the static input signals S1, S2 into 
corresponding dynamical signals (PKC and the cSrc-dependent signaling cascade).  
Phase II: Model Integration 
  In order to explore the overall dynamic behaviors of the Nox1 system and its subsequent 
ROS production in response to AngII, the four modules described above (see Phase I: Model 
Decomposition) are integrated into one structure, according to the following steps (cf. Figure 
4.6): First, the AngII-induced PKC activation module is simulated and the dynamic profile of 
PKCactive is predicted. Then, the predicted PKCactive and the output of the cSrc/EGFR/PI3K 
signaling cascade (represented by PIP3, which cannot be separately predicted like PKCactive) are 
fed into the Nox1 activation-disassembly module as “driving” inputs, regulating the activity of 
Nox1active. Finally, Nox1active is modeled to serve as a dynamic input to the ROS metabolism 
module, up- or down-regulating ROS production or concentration.  
 
Figure 4.6 Proposed process for integrating the four modules developed before.  
 The choice between three distinct module candidates for the cSrc/EGFR/PI3K signaling 
cascade leads to the possibility of three integrated model candidates. Each model candidate 
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contains different numbers of system variables, fluxes, and pertinent parameters. To translate the 
model diagrams into a mathematical structure that permits analytical or simulation-aided 
diagnoses of the integrated system, we combine the mathematical descriptions in Eqs. (4.2) -
(4.6) by reassigning the corresponding system variables and parameters. The most pertinent 
information about the system variables and mathematical description for the three integrated 
model candidates is summarized in Table 4.4. Eqs. (4.7), (4.8), and (4.9), Ni, i =1, 2, 3, show the 
stoichiometric matrix (see details of Ni in APPENDIX C.1). It quantifies the relationships 
between the dependent system variables and corresponding fluxes in each model candidate. Fi, i 
= 1, 2, 3, is the flux vector for model candidate i; it is explicitly given in Table 4.5. 
4.2.3 Data Sources 
 Over the past decades, NADPH oxidase and its product ROS have received ample 
attentions, and numerous pertinent experiments have been implemented under different 
conditions and in various types of cells. These experimental studies not only enhance our 
biological understanding of the Nox family, but also provide us a considerable amount of 
qualitative and/or quantitative data in either static or dynamic formats, which can help facilitate 
many steps of our modeling process, such as parameter estimation and model validation. Since 
quantitative results of experiments in different cell types, or targeting different Nox homologues, 
may differ substantially, we focus on experimental results for Nox1 and its subsequent ROS 
product in one particular cell type – vascular smooth muscle cells (VSMCs). The most relevant 
experimental data, collected from literature, are summarized in the following.  
Experimental Data for AngII-Induced PKC Activation in VSMCs 
 The dynamic profiles of AA, Ca2+, and DAG under AngII (100nM) treatment in VSMCs 
are found in literature [250, 255, 257] and correspondingly displayed in Figure 4.7. The solid 
black line represents the level of each type of molecule in unstimulated cells, which is considered 
119 
the control condition and represented as “1”. The circles are experimental records, which are 
recalculated as fold changes compared to the level in the control condition.  
 
Table 4.4 Systematic information of three integrated model candidates. 
Index System Variables System Equation 
Model 
Candidate 1 
X1 Nox1active X9 O2.- 
,     (4.7)  
where X11×1 is the vector of dependent 
system variables, N1 is the 11×24 
stoichiometric matrix, and F1 is a 24×1 flux 
vector. 
X2 Nox1/p22phox X10 H2O2 
X3 p47phox X11 PIP3 
X4 p47phoxP X12* PKCactive* 
X5 Rac1GDP X13* PIP2* 
X6 Rac1GTP X14* PI3Kactive*  
X7 NoxA1 X15* cSrcactive* 
X8 NoxA1P X16* Nox4active* 
Model 
Candidate 2 
X1 Nox1active X10 H2O2 
,   (4.8) 
where X12×1 is the vector of dependent 
system variables, N2 is the 12×26 
stoichiometric matrix, and F2 is a 26×1 flux 
vector. 
X2 Nox1/p22phox X11 PIP3 
X3 p47phox X12 PI3Kactive 
X4 p47phoxP X13* PKCactive* 
X5 Rac1GDP X14* PIP2* 
X6 Rac1GTP X15* EGFRactive* 
X7 NoxA1 X16* cSrcactive* 
X8 NoxA1P X17* Nox4active* 
X9 O2.-   
Model 
Candidate 3 
X1 Nox1active X10 H2O2 
, (4.9) 
where X13×1 is the vector of dependent 
system variables, N3 is the 13×28 
stoichiometric matrix, and F3 is a 28×1 flux 
vector. 
X2 Nox1/p22phox X11 PIP3 
X3 p47phox X12 PI3Kactive 
X4 p47phoxP X13 EGFRactive 
X5 Rac1GDP X14* PKCactive* 
X6 Rac1GTP X15* PIP2* 
X7 NoxA1 X16* cSrcactive* 
X8 NoxA1P X17* Nox4active* 
X9 O2.-   
Symbols with * indicate independent variables, and symbols without * indicate dependent variables. The details of 





Table 4.5 Mathematical descriptions of fluxes in three integrated model candidates. 
Index Mathematical Description of Fi 
Model 
Candidate 1 








, where each flux is given in the GMA format as:  
 
Symbols with * indicate parameters with estimated numerical values, and symbols without * indicate parameters with 
unknown numerical values. TPI3K and TEGFR respectively represent the total amount of PI3K and EGFR, including 
both active and inactive forms.  
 
 
TfffffF ][ 24233211 =
f1 = γ1X2X4X6X7 f7 = γ7X5X11
g3 f13 = γ13 f19 = γ19
* X9
f2 = γ2X1 f8 = γ8X6 f14 = γ14X1 f20 = γ20
* X9
2
f3 = γ3X1 f9 = γ9X7X12
g4 f15 = γ15 f21 = γ21
* X16
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 In unstimulated cells, the basal levels of DAG, Ca2+, and AA are found to be 
~0.5nmol/106 cells, ~150-300 nM, and at the order of µM [236, 253, 257], respectively. These 
steady state values (marked with subscript SS symbol) are recalculated into a unit of (# 
molecules/cell) as follows:  
[DAG]SS = ~0.5nmol/106 cells ≈ 0.5*10-9*6*1023 molecules/106 cells ≈ 3*108 molecules/cell.  
[Ca2+]SS = 150~300nM ≈ 150~300*10-3*6*105 molecules/cell ≈ 9~18*104 molecules/cell. 
[AA]SS = 1~ 10 µM ≈ 1~10 * 6*105 molecules/cell ≈ 0.6~6*106 molecules/cell. 
 
Figure 4.7 Experimental data for AngII-induced PKC activation in VSMCs.  
Cells were treated with AngII (100nM) at time t = 0. Solid black line indicates the level of each variable in 
unstimulated cells (or called control condition), which is represented as “1” (100%). Circles are experimental 
records [236, 253, 257], which were recalculated as fold changes compared to the level in the control condition. 
Dashed lines were added for easy readability. 
Experimental Data for cSrc/EGFR/PI3K Signaling Cascade  
 The dynamic profiles of cSrc, EGFR, and PI3K under AngII (100nM) treatment in 
VSMCs are also found in literature [259-261] and correspondingly displayed in Figure 4.8. The 
solid black line represents the level of active signaling molecules in unstimulated cells (control 
condition), which is assumed to be at “1”. The circles are experimental records that are 
recalculated in fold.  
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Figure 4.8 Experimental data for AngII-induced cSrc/EGFR/PI3K signaling cascade in VSMCs.  
The cells were treated with AngII (100nM) at time t = 0. The solid black line represents the level of active signaling 
molecule, which is represented as “1” (100%). Circles are experimental records [259-261]. Dashed lines were added 
for easy readability. 
Experimental Data for ROS Metabolism Module 
 There are mainly two types of experimental measurements for NADPH oxidase. One 
aims to detect the existence and distribution of Nox homologues in different types of cells and 
tissues by measuring their subunit expression at mRNA and/or protein levels. Although 
sometimes the expression at the mRNA level does not well correlate with its corresponding 
protein level [127], these measurements still reveal the relative abundances between measured 
subunits to some extent. In VSMCs from large arteries, Nox1 and Nox4 mRNA are found to be 
expressed to a much higher degree than Nox2 (over 103 fold) [37], and this observation is further 
confirmed by very low Nox2 protein detection, using immunoprecipitation and immunoblotting 
in human aortic smooth muscle cells [105]. In quiescent VSMC, Nox4 mRNA expression is 
much higher than Nox1 mRNA expression (over 103 fold in [36], over 20 fold in [28]). In 
proliferating VSMC, the number of Nox1 mRNA molecules is significantly increased (~2 fold), 
but the number of Nox4 mRNA molecules is decreased [36, 37], which effectively reduces the 
dramatic difference between Nox1 and Nox4 mRNA expression.  
123 
 The second class of experiments aims to explore the functionality of Nox enzymes. By 
comparing the control system as it responds to certain stimuli, plenty of Nox activators and 
regulators have been identified (see detailed reviews in [31, 34]). The conclusions drawn from 
these comparisons are usually based on experimental measurements of either the intra- or extra-
cellular ROS concentration (or production) under different conditions. However, due to 
differences of experimental set-ups and conditions, the measured ROS concentration (or 
production) might be found in different magnitudes, or have distinct transient behavioral 
patterns, even in response to the same stimulus and under the exact same condition. For instance, 
one research group found that the ROS concentration first increased significantly (~1.6 fold) 30 
seconds after AngII (100nM) treatment in VSMCs, but declined after 1 minute due to some 
unknown reasons, and then increased again to a plateau (~ 2 fold at 30 minutes) [38].  By 
contrast, another group indicated a continuous and gradual increase in ROS concentration for 
over 30 minutes for the same dose of angiotensin II treatment in the same type of cell [235]. 
Although the transient responses of ROS are thus different, they agree that, after 30 minutes of 
AngII (100nM) treatment, the ROS level is significantly increased, and this increase can last for 
a long time, indicating that AngII is a strong activator of Nox1 and can enable the ROS 
concentration to reach a much higher plateau than under unstimulated conditions. Additionally, 
these two studies suggest that 30 minutes is a time interval that is long enough to allow the 
system reach a new (quasi-) steady state where the level of ROS increases stably.  
 Although ROS molecules have multiple intracellular sources, we focus here on Nox-
catalyzed ROS production in VSMCs. In well-designed experiments with a membrane fraction 
model [36], this type of ROS production was well calibrated and accurately measured. In 
quiescent VSMCs, the measured production rates for superoxide and hydrogen peroxide in 




Experimental Data for the Nox1 Activation-Disassembly Module 
The structural and regulatory Nox1 subunits, including p22phox, p47phox, NoxA1 and 
Rac1, have been shown to co-express in VSMCs [27, 33, 99, 105]. In unstimulated cells, p47phox 
stays mainly in cytosol, according to results from immunofluorescence confocal microscopy 
[100]. The small GTPase Rac1 becomes membrane associated in its GTP-bound active form only 
if the corresponding GEF is activated [112]. In other cells, only ~0.2% endogenous Rac1 was 
experimentally observed in the GTP-bound form [96]. However, due to the lack of precise 
measurements at protein level, accurate quantitation of these subunits is not available in 
literature. Instead, the relative abundances of these subunits, as summarized in Table 4.6 (in 
consultation with experimentalists), will be used in later sections.  
Table 4.6 Numerical steady states of system variables in Nox1 activation-disassembly module. 
Variable Name Numerical Steady-State Value 
Active Nox1 complex (Nox1active) (molecules/cell) 
Nox1/p22phox (molecules/cell) 
p47phox (molecules/cell) 
Phosphorylated p47phox ( ) (molecules/cell) 
GDP-bound Rac1 (Rac1GDP) (molecules/cell) 
GTP-bound Rac1 (Rac1GTP) (molecules/cell) 
NoxA1 (molecules/cell) 













Combined Static Data for the Integrated Model 
In order to explore the possible regulatory mechanisms of the Nox1 system, a variety of 
scenarios have been experimentally executed in in vivo or in vitro environments. These scenarios 
include the knock-out, knock-down, or over-expression of certain Nox1 subunits [36, 37, 39, 98, 
262], pre-incubation with activators or inhibitors in both unstimulated and stimulated cells [28, 
37, 233, 259], and treatment with different extracellular stimuli [235, 263]. Although many of 
these kinds of experiments were only executed qualitatively or semi-quantitatively,leading to one 
“static” data point, they have helped with the identification of a series of key components and 
pathways involved in Nox1 activation. Specifically, they have provided intrinsic insights of 
regulatory signals and their potential effects on Nox1 enzymatic activity, and therefore can be 
used as reasonable criterion to facilitate the parameter estimation process. The most pertinent 
information regarding static data of the Nox1 system and its subsequent ROS production in 
VSMCs stimulated by AngII (100nM), as well as other extracellular stimuli,was collected from 
literature and is summarized in Table 4.7.  
Combined Dynamic Data for Integrated Model 
Another type of experimental data consists of records at a series of sequential time points 
(i.e., “time-series” data). Compared to static data, time-series data usually provide more detailed 
information, especially with respect to the system’s dynamic responses. However, this advantage 
of dynamic data doesn’t come for free. It usually requires more complicated experimental set-
ups. As a consequence, much fewer dynamic data than static data are available in the literature, 
especially for complicated signaling systems.  
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For the AngII-induced Nox1 activation in VSMCs, there are currently only two sets of 
dynamic data available in literature. The first set describes the dynamic profile of Rac1GTP after 
AngII (100nM) treatment [38] (displayed in Figure 4.9 top panel), while the second set 
characterizes the changes in ROS concentration (specifically, H2O2) under the same treatment 
[38] (displayed in Figure 4.9 bottom panel).  These two data sets, although measured at limited 
time points, provide very useful information about the system’s overall dynamic behaviors in 
response to AngII, and therefore can be utilized as criteria in later parameter estimation 
processes.  
 
Figure 4.9 Combined dynamic data for integrated model.  
Top panel: dynamic profile for Rac1GTP; Bottom panel: dynamic profile for H2O2. Solid black lines represent the 
levels of targeted variables in unstimulated cells, which are assumed as “1”. Circles are experimental records [38] 




Table 4.7 Static experimental data of Nox1 and ROS production in VSMCs. 
Experimental Condition Scenario Description Experimental Readout (Fold) Reference 
Control Unstimulated  1  
AngII* PKC↑, cSrc/EGFR/PI3K↑  
[Rac1GTP]30min = 2.4 
[p47phoxP]30min = 2 
[O2.-]30min = 1.8 
[36, 38, 
233] 
AdASNox1^ Unstimulated, Nox1 protein is 
knocked-down to ~1% 
 [36, 37] 
AdASNox1^ + AngII* PKC↑, cSrc/EGFR/PI3K↑, Nox1 
protein is knocked-down to ~1% 
 [36, 37] 
siNox4& Unstimulated, Nox4 mRNA is 
knocked-down to ~50% 
 [36] 
siNox4& + AngII* PKC↑, cSrc/EGFR/PI3K↑, Nox4 
mRNA is knocked-down to ~50% 
 [36] 
AngII* + AG1478$ PKC↑, cSrc↑, AngII-induced 
EGFR transactivation is blocked 
[H2O2]30min = 1.2
 [38] 
AngII* + AdRacN17# PKC↑, cSrc/EGFR/PI3K↑, 
AdRacN17 has much lower 
affinity for GTP than for GDP 
[H2O2]30min = 1.14
 [38] 
AngII* + PP1~ PKC↑, AngII-induced cSrc 
activation is blocked 
[H2O2]30min = 1.08
 [38] 
PMA@ PKC↑↑ ROS ↑ [27] 
AngII* + GF 109230X% cSrc/EGFR/PI3K↑, AngII-induced 





Scenario conditions: AngII* at 100 nM, AdASNox1^ represents Nox1-depleted cells, siNox4& represents Nox4-
depleted cells, AG1478$ represents a EGFR kinase inhibitor, at 250nmol/L, AdRacN17# is a dominant-negative 
construct of Rac1, PP1~ is a cSrc inhibitor, at 20 µmol/L, PMA@, is a PKC activator, GF 109230X% is a PKC 
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4.2.4 Parameter Estimation 
Before running model simulations and various kinds of system diagnosis, a challenging 
but indispensable step is to specify the numerical values for all parameters according to available 
experimental observations. According to the specific type of available data (qualitative or 
quantitative, static or dynamic), an appropriate parameter estimation method needs to be chosen 
carefully. Based on the currently available data sources introduced in section 4.2.3, different 
methods will be used here to estimate parameter values for different modules as well as the 
integrated models.  
Parameter Estimation for AngII-Induced PKC Activation Module 
 The parameters used in the AngII-induced PKC activation module include the rate 
constants for both forward ( ) and backward ( ) reactions for each individual biochemical 
process. The numerical values of these rate constants are found in the literature [264] and 
summarized in Table 4.8.        
Parameter Estimation for ROS Metabolism Module 
Parameters that need to be estimated for the ROS metabolism module include the rate 
constants γ1 to γ6. Due to the particular format of the flux expressions, estimating these rate 
constants is equivalent to estimating the corresponding fluxes. What’s more, in unstimulated 
cells, the assumption that the system operates at a steady state imposes a set of linear constraints 
to these fluxes. Specifically, the relevant fluxes need to satisfy Eq. (4.9). 
  




          Table 4.8 Parameter values in the AngII-induced PKC activation module. 
Reaction Index   
1 1 50 
2 2×10-10 0.1 
3 1.2705 3.5026 
4 2×10-9 0.1 
5 1 0.1 
6 2 0.2 
7 1×10-6 0.5 
8 1.3333×10-8 8.6348 
9 1×10-9 0.1 
10 3×10-8 2 
           Parameter values are adapted from[264].  
,        (4.9) 
As stated in section 4.2.3, according to experimental measurements from the membrane 
fraction model from RASMCs, the measured production rate of in a membrane fraction 
model from RASMCs was about 90 pmol/mg/min [36]. In order to convert this measured 
production rate into the metrics that we use in our simulation (#molecules/s/cell), the following 
information needs to be taken into account:  
(1) 106 smooth muscle cells (SMC) contain 80 ~ 100 mg protein (information provided 
by experimentalists) 
(2) The membrane fraction contains much less than 10% protein of whole cell (estimated 
by experimentalist, and 1%~2% is used in real calculation).  























The production of  comes from two sources. The predominant one is catalyzed via 
Nox1 (marked as f1 in Figure 4.5) [36]. The other, as a minor source, is catalyzed directly by 
Nox4 (marked as f2 in Figure 4.5) [51]. Therefore, the calculated overall production rate of  
is split into two parts with the Nox1-catalyzed production being dominant (~80%) and the Nox4-
catalyzed production being minor (~20%).  Therefore, f1 and f2 are respectively estimated as: 
 
 The degradation of can also be divided into two parts. The first part is through the 
pathway that converts  into H2O2 (marked as f4 in Figure 4.5). The second part is through the 
biochemical reaction of with other molecules (marked as f3 in Figure 4.5). Due to the limited 
reactivity of as well as the fact that the SOD enzyme is sufficient to convert into H2O2 
in VSMCs, the former pathway plays a more dominant role in degrading  (~99%) [21]; the 
latter pathway consumes much less  (~1%). Therefore, f3 and f4 are respectively estimated 
as: 
 
 Using a new state-of-the-art electron spin resonance (ESR) assay for quantitative 


























































exceeds generation by 3 ~ 5 times, and the main production of H2O2 is catalyzed by Nox4 
[36, 51]; we use 2 to fit measurements in knocked-out experiments. Therefore, the remaining 
influx and efflux of H2O2 (respectively marked as f5 and f6 in Figure 4.5) are estimated as:  
 
 After the numerical values of all pertinent fluxes in unstimulated condition are estimated, 
their corresponding rate constants are calculated given the explicit expressions of fluxes in Eq. 
(4.6) and the concentrations of and H2O2, which stay at quite low levels (at nmol/L 
magnitude). Since the exact values of and H2O2 in unstimulated condition are hard to 
measure accurately and may vary in different experimental set-ups, we use 600 molecules/cell 
(which equals 1 nmol/L) and 3,000 molecules/cell (which equals 5 nmol/L) to represent the O2.-
and H2O2 concentrations, respectively. The calculated numerical values of fluxes and rate 
constants are summarized in Table 4.9.  
Table 4.9 Parameter values in ROS metabolism module. 

























The numerical value of Nox1active in unstimulated condition is 103 molecules/cell, and the numerical value of 


























Parameter Estimation for Other Modules 
Unlike the parameters in the AngII-induced PKC activation module and the ROS 
metabolism module, whose numerical values could be either directly found in literature or 
estimated from measured experimental data, the parameter values in the other two modules, 
namely the cSrc/EGFR/PI3K signaling cascade module and the Nox1 activation-disassembly 
module, are not available in literature. Neither of them could be estimated since there are too 
many parameters but biological information and available observations are limited. Thus, finding 
a unique set of numerical values for these parameters is currently unrealistic. Therefore, we use a 
Monte-Carlo method, which is essentially independent of specific parameter values, to explore 
the possible ranges or magnitudes of the remaining unknown parameters.  
 The Monte-Carlo method is a class of computational methods that rely on repeated 
random sampling and simulation. It comes in various formats, but here follows a particular 
pattern. First, a possible input domain is defined, and input samples are randomly generated from 
a probability distribution over the domain. For each sampled input, a deterministic computation 
is implemented and its performance is evaluated.  As a result, these computed results are 
aggregated and finally analyzed. The Monte-Carlo method is especially useful for simulating 
systems with many degrees of freedom and often applied to model phenomena with significant 
uncertainty.  
 Before implementing Monte-Carlo simulations, we need to consider two aspects. The 
first pertains to parameters that need to be randomly sampled, while the second pertains to the 
criteria that are used to evaluate the simulated results. Besides, a few assumptions and 
simplifications are made in order to simplify the sampling task, and finally there are 48 defined 
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parameter combinations that are need to be investigated for three integrated model candidates. 
The details of these aspects as well as the simulation setting are separately discussed in the 
following.  
Pertinent Independent Parameters: As stated in section 4.2.2, we have proposed three 
integrated model candidates, and each model candidate contains different numbers of parameters 
(see details in Table 4.5). Among these parameters, some are already known or were estimated 
from data (marked with * in Table 4.5); the others are unknown (marked without * in Table 4.5) 
and need to be randomly sampled for their numerical values during Monte-Carlo simulations. In 
model candidate 1, there are totally 23 unknown parameters, namely γ1 - γ16, γ23, γ24, and g1 - g5. 
Model candidate 2 contains 27 unknown parameters, including γ1 -γ16, γ23 - γ26, g1 - g6, and TPI3K. 
The third model candidate has 31 unknown parameters, namely γ1 - γ16, γ23 - γ28, g1 - g7, TPI3K, 
and TEGFR.  
As stated in section 3.2.5, the Nox1 activation-disassembly system is at first assumed to 
operate at its nominal, stable steady state, which corresponds to unstimulated control conditions.  
The concentrations of all pertinent dependent variables remain unchanged in this state, which 
requires the corresponding fluxes to be dynamically balanced. This stable state of the Nox 
system (specifically, the stable activity of Nox1active) maintains a stable and low level of ROS. As 
a result, the integrated system is assumed to operate at a stable state in unstimulated control 
condition, which allows the formulation of a set of linear constraints that the fluxes must satisfy. 
These linear constraints, as summarized in Table 4.10, have different-dimensional bases, 
indicating that each model candidate will have different numbers of linearly independent fluxes 
(or parameters) that need to be characterized. In addition, the fact that all fluxes are naturally 
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non-negative values further confines the feasible search space by adding more inequality 
constraints.  
There is no unique rule to select the independent target fluxes (or parameters). According 
to different exploration demands or interests, many possible sets of independent fluxes (or 
parameters) exist. The pertinent independent fluxes (or parameters) that we select (explicitly 
shown in Table 4.10) include the common parameters for the Nox1 activation-disassembly 
module (exactly the same set of independent parameters as we specified in Chapter 3), all kinetic 
orders, and the specific parameters for each integrated model. The main reason for this selection 
is that we are interested in exploring two features of the integrated system: one is about the 
potential disassembly mechanisms of Nox1 (represented by rate constants γ2 to γ4), and the other 
is about the signal-based regulations of Nox1 (represented by kinetic orders).  
Evaluation Criteria: The performance of a given Monte-Carlo sample is evaluated through a set 
of user-defined criteria. To use all available experimental records and observations found in 
literature (see details in section 4.2.3), a set of comprehensive and strict evaluation criteria is 
created. It consists of six screening conditions that can be stated as follows:  
C1. All rate constants are positive;  
C2. Under PMA treatment, the ROS concentration is increased after 30 minutes; 
C3. Under AngII treatment, the ROS concentration reaches a new and higher plateau at 30 
minutes than under unstimulated conditions;  
C4. Simulations show consistency for up- or down- regulations for all static and dynamic 
data; 
C5. The fitting error for the static data should be within a given tolerance; 
C6. The fitting error for the dynamic data should be within a given tolerance.  
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Assumptions and Simplifications: Some of the independent parameters listed in Table 4.10 are 
common to all three model candidates. These include γ2, γ3, γ4, γ6, γ8, γ9, γ14, and γ16, which are 
particularly relevant for the Nox1 activation-disassembly module, which has been extensively 
explored and discussed in Chapter 3. According to the criteria-driven analysis in Chapter 3, the 
flux associated with the proteolytic pathway (represented by f14SS) is much smaller (at least 100 
fold smaller) than the fluxes associated with the three recycling pathways (respectively 
represented by f2SS, f3SS, and f4SS), indicating the numerical value of γ14 should be at least 100 fold 
smaller than the numerical values of γ2, γ3, and γ4. Therefore, in order to reduce the number of 
independent parameters and reduce searching space, we temporarily ignore the small 
contribution of the proteolytic pathway by setting its corresponding rate constant γ14 equal to 
zero.  
 Each rate constant is associated with a specific biochemical reaction, and its numerical 
value quantifies the speed of the corresponding biochemical reaction. For the seven remaining 
common independent rate constants, we find that some are associated with similar biochemical 
reactions. For instance, γ2 and γ9 are respectively associated with biochemical reactions involved 
in phosphorylation of NoxA1 in its complex or free forms; γ3 and γ6 are respectively associated 
with biochemical reactions involved in dephosphorylation of p47phoxP in its complex or free 
forms; γ4 and γ8 are respectively tied to biochemical reactions involved in the hydrolysis of GTP-
bound Rac1 into Rac1GDP in its complex or free forma.  In order to reduce the number of 
independent parameters further and shrink the search space, we assume that rate constants that 
are associated with similar biochemical reactions should have numerical values of similar 
magnitudes. Thus, the seven remaining independent rate constants are divided into 4 distinct 
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sets: γ2 and γ9; γ3 and γ6; γ4 and γ8; and γ16. The numerical values of rate constants in each set are 
assumed to be of the same magnitude.  
Definition of 48 Possible Parameter Combinations for Three Integrated Model Candidates: 
Based on the assumptions and simplifications in the previous section, we are in a position to 
reduce the original eight common independent parameters to 4 sets. Since little experimental 
information is available regarding the absolute values or magnitudes of any of these parameters, 
we use again a Monte-Carlo method, which permits the exploration of large searching spaces 
with reasonable effort and minimally depends on specific parameter values. Specifically, the 
parameters in each set are randomly sampled from a uniform distribution within either a “low” 
range or a “high” velocity range over an appropriate non-negative domain. This sampling 
strategy leads to two combinations for each set and results in 42 = 16 combinations for each 
model candidate. As a result, it totally leads to 3 × 16 = 48 combinations for all three integrated 
model candidates. The details of these combinations are summarized in Table 4.11. Each 
individual combination has a specific designation of the sampling ranges for the investigated 
parameters, and is also tied to a particular model candidate. For instance, the combination MC2-
5 refers to model candidate 2, a sample γ2/γ9, γ4/γ8, and γ16 from the “low” velocity distribution, 
and a sample γ3/γ6 from the “high” velocity distribution.  
Monte-Carlo Simulation Settings: All simulations are implemented in MATLABR2010a. The 
sample size for each combination (totally 48 parameter combination) is ten thousand. The 
common independent parameters are divided into 4 distinct sets, and each set is randomly 
sampled from either the uniform distribution with a relatively “low” range U(10-4, 10-3) 
(implemented with U(-4, -3) in log10 space) or the uniform distribution with a relatively “high” 
range U(10-3, 10-2) (implemented with U(-3, -2)). Other independent parameters are randomly 
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sampled according to our empirical experience as the following: the kinetic order gi is sampled 
with U(0, 2) for i = 1, 2, …, 7; other rate constants γi are sampled with U(0.1, 10) (implemented 
with U(-1, 1) in log10 space) for i = 23, 25, and 27; TPI3K and TEGFR are sampled with U(2, 10) 
when they are needed in corresponding the model candidate. 
For each Monte-Carlo sample, several scenarios are simulated, including the 
unstimulated control condition, treatment of AngII (100nM), a Nox1 knock-down, a Nox4 
knock-down, treatments with PP1 (a cSrc inhibitor), PMA (a  PKC activator), GF 10923X (a 
PKC inhibitor), and AdRacN17 (a dominant-negative construct of Rac1). The performance of 
each sample is evaluated against the set of criteria defined in section 4.2.4. Specifically, this set 
of criteria is numerically implemented as follows:  
C1. All rate constants are positive:  γi > 0, for i = 1, 2, …, 28.  
C2. Under PMA treatment, the ROS concentration increases at 30 minutes:  
X10 (t = 30min)








−1> 0.1  
C3. Under AngII treatment, the ROS concentration reaches a new plateau at 30 minutes: this 
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C3-3: . 
(Derivatives of X6 and X10 at 30 minutes are as close as the estimations of their 
derivatives from experimental dynamic data (displayed in Figure 4.9). The estimations of 
derivatives of X6 and X10 at 30 minutes are respectively -3.33*10-4 and 5.0*10-5. So, here 
10-3 is used as a loose cut-off. ) 
C4. (simulated_data(i) – 1) × (static_data(i) – 1) > 0, for i = 1, 2, …17, and  
(simulated_data(i) – 1) × (dynamic_data(i) – 1) > 0, for i = 1, 2, …12.  
(Details of static_data and dynamic_data are summarized in Table 4.12.) 
C5. , for i = 1, 2, …, 17. 











































Table 4.10 Flux constraints and independent parameters for three integrated model candidates. 























































































































































































































fiSS, i = 1, 2, 3, …, 27, 28, represents the steady state flux value for the ith pathway in unstimulated conditions. Fluxin 
indicates the selected independent flux vector, and Parain indicates the selected independent parameter vector for 
each model candidate. 
 
Table 4.11 48 possible parameter combinations for three integrated model candidates. 
[γ2/γ9, γ3/γ6, γ4/γ8, γ16] Model Candidate 1 Model Candidate 2 Model Candidate 3 
[0 0 0 0] MC1-1 MC2-1 MC3-1 
[0 0 0 1] MC1-2 MC2-2 MC3-2 
[0 0 1 0] MC1-3 MC2-3 MC3-3 
[0 0 1 1] MC1-4 MC2-4 MC3-4 
[0 1 0 0] MC1-5 MC2-5 MC3-5 
[0 1 0 1] MC1-6 MC2-6 MC3-6 
[0 1 1 0] MC1-7 MC2-7 MC3-7 
[0 1 1 1] MC1-8 MC2-8 MC3-8 
[1 0 0 0] MC1-9 MC2-9 MC3-9 
[1 0 0 1] MC1-10 MC2-10 MC3-10 
[1 0 1 0] MC1-11 MC2-11 MC3-11 
[1 0 1 1] MC1-12 MC2-12 MC3-12 
[1 1 0 0] MC1-13 MC2-13 MC3-13 
[1 1 0 1] MC1-14 MC2-14 MC3-14 
[1 1 1 0] MC1-15 MC2-15 MC3-15 
[1 1 1 1] MC1-16 MC2-16 MC3-16 
“0” represents the uniform distribution with a relatively “low” range; “1” represents the uniform distribution with a 









Table 4.12 Static and dynamic data structure used in criteria. 
Index Static_Data Structure Dynamic_Data Structure 
Scenario Data Scenario Data 
1 +AngII (f17+f18)t=30min/(f17+f18)t=0 = 2
 +AngII X6(t = 1 min)/X6(t = 0) = 2.1 
2 AdASNox1 (f17+f18)t=30min/(f17+f18)t=0 = 0.22




 +AngII X6(t = 10 min)/X6(t = 0) = 2.2 
4 siNox4 (f17+f18)t=30min/(f17+f18)t=0 = 0.87




 +AngII X6(t = 30 min)/X6(t = 0) = 2.4 
6 +AngII (f21+0.5×f20)t=30min/(f21+0.5×f20)t=0 = 1.29 +AngII X10(t = 10sec)/X10(t = 0) = 1.05
 




(f21+0.5×f20)t=30min/(f21+0.5×f20)t=0 = 0.98 +AngII X10(t = 1min)/X10(t = 0) = 1.27
 




(f21+0.5×f20)t=30min/(f21+0.5×f20)t=0 = 0.87 +AngII X10(t = 10min)/X10(t = 0) = 
1.65 
11 +AngII X4(t = 30min)/X4(t = 0) = 2 +AngII X10(t = 15min)/X10(t = 0) = 1.7
 
12 +AngII X9(t = 30min)/X9(t = 0) = 1.8 +AngII X10(t = 30min)/X10(t = 0) = 
1.79 
13 AngII + 
AG1478 
X10(t = 30min)/X10(t = 0) = 1.2   
14 AngII + 
AdRacN17 
X10(t = 30min)/X10(t = 0) = 1.14   
142 
15 AngII+PP1 X10(t = 30min)/X10(t = 0) = 1.08   
16 AngII+GF 
10923X 
X10(t = 30min)/X10(t = 0) = 1.12   
17 AngII + GF 
10923X 
X10(t = 30min)/X10(t = 0) = 1.45   
4.3 Results 
4.3.1 Prediction of AngII-Induced PKC Activation in VSMCs 
Two distinct scenarios, respectively representing the unstimulated control condition and 
the stimulated AngII(100nM) treatment condition, are simulated separately.  
Figure 4.10 shows the simulation result for unstimulated control conditions, where no AngII is 
added to the system, and AA, Ca2+, and DAG constantly stay at their basal levels. The level of 
total active PKC (the sum of X2, X3, X4, X5, X6, and X7, variables defined in Table 4.1) in the 
simulation starts from zero and quickly approaches a stable value at ~1.76*105 molecules/cell  
(see left panel in Figure 4.10). This value represents the basal level of PKCactive and is used as the 
initial condition for the simulation of AngII treatment scenario. The uneven distribution of active 
PKC in different forms (see right panel in Figure 4.10) suggests that  the active complex 
AA·PKC·DAG in unstimulated control conditions (marked as index 6) plays a dominant role in 
maintaining the basal enzymatic activity of PKC.  
Figure 4.11 shows the simulation results for the scenario where extracellular AngII 
(100nM) is added to the system and the levels of AA, Ca2+, and DAG no longer remain constant, 
but vary dynamically. Compared to the constant PKCactive level in unstimulated conditions, the 
level of PKCactive increases in a particular biphasic fashion with AngII treatment (see Figure 4.11 
upper panels). The first phase of PKC activation is acute and transient, peaking ~1.5 fold over 
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the control level at 30 seconds after AngII treatment. The second phase is gradual and sustained, 
which approaches ~2 fold over control level and can last for at least 30 minutes.  
The following PKCactive distribution analysis at different time points reveals that the 
importance and roles of different PKCactive forms may vary over time. At 30 seconds, the large 
amounts of active complex Ca2+·PKC·DAG (marked as index 5) and AA·PKC·DAG (marked as 
index 6) show the effectiveness of these two active complexes, indicating the equally important 
roles of all three molecules AA, Ca2+, and DAG in the first phase of PKC activation. By contrast, 
at 30 minutes, the overwhelming amount of active complex AA·PKC·DAG (marked as index 6) 
suggests the dominate roles of only two molecules AA and DAG in the second phase of PKC 
activation.  
 
Figure 4.10. Simulation results of PKCactive in unstimulated control conditions.  
Left panel: the summation of active PKC in unstimulated control condition. Right panel: Distribution of active PKC 
in different forms in unstimulated control conditions. Numbers along the x-axis of the right panel indicate the index 
of different PKCactive forms. The simulation starts with the initial condition X0 = [6*105 0 0 0 0 0 0 0 0 0 0 6*106 
6*104 6*107].  
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4.3.2 Monte-Carlo Simulations for Three Integrated Model Candidates 
 Monte-Carlo simulations are implemented for 48 possible parameter combinations for 
three integrated model candidates (see details of simulation settings in section 4.2.4). The 
simulated results are assessed against different screening criteria. Table 4.13 shows the screening 
results for 48 possible combinations against each individual criterion from C1 through C6 as well 
as their combinations. The original sampling size for each combination is ten thousand, and the 
numbers in the Table 4.13 indicate the numbers of remaining samples for each combination 
(represented by rows in Table 4.13) that are satisfying the screening criteria specified in the 
corresponding column.  
 
 
Figure 4.11.  Simulation results of PKCactive with AngII (100nM) treatment.  
Upper-left panel: sum of active PKC forms under AngII treatment. Upper-right panel: Dynamics of PKCactive under 
AngII treatment when the total amount of PKCactive under control is assumed to be at “1”. Lower-left panel: 
distribution of active PKC in different forms at 30 seconds. Lower-right panel: distribution of active PKC in 
different forms at 30 minutes. Numbers along the x-axes of the lower panels indicate the index of different PKCactive 
forms. The simulation starts with the initial condition: X0 =[2.375 0.048 0.029 0.103 0.034 0.264 1.283 0.285 0.026 
1.425 0.128 60 0.6 600]*105. 
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We begin the analysis by screening the sampled points against each individual criterion 
from C1 to C6, and the numbers of remaining points, compared to the original 10,000, are 
respectively listed in column 2 to column 9 in Table 4.13. Among them, C4, C5, and C6 appear 
to be the most stringent criteria, because they exclude numerous random samples, and even result 
in no admissible candidates for some combinations of parameter settings. There are three options 
for implementing criterion C3. Comparing their screening results, these three conditions have 
quite similar filtering patterns, but differ in the numbers of remaining admissible sample points. 
Specifically, for one parameter combination, criterion C3-2 tends to allow the largest number of 
remaining sampling points, while criterion C3-3 tends to retain the least number of admissible 
points, indicating that C3-3 and C3-2 are respectively the strictest and loosest screening 
conditions among three options for criterion C3.  
 The originally sampled points are then filtered cumulatively against several criteria. As 
shown in columns 10 to 20 in Table 4.13, each addition of a criterion further reduces the size of 
remaining sample for every combination. This situation is particularly obvious when criteria C4, 
C5, and C6 are gradually added. For instance, studying Model Candidate 1 (MC1), the choice of 
C3-1, C3-2 or C3-3 is unimportant, when C4 is added to the screening conditions: no admissible 
points are left. In another words, the results suggest that it is impossible to find admissible 
candidates that simultaneously satisfy the first 4 criteria (from C1 to C4) when the PI3K data is 
used as the “offline” input.   
 An analogous situation holds for Model Candidate 3 (MC3) where almost no parameter 
combination satisfies the combined screening criteria from C1 to C5 (with only one exception for 
using either C3-1 or C3-2), which illustrates that the integrated model has poor performance of 
reproducing observed experimental records, when cSrc data are used as input.  
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Table 4.13 Monte-Carlo simulation results for 48 parameter combinations. 
Model 
Index 





























C6 for i 
= 1, 2,3 
MC1-1 10000	   4411 7924 9379 4781 0 0 0 4411 3380 4105 1868 0 0 0 0 0 0 0 
MC1-2 5447 1524 8966 9714 7312 4553 4553 4553 1524 1163 1428 646 0 0 0 0 0 0 0 
MC1-3 10000 4291 7831 9739 3130 0 198 0 4291 3270 4155 1203 0 0 0 0 0 0 0 
MC1-4 5612 1400 8875 9867 6264 4388 4465 4388 1400 1062 1354 383 0 0 0 0 0 0 0 
MC1-5 10000 5568 8591 9688 5780 0 462 0 5568 4757 5401 3298 0 0 0 0 0 0 0 
MC1-6 5518 1894 9336 9839 7831 4482 4722 4482 1894 1665 1839 1161 0 0 0 0 0 0 0 
MC1-7 10000 5213 7018 9515 2728 0 245 0 5213 3598 4950 1370 0 0 0 0 0 0 0 
MC1-8 5609 1754 8312 9715 5927 4391 4499 4391 1754 1199 1677 443 0 0 0 0 0 0 0 
MC1-9 10000 4658 7702 9424 4309 0 377 0 4658 3385 4321 1755 0 0 0 0 0 0 0 
MC1-
10 
10000 2507 8126 9545 4721 0 299 0 2507 1866 2331 978 0 0 0 0 0 0 0 
MC1-
11 
10000 4348 7456 9714 2837 0 214 0 4348 3124 4218 1041 0 0 0 0 0 0 0 
MC1-
12 
10000 2230 7646 9702 3250 0 112 0 2230 1579 2137 500 0 0 0 0 0 0 0 
MC1-
13 
10000 5507 8689 9721 5918 0 558 0 5507 4777 5358 3415 0 0 0 0 0 0 0 
MC1-
14 
10000 2970 8832 9749 6063 0 460 0 2970 2577 2874 1769 0 0 0 0 0 0 0 
MC1-
15 
10000 5093 6869 9461 2606 0 226 0 5093 3410 4809 1268 0 0 0 0 0 0 0 
MC1-
16 
10000 2707 6927 9412 2889 0 135 0 2707 1806 2551 669 0 0 0 0 0 0 0 
MC2-1 10000 4490 7957 9629 4131 198 0 0 4490 3313 4271 1438 52 115 8 0 0 0 0 
MC2-2 5516 1495 9049 9836 6945 4587 4484 4484 1495 1132 1428 502 20 39 2 0 0 0 0 
MC2-3 10000 4152 8220 9786 4098 0 445 0 4152 3228 4033 1306 0 0 0 0 0 0 0 
MC2-4 5556 1341 9178 9916 6977 4444 4651 4444 1341 1031 1306 410 0 0 0 0 0 0 0 
MC2-5 10000 5505 9352 9931 6710 480 313 0 5505 5124 5467 3620 138 207 39 32 47 6 0 
MC2-6 5441 1785 9705 9972 8347 4809 4716 4559 1785 1671 1771 1131 45 64 14 8 15 3 0 
MC2-7 10000 5227 9727 9983 7659 122 544 0 5227 5046 5216 3868 87 87 71 10 10 7 0 
MC2-8 5600 1756 9884 9997 8796 4449 4676 4400 1756 1698 1754 1284 21 21 12 2 2 1 0 
MC2-9 10000 4556 7895 9701 3709 27 240 0 4556 3430 4385 1337 8 23 1 2 5 0 0 
MC2-
10 
10000 2331 8358 9774 4336 42 211 0 2331 1767 2246 694 19 26 4 0 0 0 0 
MC2- 10000 4149 8256 9798 4118 0 502 0 4149 3177 4039 1291 0 0 0 0 0 0 0 
MC2-
12 
10000 2176 8626 9843 4736 0 398 0 2176 1707 2123 712 0 0 0 0 0 0 0 
MC2-
13 
10000 5508 9508 9955 7084 300 359 0 5508 5207 5479 3846 110 143 32 26 41 7 0 
MC2-
14 

































C6 for i 
= 1, 2,3 
MC2-
15 
10000 5188 9735 9988 7748 92 519 0 5188 5005 5179 3831 59 63 46 6 6 6 0 
MC2-
16 
10000 2739 9802 9988 7842 98 395 0 2739 2650 2734 2011 46 46 32 4 4 4 0 
MC3-1 10000 4412 8130 9668 4271 3 0 0 4412 3392 4226 1440 0 1 0 0 0 0 0 
MC3-2 5543 1557 9082 9845 7000 4459 4457 4457 1557 11969 1494 530 0 0 0 0 0 0 0 
MC3-3 10000 4227 7355 9452 3586 0 367 0 4227 2852 3937 1160 0 0 0 0 0 0 0 
MC3-4 5508 1344 8726 9740 6536 4493 4649 4492 1344 928 1244 350 0 0 0 0 0 0 0 
MC3-5 10000 5534 8979 9768 6073 4 227 0 5534 4959 5398 3283 0 1 0 0 0 0 0 
MC3-6 5497 1857 9497 9892 8028 4505 4610 4503 1857 1650 1817 1124 0 1 0 0 0 0 0 
MC3-7 1000 5128 8864 9782 6106 3 403 0 5128 4473 4991 3033 0 0 0 0 0 0 0 
MC3-8 5499 1735 9422 9899 7991 4501 4698 4501 1735 1508 1691 1006 0 0 0 0 0 0 0 
MC3-9 10000 4572 7659 9586 3696 1 187 0 4572 3294 4341 1351 0 1 0 0 0 0 0 
MC3-
10 
10000 2353 8122 9679 4211 2 149 0 2353 1740 2241 707 0 0 0 0 0 0 0 
MC3-
11 
10000 4193 7329 9376 3708 0 389 0 4193 2832 3841 1249 0 0 0 0 0 0 0 
MC3-
12 
10000 2249 7643 9531 4036 0 323 0 2249 1474 2062 640 0 0 0 0 0 0 0 
MC3-
13 
10000 5485 9036 9787 6203 1 253 0 5485 4930 5363 3342 0 0 0 0 0 0 0 
MC3-
14 
10000 2957 9222 9843 6678 0 188 0 2957 2672 2905 1835 0 0 0 0 0 0 0 
MC3-
15 
10000 5170 8926 9769 6293 3 431 0 5170 4574 5041 3152 1 1 0 1 1 0 0 
MC3-
16 
10000 2691 9039 9834 6593 3 296 0 2691 2391 2630 1743 1 1 1 0 0 0 0 
The original sample size for each combination is 10,000. Numbers indicate the numbers of admissible samples for each combination (row) of screening against 
combined criteria (column).  
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Quite different from the above two model candidates, Model Candidate 2 exhibits better 
screening results with many more remaining points that simultaneously satisfy the first 5 criteria 
(from C1 to C5). Specifically, eight combinations in MC2 (MC2-5, MC2-6, MC2-7, MC2-8, 
MC2-13, MC2-14, MC2-15, and MC2-16) contain candidates satisfying the first 5 criteria. As 
soon as the last criterion (C6) is added to the screening conditions, none of candidates exist in 
any of the 48 combinations for MC1, MC2 and MC3.  
 The combined criteria-driven candidate selection clearly shows that Model Candidate 2 
shows much better performance than Model Candidates 1 and 3, and suggests the effectiveness 
of the corresponding EGFR data as input to the integrated system in reproducing observed 
experimental records. Additionally, the simulation results indicate eight specific combinations 
from MC2 (indices 5, 6, 7, 8, 13, 14, 15, and 16) that have many admissible candidates. This 
combined selection greatly reduce the size of possible parameter combinations from 16 to 8 
(~50% reduction of parameter searching space), and also gives us some hints regarding the 
possible ranges of corresponding parameters they represent.  
 However, the current simulation finds no admissible sampling points that simultaneously 
satisfy all six screening criteria. One possible reason could be that the current sample size (10 
thousand) is not large enough to sample the parameter space with over twenty dimensions. 
Another possible reason may be that the numerical assignments of the relatively “low” and 
“high” velocity ranges, which are currently expressed with the uniform distribution U(10-4, 10-3) 
and U(10-3, 10-2), are not large enough. This low numerical assignment could give smaller 
parameter values and thus lead to relatively slow biochemical reactions. Examining the relevant 
dynamic data utilized in criterion C6, we find that the H2O2 concentration increases very quickly 
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(first noticed at 10 seconds with a peak at 30 seconds after AngII treatment). This acute increase 
of H2O2 strongly indicates the relatively faster speed of involved biochemical reactions, 
suggesting that we might need to use larger numerical assignments to represent different velocity 
ranges. 
4.3.3 Monte-Carlo Simulations for Integrated Model Candidate 2 
 Following the suggestions given in the above section, we implement another round of 
Monte-Carlo simulations particularly for the most promising Model Candidate 2. Different from 
the previous simulation settings, the sampling size for each possible combination in this round is 
increased by three times from 10,000 to 30,000. Also, a new numerical assignment for the 
relatively “low” and “high” speed ranges is used. Specifically, the relatively “low” speed range is 
represented with the uniform distribution U(10-3, 10-2), and the “high” speed range is assigned 
with U(10-2, 10-1). Compared to the previously used speed ranges, the relative ratios for “low” 
and “high” speed categories have not changed, but the absolute values for each range boundary 
increases by one order of magnitude. The independent parameters that need to be sampled, the 
evaluation criteria, and other simulation settings are kept exactly the same as before (section 
4.2.4).  
As before, the analysis begins with screening the sampled points against each individual 
criterion as well as the combined criteria. The filtered results are respectively summarized in 
corresponding rows in Table 4.14. With increased sampling size and new assigned numerical 
values of “low” and “high” speed ranges, the number of admissible samples has greatly 
increased especially for accumulated screening criteria. For instance, screening against the 
combined criteria of C1, C2, C3-2, C4 and C5, the previous Monte-Carlo simulations show a 
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total number of 151 admissible samples for 16 combinations in Model Candidate 2, while in the 
current round, the simulations increases the size of remaining points to 219 (~45% increase).  
More importantly, the current simulations successfully identify 12 admissible samples that 
simultaneously satisfy all 6 criteria (from C1 to C6), which could not be achieved in the previous 
round of Monte-Carlo simulations.  
 Independent of whether C3-1, C3-2 or C3-3 is utilized in the combined criteria, the 
selected 12 (or 11 when C3-3 is used) samples have the exactly same distribution over 16 
combinations for MC2. Specifically, the existences of these samples focus on three combinations 
MC2-7, MC2-15, and MC2-16. As defined in Table 4.11, these three combinations can be 
directly translated into the index vectors [0 1 1 0], [1 1 1 0], and [1 1 1 1]. We find some 
common features of these three index vectors: the second and third elements in these vectors are 
always assigned with the numerical value “1”, which indicates the rate constants in sets 2 and 3 
are sampled from the relatively “high” speed range. In other words, this result suggests that the 




Table 4.14 Monte-Carlo simulation results for Model Candidate 2. 
Model 
Index 
MC2-1 MC2-2 MC2-3 MC2-4 MC2-5 MC2-6 MC2-7 MC2-8 MC2-9 MC2-10 MC2-11 MC2-12 MC2-13 MC2-14 MC2-15 MC2-16 
C1 30000 16502 30000 16600 30000 16502 30000 16591 30000 30000 30000 30000 30000 30000 30000 30000 
C2 8278 16221 8160 16242 8242 16220 8162 16246 8080 5002 8037 4966 7972 5079 8141 4931 
C3-1 29417 29730 29442 29762 29890 29950 29791 29903 29511 29658 29486 29611 29893 29942 29767 29846 
C3-2 29975 29986 29951 29981 29996 29999 29980 29994 29976 29987 29951 29961 29995 29999 29980 29993 
C3-3 23672 26342 23897 26248 25321 26668 23870 25893 23617 23880 23939 23813 25200 25027 23988 23527 
C4 334 147 2 0 1090 430 436 189 143 114 0 0 1013 835 329 227 
C5 1114 547 1194 524 1107 542 1185 525 1236 775 1203 792 1204 816 1156 790 
C6 0 0 4 2 0 0 134 101 0 0 4 7 2 1 108 195 
C1, C2 8278 2723 8160 2842 8242 2722 8162 2837 8080 5002 8037 4966 7972 5079 8141 4931 
C1, C2, 
C3-1 
8012 2607 7923 2754 8202 2706 8130 2806 7873 4869 7831 4836 7934 5061 8071 4888 
C1, C2, 
C3-2 
8262 2714 8137 2835 8240 2721 8158 2832 8067 4995 8015 4951 7968 5078 8131 4925 
C1, C2, 
C3-3 
6192 1979 6287 2207 7126 2338 6856 2362 6108 3762 6209 3824 6846 4382 6849 4112 
C1, C2, 
C3-1, C4 
133 39 2 0 261 89 162 64 85 59 0 0 267 193 147 109 
C1, C2, 
C3-2, C4 
135 42 2 0 263 89 163 64 86 60 0 0 269 193 148 109 
C1, C2, 
C3-3, C4 



























0 0 0 0 0 0 3 0 0 0 0 0 0 0 3 5 
The original sample size for each combination is 30 thousand. Numbers in the table indicate the amount of satisfying samples for each combination (column) 
screening against the specific combined criteria (row).  
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The twelve selected samples are then further analyzed for their value distributions. The 
relative ratios between individual rate constants, including γ2, γ3, γ4, γ6, γ8, γ9, and γ16, are 
calculated and displayed in Figure 4.12. Carefully examining these ratio distributions, we find 
some specific features of the investigated rate constants. First, comparing the rate constants 
associated with reversible reactions (γ6, γ8, and γ9) and recycling pathways (γ2, γ3, and γ4) (results 
displayed in the first row in Figure 4.12), we find that the rates associated with reversible 
reactions with positive signals (γ6 and γ8) tend to be higher than the rates associated with 
corresponding recycling reaction (γ3 and γ4). In contrast, the reversible reaction rate with 
negative signal (γ9) seems to have the opposite trend: being smaller than the corresponding 
recycling rate (γ2). Ten out of twelve (83.3%) selected samples follow this trend (with 2 
exceptions). 
 
Figure 4.12 Relative ratio between individual independent rate constants for 12 selected samples.  
The x-axis in each plot indicates the index of 12 selected samples. The y-axis in each plot is expressed in log10 space. 
Different colors indicate the samples from different parameter combinations.  
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Second, comparing the relative magnitudes between individual recycling reaction rates 
(γ2, γ3, γ4) and the reaction rate for the efflux (γ16), we find that the twelve admissible samples 
follow two specific patterns: The first pattern covers all samples selected from combinations 
MC2-7 and MC2-15 and retains the following relative magnitudes of the rate constants: γ3 > γ4, 
γ2 > γ16. With this specific pattern, the recycling pathway associated with γ3 serves as the most 
efficient disassembly pathway in degrading Nox1active. The second pattern holds for the samples 
selected from combination MC2-16, among which 80% samples (4 out of 5) have their rate 
constants follow the relationship γ2 > γ16 > γ3, γ4, suggesting that the recycling pathway 
associated with γ2 plays the dominant role in degrading Nox1active. There is one exception in 
combination MC2-16 that follows a different order: γ16 > γ3 > γ2 > γ4. Compared to the 
magnitude of γ16, which is the smallest one in the first pattern, the magnitude of γ16 in the second 
pattern increases a lot, ranking from the last position to the first (or the second) place.  
In addition to comparing the relative magnitudes of rate constants, we explore the 
distributions of other independent parameters as well. Figure 4.13 shows the distributions of all 
pertinent kinetic orders, which characterize the effect of input signals on relevant biochemical 
reactions. These kinetic orders are originally sampled with the same uniform distribution U(0, 2), 
but turn out to have quite different histograms after screening against the six criteria. Among 
them, we are particularly interested in the kinetic orders g1 and g2, which respectively 
characterize the regulatory effects of two distinct signaling molecules PKC and cSrc on the same 
process of p47phox phosphorylation. As shown in Figure 4.13, g1 has an uneven distribution 
ranging from 0.5 to 2; while g2 has a rather even distribution ranging from 0 to 1. The following 
ratio analysis of g1 over g2 (shown in Figure 4.14 (a)) further reveals a trend for the relative 
magnitudes of these two parameters. 11 out of 12 (~92%) selected samples have a g1 value at 
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least as large as g2, and nine of them have a g1 value at least one order of magnitude  larger than 
g2. This finding strongly indicates the relatively important and dominant role of the signaling 
molecule PKC in regulating p47phox phosphorylation.   
In order to compare and validate the roles of PKC and cSrc in regulating p47phox 
phosphorylation further, simulations are implemented to mimic the scenarios when the regulation 
of PKC or cSrc is blocked in AngII treatment condition; this is accomplished by setting either g1 
= 0 or g2 = 0. As shown in Figure 4.14 (b), when the regulation of PKC is blocked (denoted by 
the green line in Figure 4.14 (b)), the dynamics of phosphorylated p47phox is far different from its 
behavior in normal AngII treatment (denoted by red line). The most significant difference occurs 
during the first 30 seconds after AngII treatment when the phosphorylated p47phox completely 
loses its acute activation without the PKC-dependent regulation. Moreover, the stable increase of 
H2O2 lags far behind the normal one (~50% decrease) if the PKC-dependent regulation is absent. 
In contrast, when the regulation of cSrc on p47phox phosphorylation is blocked (denoted by the 
blue line in Figure 4.14 (b)), the dynamics of phosphorylated p47phox and the increase of H2O2 
change insignificantly. However, the dynamics of Rac1GTP appears to change only insignificantly 
when compared to the normal case. From this set of comparative simulations, we can infer the 
different roles of PKC and cSrc in regulating p47phox phosphorylation, which could lead to totally 
different responses of Nox1 and its subsequent ROS production in AngII treatment condition. 
Although both signaling molecules have been documented to be able to regulate p47phox 
phosphorylation, our simulation analysis suggests that PKC seems to play a more dominant role 
and the dynamic behavior of the integrated system will change significantly if this PKC-
dependent regulation is absent.  
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Figure 4.13 Distributions of kinetic orders for 12 selected samples.  
 
Finally, we implement the dynamic simulations of the integrated model candidates for 
various scenarios. From the simulated results (displayed in APPENDIX C from Figure C.1 to 
C.12), we find some common features for 12 selected samples: (i) AngII-induced ROS increase 
happens immediately, and maintains at a higher plateau at 30 minutes; (ii) The simulated 
dynamics of Rac1GTP under AngII treatment is well consistent with experimental evidence; (iii) 
Increase of phosphorylated p47phox in AngII treatment happens in two phases: the first phase is 
acute and transient, and the second phase is sustained; (iv) The simulated levels of ROS 
(specifically, H2O2) are kept well consistent with the experimental records for all scenarios, 







Figure 4.14 Simulation results illustrating the effects of PKC and cSrc on p47phox phosphorylation.  
(a) Ratio analysis of g1/g2 in log10 space. (b) Simulation results for scenarios with either g1=0 or g2=0. This 
simulation is a representative result, using one parameter set from 12 selected samples. The numerical values of 
parameters used in this simulation are: Parain = [0.0176 0.0908 0.02320.0769 0.0972 0.0512 0 0.0027 1.6792 1.5401 




4.3.4 cSrc- and Ca2+-Dependent EGFR Activation 
 From the criteria-driven analysis in section 4.3.2, we know that Model Candidate 2 
exhibits much better performance in reproducing most experimental observations under various 
scenarios than Model Candidates 1 and 3. This result strongly indicates the effectiveness of 
corresponding EGFR data, and at the same time raises several questions: Is this model able to 
reproduce the EGFR dynamics by using its upstream signal cSrc data? Why is the performance 
of respectively using cSrc and EGFR data as system input not consistent in the two cases?  
 In order to answer these questions, a mathematical model describing the mechanism of 
cSrc-dependent EGFR activation (model structure shown in Figure 4.15 (a)) is constructed and 
implemented (see details in APPENDIX C.3). The dynamic profile of cSrc is considered as an  
input, driving the downstream signal EGFR change correspondingly. The numerical values of 
pertinent parameters are found with nonlinear optimization functions in MATLAB, and large 
numbers of randomized initial conditions are used to ensure that a relatively better local optimal 
point is achieved. The simulated EGFR dynamics is then compared with experimental findings. 
Although there are local optimal points with distinct numerical parameter values, their simulated 
EGFR dynamics appears to show quite similar trends. As shown in Figure 4.15 (b), the 
simulation result well reproduces the long-term effect of EGFR activation (for time t > 5 
minutes), but shows a dramatic difference to the experimental records for time t < 5 minutes: 
EGFR was observed to increase acutely and immediately during the first 5 minutes, peaking over 
7 fold at 1 minute and decreasing gradually after that [259], while, the simulation shows a 
gradual and much slower and lower increase without any decline.  
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 The comparison of the simulation result with experimental findings reveals an 
inconsistency, especially for the time interval t < 5 minutes. This inconsistency shows the fact 
that the sole use of the cSrc data does not reproduce the EGFR dynamics well. At the same time, 
it provides a good explanation for the demonstrated different results when cSrc and EGFR data 
are separately utilized as inputs in the previous Monte-Carlo simulations.  
 
Figure 4.15. cSrc-dependent EGFR activation.  
(a) Schematic representation of model structure. (b) Simulated EGFR dynamics. See detailed descriptions of 
mathematical equations and the optimal parameter values used in simulation in APPENDIX C.3.    
 
Several potential factors may cause this inconsistency. One possible reason is that due to 
some limitations of the experimental set-ups or protocols, the measurements of cSrc, especially 
during the first few minutes, may not be accurate enough, and thus are not very reliable. An 
alternative reason with higher possibility is that except for cSrc, there exist other signaling 
molecules that could potentially activate EGFR independently. Because cSrc-independent EGFR 
activation mechanisms have not been incorporated in the present model, the current simulation is 
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not able to reproduce the EGFR dynamics even if the cSrc data are accurate and reliable. Thus, 
the task at hand is to search whether there are other important signaling molecules that can 
independently activate EGFR in VSMCs in AngII treatment condition.  
One potential candidate is Ca2+. Several studies have documented that Ca2+ is involved in 
AngII-induced EGFR transactivation The potential underlying mechanism is proposed to be 
redox-insensitive and thus differs from the cSrc-dependent redox-sensitive EGFR activation [38, 
265]. In order to test whether Ca2+ is a possible missing signaling molecule in EGFR activation, 
we reconstruct a model that takes Ca2+ into account; the reconstructed model structure is shown 
in Figure 4.16 (a).  The dynamic profile of Ca2+ in AngII (100nM) treatment condition is 
collected from the literature [257] and considered as a second  input. The reconstructed system is 
then numerically implemented (see details in APPENDIX C.4) and the newly simulated EGFR 
dynamics is compared with experimental findings.  
 With the new mechanism incorporated in the model, the simulated EGFR dynamics 
(denoted by green line in Figure 4.16 (b)) is well consistent with its experimental records 
(denoted by red circles in Figure 4.16 (b)) during the entire simulated time intervals. This result, 
and especially the improved simulation during the first 5 minutes, effectively demonstrates the 
effect of Ca2+ on EGFR activation, particularly on the transient behavior of EGFR during the 
first few minutes. Moreover, the consistency between the new simulation result and experimental 
evidence validates our original hypothesis of the existence of a missing cSrc-independent EGFR 
activation mechanism.  
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Figure 4.16 cSrc- and Ca2+-dependent EGFR activation.  
(a) Schematic representation of reconstructed model structure. (b) Simulated EGFR dynamics. See detailed 
descriptions of mathematical equations and the optimal parameter values used in simulation in APPENDIX C.4.     
 
4.3.5 H2O2-Induced Positive Feedback 
 From the analyses of two rounds of Monte-Carlo simulations (section 4.3.2 and 4.3.3), 
we have not only identified EGFR data as the most effective input to the integrated model, but 
also generated 12 selected samples that are able to fulfill the requirements of both qualitative and 
quantitative criteria as well as to reproduce satisfactory systematic dynamics under all considered 
scenarios. Although these two Monte-Carlo simulations contain some subtle differences in 
settings, such as the sampling size and numerical assignments of parameter searching ranges, 
these simulations have been implemented in quite a similar fashion. They consider active PKC 
and the other signaling molecule from the cSrc/EGFR/PI3K signaling cascade (cSrc, EGFR, or 
PI3K) as two independent inputs, whose values will affect the system but are not affected by the 
system.  
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In reality, these two input signals are actually not independent of each other, and the 
activation of the second signal is in fact dependent on the availability of the first signal and its-
induced acute activation of Nox1 and subsequent ROS release. More specifically, an AngII-
induced PKC signal acutely enhances Nox1 activity and leads to the initial release of H2O2. This 
increased H2O2 then activates cSrc and its down-stream signals including EGFR and PI3K, 
which in turn further strengthens Nox1 activation by stimulating the activation process of 
Rac1GDP, leading to more ROS generation [38]. Thus, this H2O2-dependent cSrc activation forms 
a positive feedback loop and plays an important role in maintaining Nox1 activation and 
sustained ROS generation.  
 In order to analyze the function of this specific H2O2-dependent positive feedback in 
regulating systematic behavior, we add to the model one more regulatory pathway from H2O2 to 
cSrc activation. At the same time, we allow one signal (PKC) instead of two as the input. 
Accounting for the cSrc-independent and Ca2+-dependent EGFR activation mechanism proposed 
in section 4.3.4, Ca2+ is also considered as an independent input because this pathway is redox-
insensitive and therefore not affected by the target system. As a result, AngII-induced Nox1 
activation in VSMCs is represented by the modeled system as completely driven by AngII-
induced PKC activation and Ca2+ mobilization.  
The final model integrates three distinct modules, including the Nox1 activation-
disassembly module, ROS metabolism module, and H2O2-dependent cSrc/EGFR/PI3K activation 
module, and has two independent inputs, namely PKC and Ca2+. It contains 14 system dependent 
variables, 31 individual fluxes, and 43 parameters in total. Most parameter values are already 
found in previous simulations and analysis, and the few remaining parameter values, which are 
particularly involved in H2O2-induced cSrc activation, will be determined during the final 
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simulations. (See the details of mathematical description and numerical assignments for all 
parameters for the final model in APPENDIX C.5).  
 One representative simulation result is shown in Figure 4.17 (see other 11 simulation 
results in Figures C.13 to C.23). This result clearly demonstrates that the addition of H2O2-
induced positive feedback into the system does not significantly change the overall system 
behavior. The simulated dynamics of most dependent variables, including cSrc, EGFR, H2O2, 
and GTP-bound Rac1 are well consistent with their experimental observations. However, there 
exist some discrepancies for PI3K: the simulation shows a similar up-regulation activity of PI3K, 
but it differs in transient patterns from experimental records.  
 
4.4 Discussion 
Angiotensin II (AngII)-induced Nox1 activation and subsequent ROS release in VSMCs 
have been investigated in numerous studies [31, 34, 36, 37, 96, 105] . These experimental and 
clinical studies have greatly enhanced our understanding of this complicated system in terms of 
the pertinent regulatory signals, key components, and the involved pathway structures. With this 
biological information and a variety of other biological data available in the literature, it is 
possible to assemble quite a detailed picture of how individual subunits of Nox1 are organized to 
form an active enzyme complex within response to a stimulus like AngII. While the components 
and basic interactions are known, the overall functionality of the Nox1 system is not easy to 
intuit, especially when the regulatory signals are dynamically changing. Another issue that 
complicates our understanding Nox1 dynamics is the Nox1 disassembly. Although Chapter 3 
discussed some generic questions regarding Nox1 disassembly mechanisms under nominal,  
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Figure 4.17 Simulation result of AngII-induced Nox1 activation in VSMCs with H2O2-dependent positive 
feedback.  
Red solid line represents the simulation under AngII(100nM) treatment. Black dashed line represents the level of 
eachvariable in unstimulated control condition. Green circles are experimental records, which are recalculated into 
fold changes compared to the control level. The numerical values of parameters used in this simulation are: Parain = 
[0.0075 0.0629 0.0183 0.0580 0.0471 0.0018 0.0016 0.8242 5.9634 0.8130 0.8408 0.9224 0.9061 1.3807 1.7573 5]. 
 
unstimulated condition, there still remain open questions. For instance, does the order of 
importance of each individual Nox1 degradation pathway change in response to dynamic input 
signals? Can we extract more useful indications or conclusions from the currently available 
experimental observations? Is the current model structure sufficient? As we have shown with our 
computational analysis here, a specific order of importance of each individual disassembly 
pathway is needed to satisfy all qualitative and quantitative criteria, and the current model 
structure needs to be augmented with a new regulatory pathway to achieve better performance 
and data consistency.  
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 A two-phased modeling strategy was pursued. In the first phase, the model was 
decomposed into four distinct modules, and each module was separately constructed and 
analyzed (see detailed description in section 4.2.2). As far as possible, the parameters in each 
module were separately estimated with available experimental data. In the second phase, the four 
individually constructed modules were integrated into a single computational model structure. 
The parameters were combined from the modules, and their potential numerical ranges or 
magnitudes were explored with Monte-Carlo methods. Available experimental data and other 
pieces of information, whether static or dynamic, quantitative or qualitative, were collected from 
the literature and used as evaluation criteria. Since there are three options for modeling the 
cSrc/EGFR/PI3K signaling cascade, depending on different data used as input, the modeling 
process resulted in three integrated model candidates (MC1, MC2, and MC3). These candidates 
required a total of 48 parameter combinations (16 combinations for each model candidate) to be 
explored and evaluated simultaneously.  
 The analysis of the initial round of Monte-Carlo simulations led to an interesting result. 
When the originally sampled points were screened with combined criteria from C1 to C5, all 
admissible candidates belonged to model candidate 2 (MC2), indicating the effectiveness of the 
available EGFR data as input. However, when we attempted to use cSrc data to reproduce the 
EGFR dynamics, we failed to regenerate consistent EGFR dynamics, especially for the time 
interval t < 5 minutes, no matter which parameter values were used. It is a priori not easy to 
explain why two datasets coming from up-stream and direct down-stream signals are not 
consistent with each other, suggesting that there was something missing in the model. This 
deduction led us to propose the hypothesis that some other EGFR activation mechanisms were 
missing in the model, and that these mechanisms should be cSrc-independent. Searching the 
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literature, we identified the signaling molecule Ca2+ as a candidate, and it turned out that it 
remedied the former inconsistency. Although the role of Ca2+ in AngII-induced Nox1 activation 
has not been particularly emphasized by the scientific community, Ca2+ has been suggested to be 
able to stimulate EGFR transactivation in a redox-insensitivity manner, which thus substantially 
differs from the redox-sensitive cSrc-dependent EGFR trans-activation. In order to validate our 
hypothesis, we revised the EGFR activation module by adding an activation pathway separately 
regulated by Ca2+. With the newly added pathway, the simulated EGFR dynamics was well 
consistent with experimental records during the entire time interval.  
 Focusing on MC2, the second round of Monte Carlo simulations generated several good 
samples capable of satisfying all combined criteria from C1 to C6, which were achieved in the 
first round of simulations. These candidates are distributed in three specific combinations with 
indices MC2-7, MC2-15, and MC2-16 (see results shown in Table 4.14 and definition of these 
indices in Table 4.11). The correspondences between these index vectors and the relative 
magnitudes of related rate constants help us interpret this result. It suggests that among three 
different recycling pathways of Nox1, the disassembly pathway via dephosphorylation of p47phox 
(associated with γ3) and the pathway via deactivation of Rac1GTP (associated with γ4) are playing 
more important roles in effectively disassembling Nox1 since the numerical values of γ3 are γ4 
are always shown to be sampled with larger values or magnitudes.  
The subsequent ratio analysis of individual rate constants further revealed two specific 
patterns to describe the relative magnitudes of these rate constants. Specifically, in seven out of 
twelve selected samples (~60%), γ3 has the largest numerical value, indicating its prominent role 
of dephosphorylation of p47phox in disassembling active Nox1. Four out of twelve admissible 
samples (~33%) follow a second pattern, with γ2 having the largest numerical value, suggesting 
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the dominant role of phosphorylation of NoxA1 in disassembling active Nox1. This ratio 
analysis also investigates the possible ranges or relative magnitudes of other rate constants, 
providing for the first time detailed information about the importance of individual reactions 
within the Nox1 system.  
  Two distinct signaling molecules, PKC and cSrc, have been proposed to regulate the 
process of p47phox phosphorylation [33, 38, 233]. This duality raises the question of whether 
these two signaling molecules are equally important in regulating the target process. The ratio 
analysis of g1 over g2 (shown in Figure 4.14 (a)) demonstrates that g1 is much larger than g2 in 
most cases indicating the relatively dominant role of PKC on p47phox phosphorylation. This 
inference is further supported by subsequent scenario simulations where either PKC- or cSrc-
dependent regulation was blocked by setting g1 = 0 or g2 = 0. When the regulation of PKC was 
completely blocked, the simulated system dynamics appeared to vary greatly from the normal 
case (Figure 4.13 (b)). By contrast, when the regulation of cSrc was absent from the system, the 
simulated system dynamics changed only insignificantly. This comparative simulation strongly 
demonstrates the more important role of PKC in regulating p47phox phosphorylation as well as 
the dynamic responses of the system.  
One interesting feature of AngII-induced Nox1 activation in VSMCs is the existence of 
H2O2-induced positive feedback through the cSrc/EGFR/PI3K signaling cascade. Accounting for 
this feedback pathway enables the entire system to be driven exclusively by one input signal 
PKC and to run sustainably on its own. To test the importance of this positive feedback as well 
as to see whether our model is able to capture this prominent feature, we reconstructed the model 
by incorporating this H2O2-mediated cSrc activation pathway. After tuning the relevant 
parameters, the final integrated system reproduced the overall system dynamics for most 
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variables very well (Figure 4.17). The only remaining inconsistency is the dynamics of PI3K. 
One possible reason causing this inconsistency is that the current dynamic data of PI3K is 
collected from the assessment of the AngII-induced tyrosine phosphorylation of p85, a catalytic 
subunit of PI3K, through immunoprecipitation and Western blot analysis [261]. As a 
consequence, the data may not reflect the overall behavior of PI3K since AngII is also proposed 
to affect PI3K activity through other mechanisms, such as the AngII-induced distribution 
changes in the subcellular pools of PI3K and the translocation of the p85 subunit and its 
association with activated growth factor receptors as well as adapter proteins [261]. The 
existence of multiple regulatory mechanisms of AngII-induced PI3K activation may render the 
experimental observation from only one mechanism incomplete and insufficient to represent the 
overall PI3K behavior. This conclusion may suggest that other PI3K activation mechanisms need 
to be explored and evaluated.  
168 
CHAPTER 5 
CONCLUSIONS AND FUTURE WORK  
5.1 Conclusions  
The body of work presented in this dissertation advances knowledge of the underlying 
regulatory mechanisms of NADPH oxidase 1 (Nox1) in vascular system. The systematic analysis 
of Nox1-mediated mechanotransduction pathway stimulated by different types of shear stresses 
in endothelial cells (ECs) (Chapter 2), the function and design analysis of a generic Nox1 
activation-disassembly system regulated by static signals in vascular smooth muscle cells 
(VSMCs) (Chapter 3), and the dynamic analysis of Nox1 and its subsequent ROS production in 
response to the hormone angiotensin II in VSMCs (Chapter 4), provide novel insights into the 
possible Nox1 activation and disassembly mechanisms as well as their distinct roles under 
treatments with different extracellular stimuli. 
As an important endogenous source of ROS, Nox1 often works in a collaborative and 
cooperative manner with other non-Nox ROS sources, as well as with other Nox homologues co-
existing in the same cell. The resulting interactive network is complicated and makes 
interpretations and predictions of Nox1 activity and its dynamics difficult and non-intuitive. 
Additionally, the intrinsic properties of Nox1-catalyzed ROS, which are biochemically reactive 
and short-lived, complicate the experimental detection and often render measurements of these 
molecules less accurate than for stable molecules. Furthermore, these experimental 
measurements often reflect a global response of the target cell, which not only includes the 
Nox1-catalyzed ROS, but also contributions from other sources. As a result, it becomes difficult 
to infer the details of Nox1 activity with pure experimental methods. In order to overcome some 
of the limitations of experimental studies and to extract maximal information from available 
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experimental information, this research utilizes computational and modeling methods to study 
detailed properties of Nox1 activation and disassembly mechanisms in vascular cells. 
 Experimental evidence shows that Nox1 can be activated by a variety of stimuli. One 
prominent stimulus that is directly relevant to cardiovascular disease and atherosclerosis is shear 
stress, which is naturally generated on the surface of ECs when blood flows through arteries. 
Generally, two physiological or pathological shear stresses occur in different areas of arteries: 
laminar shear stress (LSS) in healthy, straight sections of vessels, and oscillatory shear stress 
(OSS) at branches and occlusions, which is mainly caused by disturbed flow. These two types of 
shear stress differently regulate Nox1 activity and subsequent ROS production, and therefore 
have essentially opposite roles in the initiation and genesis of atherosclerosis.  
 Nonetheless, an interesting experimental observation shows that these two shear stresses 
actually have similar short-term effects in increasing ROS production in vitro (t = 1 hour) but 
opposite long-term effects (t = 24 hour). In order to investigate this phenomenon, we developed a 
dynamic mathematical model (see pathway structure in Figure 2.1) that incorporates the main 
known Nox1 component in ECs (p47phox and Nox1 subunits) and accounts for regulation of 
Nox1 activity at multiples levels, including transcriptional and translational regulation, as well as 
signal-based regulation.  The simulation analysis not only reproduced the experimental 
observations well (Figure 2.2 to Figure 2.4), but also illustrated the distinct roles for each 
individual type of regulation. The analysis revealed that the similar short-term effect of two shear 
stresses is mainly due to the acute signal-based regulation of p47phox phosphorylation (Figure 2.6 
and Figure 2.7), while the opposite long-term effects may be caused by the different regulatory 
processes of two shear stresses on Nox1 mRNA and protein expression through a BMP4-
dependent pathway. These longer-term transcriptional and translational processes were modeled 
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with time-delays (τ), and the simulations demonstrated that these delays are critical for good 
performance, thereby demonstrating the multi-time scale nature of the system. 
The originally proposed model in Chapter 2 only contained two Nox1 subunits, namely 
the Nox1/p22phox complex (Nox1 is not stable outside a complex with p22phox) and the organizer 
subunit p47phox. Other pertinent components that could potentially affect Nox1 activity, such as 
Rac and the activator subunit, were not considered, because information regarding these 
regulatory subunits in ECs is scarce. Moreover, ECs contain three Nox homologues, among 
which Nox1 and Nox2 have very similar molecular compositions and activation mechanisms. As 
a result, it is not clear whether a specific regulatory subunit will complex with Nox1, Nox2, or 
both of them, to initiate the enzyme activity, and it is difficult to identify the exact sources of 
ROS from these two Nox homologues.  
 In order to overcome the limitations of the EC model, we switched to another type of 
cells, namely vascular smooth muscle cells (VSMCs), for which more information is available. 
Compared to ECs, Nox2 shows extremely low expression and its subunit requirements and the 
contribution to ROS can reasonably be ignored. Another expressed Nox homologue in VSMCs is 
Nox4. As discussed in section 1.2.2, Nox4 only requires p22phox (abundant in VSMCs) for its 
ROS-producing activity, and its activity is proposed to be mainly dependent on its protein 
expression. Thus, there is little subunit competition for Nox1 and Nox4. More importantly, as 
long as its protein expression is not significantly changed, Nox4 can be considered a constant 
supply to ROS. In summary, the simpler composition of the Nox family in VSMCs makes these 
cells a better template for exploring the specific properties of Nox1 activation and disassembly.   
 A detailed model describing the Nox1 activation-disassembly system in VSMCs  is 
proposed in Chapter 3 (see pathway structure shown in Figure 3.1). Four different, potentially 
171 
simultaneous disassembly pathways of Nox1 were incorporated, and their ability to control Nox1 
activity was explored by using different kinds of user-defined criteria. Assessments of these four 
deactivation mechanisms with respect to different criteria led to similar results (Figure 3.2 and 
Figure 3.3). For effective functioning, the flux associated with proteolytic pathway must be much 
smaller (by at least two orders of magnitude) than the fluxes associated with the recycling 
pathways, indicating the relative inefficiency of proteolysis for disassembling Nox1 under 
nominal, physiological conditions. Furthermore, the subsequent analysis revealed several generic 
design features that could possibly affect the system’s optimal responsiveness. The identified 
features include the material distributions of key subunits in their active or inactive state (Figure 
3.2), the rates and directional balances of reversible reactions (Figure 3.6 to Figure 3.8), and the 
relative magnitude of the system’s efflux (Figure 3.6 to Figure 3.8). These findings enable us to 
understand the Nox1 system from an entirely different point of view and allow us identify 
potential strategies for controlling Nox1 activity (see discussion in Chapter 3).  
 Although the analysis in Chapter 3 revealed some specific features regarding the 
disassembly mechanisms of Nox1 as well as its optimal performance, this type of analysis was 
mainly executed at the steady state. As a consequence, it had limitations in providing further 
insights into the system when it is exposed to dynamic signals. To improve our understanding of 
the dynamic behavior of Nox1, we proposed in Chapter 4 a mathematical model focusing on the 
AngII-induced Nox1 dynamic activation in VSMCs (see pathway structure shown in Figure 4.1). 
This model incorporates not only the Nox1 activation-disassembly module proposed and 
discussed in Chapter 3, but also other signal relevant modules, such as AngII-induced PKC 
activation and the cSrc/EGFR/PI3K signaling cascade. Additionally, a simple module of ROS 
metabolism was added to relate the Nox1 system directly to available experimental observations. 
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Similar to the efforts in Chapter 3, Chapter 4 had to deal with many unknown parameters and 
scarce information. To solve this problem, we resorted again to a Monte-Carlo screening method, 
which was only minimally dependent on specific parameter values.  
 Three integrated model candidates were generated, and 48 parameter combinations in 
total were considered in Monte-Carlo simulation (see detailed description in section 4.3.2). 
Pertinent experimental information from the literature was collected and translated into a series 
of criteria, which were used to evaluate the performance of each Monte-Carlo sample. This 
criteria-driven analysis gave us intriguing results: In the first round of Monte Carlo simulation, 
Model Candidate 2 (MC2) was found to have better performance than the other two models 
(Table 4.13), indicating the effectiveness of using EGFR data as input. The results from the 
second round of Monte-Carlo simulation, which focused on MC2, further revealed the 
outstanding performance of three parameter combinations out of 16 (Table 4.13), and suggested 
two specific patterns for the relative magnitudes of investigated rate constants (see detailed 
discussion in section 4.4). These computationally inferred patterns clearly demonstrated the 
probably dominant disassembly pathway of Nox1 under different situations. Moreover, later 
simulations and comparisons of different data from cSrc helped us determine that a signaling 
pathway was missing from the model. This pathway is presumably associated with calcium. 
Although a Ca2+-dependent and cSrc-independent EGFR trans-activation pathway has been 
documented in literature, its particular role in regulating EGFR dynamics, especially for its 
transient behavior, had not been emphasized by the scientific community. Finally, a known 
H2O2-induced positive feedback was added to complete the model integration. This integrated 
system well reproduces most observed system dynamics (see detailed discussion in section 4.4), 
which supports the structure and implementation of the proposed mathematical model.  
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5.2 Future Work  
I have constructed and implemented two individual models for describing the relevant 
Nox1 system in ECs and VSMCs. Comparing their model structures, I find some common 
properties. For instance, both models target the Nox1 system, include some basic Nox1 
components and interactions between components, and take various regulatory processes of 
Nox1 into account. At the same time, each model displays its own specific features. Therefore, 
these two models can learn from each other and may facilitate and expand each other’s 
capabilities.  
 The model for Nox1-mediated mechanotransduction in ECs has a more “vertical” 
structure. It incorporates not only the shear stress-regulated BMP4 production located at the very 
top level of the pathway, but also the ROS-mediated NFκB signaling and subsequent monocyte 
adhesion located downstream. This vertical model structure enables us to connect the target 
system to its possible physiological functions. Specifically, any changes of Nox1 activity can be 
directly reflected in the level of bound monocyte molecules. As a result, it is easier for 
experimentalists and clinicians familiar with the importance of monocyte adhesion in the 
initiation and genesis of atherosclerosis to interpret the model within a familiar physiological 
context. However, detailed features with respect to Nox1 activation and disassembly processes 
are not described and explored in this model.  
 By contrast, the Nox1 model in VSMCs is particularly constructed in a “horizontal” way, 
which emphasizes the detailed interactions between Nox1 subunits, but pays less attention to the 
relevant physiological functions at the input and downstream levels. The analysis of this type of 
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model reveals more features of the Nox1 system itself, but does not directly link Nox1 to its 
physiological roles.  
 Thus, each type of model has its advantages and drawbacks with respect to its 
capabilities. One might consider the following aspects as direct extensions to the work presented 
here:   
 Expand the Nox1 model in ECs “horizontally” by considering more Nox1 components and 
interactions between these components. Use the findings of potential Nox1 disassembly 
mechanisms in VMSCs to enrich the model structure in ECs.  
 Expand the Nox1 model in VMSCs “vertically” by directly relating the Nox1-catalyzed ROS 
to down-stream signals and potential physiological functions regarding a specific disease. 
Since AngII is often used as a stimulus in this model, one could consider a connection 
between the Nox1 model in VSMCs and a specific disease like hypertension.  
 Expand the Nox1 model in ECs by taking other Nox homologues into account and 
investigate the collaboration and cooperation between distinct Nox homologues if more 
biological information is available. In such an expansion, the issue of subunit competition 
and the identification of ROS sources between Nox1 and Nox2 need to be addressed.  
 
Beyond the analysis of Nox1, the methodology used in this dissertation can be applied 
with relatively minor adaptations to investigations of other, similar biological systems. A 
particularly intriguing example is the Nox2 system, which is found in “professional” phagocytes 
and B lymphocytes, and is very similar to Nox1 in terms of molecular composition as well as its 
activation mechanisms. The superoxide generated by Nox2 serves as the starting material for the 
production of a vast assortment of reactive oxidants (including oxidized halogens, free radicals, 
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singlet oxygen, etc.), which are used by phagocytes to kill invading microorganisms. However, 
these oxidants can also cause a substantial collateral damage to nearby tissues. Thus, the 
production of these ROS has to be tightly regulated to ensure they are only generated when and 
where required. Therefore, the interesting question of how the Nox2 system and its subsequent 
ROS production are accurately regulated and controlled will require more detailed investigation. 
Using computational and modeling methods, as complimentary methods to experimental studies, 
can help to enhance our understanding of the Nox2 system in phagocytes by identifying and 
analyzing potential association and disassociation mechanisms as well as their interaction and 
cooperation. The combination of experiment and computational analysis might also help with the 
design of strategies to control Nox2 activity better.   
Outside the Nox enzyme family, many biological systems exhibit properties and 
behaviors that are structurally similar to the assembly and disassembly of Nox1. For instance, 
other enzymes or complex proteins exist whose activation requires the assembly of multiple 
subunits and that can be triggered by different upstream signals in multiple steps. The 
computational and modeling methods used in this dissertation may be applied to these systems, 
where they could demonstrate the efficacy of  their potential association and disassociation 
mechanisms and characterize how the system’s performance is differentially regulated by 
different signals.  
Moreover, the design principles that were discovered in this dissertation research may be 
applicable to other biological systems. For instance, with the simulation analysis in Chapter 3, I 
find that some subunits (p47phox and Rac1) are required to reside mainly in an inactive form 
under normal physiological conditions and that this arrangement is responsible for optimal 
system performance. Whether such an arrangement is a general rule for similar biological 
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systems that require signaling-based regulations is an interesting open question, and is therefore 




PARAMETER ESTIMATION AND SIMULATION SETTINGS IN SYSTEM 
ANALYSIS OF THE ROLE OF BMP4 IN ENDOTHELIAL 
INFLAMMATION  
 
A.1 Parameter Estimation 
Due to the paucity of available time-series and quantitative data, the rate constant and 
kinetic order parameter values (γi and gi) were estimated in an ad hoc fashion as described in the 
Materials and Methods section. All constraints (both for kinetic orders and rate constants) 
derived from equations with two terms (see Eq. (2.3)) are presented in Table A.1.  
Given these constraints and assigning a default value (such as 0.5 for substrate 
dependency or activation and -0.5 for inhibition) to one of the two relevant kinetic orders yields 




M . Either 
one of the ratios of experimental measurements to the control can be used for the computation. 
When both ratios are experimentally available, the ratio measured under OSS condition was 
used. The available ratios that were recalculated from experimental measurements are listed in 
Table A.2.  
Once the kinetic orders are set, the rate constants are secondarily deduced with the 
constraint equations in a similar fashion. While these methods determine a good portion of the 
needed parameter values, other parameters require default assumptions, experience and 
additional efforts for fine tuning and validating, based on available biological observations. 
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Examples are the parameters in the system equations in Equation (2.3) that contain external 
inputs or more than two terms.  
A.2 Simulation Settings 
All simulations (with results displayed in Figure 2.2 to Figure 2.7 in the dissertation) use 
the same numerical sets of initial conditions (Table A.3) and parameter values (Table A.4), with 
the exception of parameters under investigation in a specific simulation, as described in the 
dissertation and the corresponding figure legends.  
The signal of shear stress acting on the phosphorylation of p47phox is represented by an 















,      (A.1) 
where ρ represents the intensity of the phosphorylation signal after shear stress is added to the 
























       Table A.1 Parameter constraint equations. 
 
Kinetic Orders Constraint Equations 



























































































































































































Rate Constants Constraint Equations 















































































































































































M == ,  represent the ratios of the steady-state values under OSS and ULS in relation to the 
static control condition.  
 
 
          Table A.2 Experimental ratios of steady-state values under OSS and LSS.  





1 (BMP4 mRNA) 1.5 0.3 
2 (BMP4 precursor) 2 0.25 
3 (mature BMP4) 1.2 0.15 
5 (BMP4 antagonist) 1.25 0.1 
6 (nox1 mRNA ) 3.5 1.5 
10 (superoxide) 1.7 0.3 
11 (hydrogen peroxide) 2 - 
13 (NFқBactive) 3.4 - 
14 (ICAM1) 3.0 - 
The steady states for the above variables in static control are assumed to be 1 (100%). Listed numerical values are 
recalculated in relation to static control. ULS: 15 dyn/cm2. OSS: ± 5 dyn/cm2. Symbol “-“ indicates that no 
experimental measurement are presently available.  
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Table A.3 Numerical values of initial conditions (ICs) and independent variables. 









BMP4 mRNA 1 nox1 1 S (ULS) 5~15 dyn/cm2 
BMP4 precursor 1 NADPH 
oxidaseactive 
1 S (OSS) ± 5 dyn/cm2 
mature BMP4 1 superoxide 1 S (STATIC) 1 
BMP4/R complex 1 hydrogen 
peroxide 
1 Constant Numerical Value 
C 1 
κ  1 
BMP4 antagonist 1 nitric oxide 1 ρ  5 
nox1 mRNA 1 NFқBactive 1 σ  0.1 
p47phoxphorylated 0.2 ICAM1 1 offset 1 
 

















g1 0.786 g17 0.52 r1 0.94 r17 40 
g2 2.289 g18 1 r2 0.94 r18 60 
g3 1.433 g19 1 r3 0.42 r19 20 
g4 2.5 g20 2 r4 0.42 r20 10 
g5 3.5 g21 1.615 r5 0.286 r21 70 
g6 3.5 g22 1 r6 0.134 r22 10 
g7 4.782 g23 1 r7 0.286 r23 100 
g8 0.8 g24 0.631 r8 0.134 r24 100 
g9 4.593 g25 1 r9 100 r25 100 
g10 0.5 g26 1.067 r10 100 r26 100 
g11 1 f1(OSS) 0.2 r11 0.6   




g13 1 f1(STATIC) 0 r13 2 1τ  10h 
g14 0.8 f2(OSS) 0.72 r14 0.4 2τ  11h 
g15 1 f2(ULS) -2 r15 0.4 
3τ  0.1h 
g16 1 f2(STATIC) 0 r16 40 4τ  0.1h 
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APPENDIX B 
SUPPLEMENTARY INFORMATION OF FUNCTION AND DESIGN OF 
THE NOX1 ACTIVATION-DEACTIVATION 
SYSTEM IN VASCULAR SMOOTH MUSCLE CELLS 
 
B.1 Stoichiometric Matrix 
 The matrix N in Eq. (3.1) is explicitly given as follows:  
N8×16 =
1 −1 −1 −1 0 0 0 0 0 0 0 0 0 −1 0 0
−1 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0
0 0 1 0 −1 1 0 0 0 0 1 0 0 0 0 0
−1 1 0 1 1 −1 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 −1 1 0 0 0 1 0 0 0 0
−1 1 1 0 0 0 1 −1 0 0 0 0 0 0 0 0
−1 0 1 1 0 0 0 0 −1 1 0 0 0 1 0
























B.2 Input Signal Vectors for the Assessment of Nox1 Disassembly (First Criterion) 
The input signal vector ([S1 S2 S3]) is represented by the numerical values listed in Table 
B.1.  
 
Table B.1 Numerical values of input signals under different conditions. 
Experimental 
Condition 
S1 signal  
added 
S2 signal  
added 
S3 signal  
added 
S1& S2 signals  
added 
Control [1 1 1] [1 1 1] [1 1 1] [1 1 1] 





B.3 Assessment of Nox1 Disassembly Mechanisms According to the Second Criterion 
Numerical values of initial conditions were assigned according to experimental 
observations (in consultation with experimentalists); they are summarized in Table B.2. The 
experimental treatment with angiotensin II (AngII) is translated in to a combination of input 
signals S1 and S2, and the treatment with 12-myristate-13-acetate (PMA) is translated in input 
signal S1. Considering realistic magnitudes with which AngII and PMA can up-regulate these 
signals, the numerical values of S1 and S2 are conservatively considered as ~ 2 fold over control 
level (as “1”) for AngII, and the numerical value of S1 is considered as ~4 fold over control level 
for PMA. Therefore, the input signals of AngII and PMA treatments are respectively represented 
by [2 2 1] and [4 1 1] in this set of simulations.  
The second criterion consists of a combination of three conditions. They are separately 
implemented in simulations as defined below:  










tXtX hourhour .  
(2) The second criterion of a (quasi-) steady state and up-regulated X1 after 30 minutes of AngII 
treatment is implemented as:  








tX .  







tX .  
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 Table B.2 Steady-state values of initial conditions. 
Variable  Steady-State Value  
X1 310 (molecules/cell) 
X2 4104.2 ⋅ (molecules/cell) 
X3 3104.5 ⋅ (molecules/cell) 
X4 3102.1 ⋅ (molecules/cell) 
X5 3106 ⋅ (molecules/cell) 
X6 3102.1 ⋅ (molecules/cell) 
X7 
3104.5 ⋅ (molecules/cell) 
X8 
3106.0 ⋅ (molecules/cell) 
 
B.4 A Thought Experiment Illustrating Responses of the Nox1 System to Persistent Signals 
of Type S1 under Three Extreme Scenarios 
In order to illustrate the distinct roles of the three disassembly and recycling pathways in 
affecting the responses of the Nox1 system, we perform the following thought experiment. 
Suppose the Nox1 system is exposed to a persistent signal S1, and only one recycling pathway is 
available, as depicted with modules 1, 2 and 3 in Figure 3.5 of the Text. Specifically, in scenario 
1, only the recycling pathway via phosphorylation of NoxA1 is available (marked as f2 in Figure 
3.1 of the Text). In scenario 2, only the recycling pathway via dephosphorylation of p47phox 
(marked as f3 in Figure 3.1) exists. In scenario 3, only the recycling pathway via deactivation of 
Rac1GTP (marked as f4 in Figure 3.1) is present. The system’s responses to S1 are evaluated with 
respect to the new steady state of X1 in one scenario compared to that in another scenario.   
In all cases, the simulation settings are the same in terms of other parameter values and 
initial conditions for each round of simulation. Moreover, to reduce other possible discrepancies 
induced by different simulation settings, parameters and initial conditions are generated through 
uniform sampling within a relatively large range. For different rounds of simulations, parameters 
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are randomly sampled as follows: The independent rate constants γi are sampled from U(0, 100), 
for i = 6, 8, 10, 16. Under different scenarios, γ2 (or γ3 or γ4) is respectively set at 10. The steady 
states of dependent variables in unstimulated state are set as: X1 = 10, X2 = 100, Xi ~ U(1, 99) for 
i = 3, 4, …8 with the assumption that X3 and X4, X5 and X6, X7 and X8, respectively, sum to 100. 
The overall sampling size is 10,000. All simulations were implemented in MATLABR2010a. 
Figure B.3 shows the results. They consist of distributions resulting from Monte-Carlo 
simulations, where each entry represents one ratio between the steady-state values of X1 in two 
scenarios. The top panel shows the ratios under scenario 2 over scenario 1. These ratios are 
distributed strictly to the right side of zero (in log10 space), demonstrating that the new steady 
state of X1 in scenario 2 is always as high or higher than the one in scenario 1, no matter what the 
simulation setting is. Indeed, the ratios of new steady state of X1 in scenario 2 differ up to ~2.5 
fold (100.4≈2.5) over the corresponding steady state in scenario 1. 
A similar result holds when we compare the ratios of new steady-state values of X1 under 
scenario 2 versus scenario 3 (bottom panel): Scenario 2 always leads to as strong or stronger 
responses than scenario 3. Combined, the results in top and bottom panels suggest that, in the 
presence of a persistent signal S1, recycling via dephosphorylation of p47phox (scenario 2) allows 
stronger responses than the other two recycling mechanisms (scenario 1 and 3). Between 
scenarios 1 and 3, the effectiveness of response is not much different (center panel of Figure 
B.3).  
The example demonstrates that the effectiveness of a particular recycling pathway is 
interrelated with the demands of the system. For the specific case of a persistent signal S1, which 
was studied here, the most efficient recycling mechanism appears to be the dephosphorylation of 
p47phox (scenario 2). This deduction becomes even stronger when the cell has the option of 
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selecting (or discarding) certain combinations of numerical settings for the rate constants, which 
in the results in Figure B.3 are based on random sampling. For persistent signals of type S2, S3, 
combinations of these signals, or other types of signal trains, the optimal recycling strategy is 
certainly different.  Thus, under the assumption that the cell optimizes responses, one should 
expect that the cell has developed regulatory mechanisms that control the distribution of 
recycling fluxes, depending on signaling demands. 
 
B.5 Supplementary Figures 
 
 
Figure B.1 Original result of Monte Carlo simulation with criterion of the second type.  





Figure B.2 Schematic representation of closed Nox1 system. 
 
Figure B.3 Simulated responses of the Nox1 system to persistent signals of type S1 under three extreme 
recycling mechanisms.  
Scenario 1: Only the recycling pathway associated with phosphorylation of NoxA1 (marked as f2 in Figure 3.1) 
exists; Scenario 2: Only the recycling pathway associated with dephosphorylation of p47phox (marked as f3) exists; 
Scenario 3: Only the recycling pathway associated with deactivation of Rac1GTP (marked as f4) exists. The horizontal 
axis indicates the ratio, in log10 space, of new steady-state values of X1 under two different scenarios. For instance, 
the top panel shows the ratios of X1 values in Scenario 2 in comparison to Scenario 1 in 10,000 Monte-Carlo 
simulations. See text for further details. 
188 
APPENDIX C 
SUPPLEMENTARY INFORMATION OF SYSTEM ANALYSIS OF THE 
DYNAMICS OF ANGIOTENSIN II-INDUCED NOX1 ACTIVATION IN 
VSMCS  
C.1 Stoichiometric Matrix 
 The stoichiometric matrix Ni, i = 1, 2, 3 in Eqs. (4.7), (4.8) and (4.9) are respectively 









































































































































































































































































C.2 Dynamic Simulations with the Integrated Model for 12 Selected Samples 
 Various scenarios, including unstimulated conditions, AngII (100nM) treatment,a Nox1 
knock-down experiment, a Nox4 knock-down experiment, treatments with AG1248, PP1, PMA, 
GF 10923X, and AdRacN17, are simulated for Model Candidate 2 (MC2). Totally, there are 12 
sets of simulation results, which are respectively displayed in Figure C.1 to Figure C.12.  
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Figure C.1 Dynamic simulations of MC2 by using parameter values in selected sample set 1. 
The units of the x-axis and y-axis are respectively seconds and # molecules/cell. Colored circles indicate 
experimental measurements under different scenarios: dark circles-AngII treatment; pink circle-AngII+GF 10923X; 
green circle-AngII+AG1248; light blue circle-AngII+PP1; dark blue circle-AngII+AdRacN17. Colored lines are 
simulated results under different scenarios: dashed dark line-control condition; solid dark line-AngII treatment; solid 
red line-Nox1 knocked-down condition; solid green line-Nox1 knocked-down condition with AngII treatment; 
dashed green line-AngII+AG1248; solid dark blue line-AngII+AdRacN17; solid light blue line-AngII+PP1; solid 
pink line-PMA treatment; dashed pink line-AngII+GF 10923X. (The indications of these symbols are the same for 
Figure C.1 to Figure C.12). The parameter values used in this simulation are: Parain = [0.0052 0.0879 0.0196 0.0830 
0.0930 0.0012 0.0037 0.3393 0.7817 1.3660 0.0749 0.6380 0.7274 1.8914 6] (see detailed description of Parain in 
Table 4.10).  
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Figure C.2 Dynamic simulations of MC2 by using parameter values in selected sample set 2.  
The parameter values used in this simulation are: Parain = [0.0093 0.0286 0.0130 0.0807 0.0395 0.0037 0.0018 
0.5067 0.4351 0.9721 0.1349 0.6377 1.1940 1.7580 7]. See Figure C1 for further details. 
 
Figure C.3 Dynamic simulations of MC2 by using parameter values in selected sample set 3.  
The parameter values used in this simulation are: Parain = [0.0075 0.0629 0.0183 0.0580 0.0471 0.0018 0.0016 
0.8242 5.9634 0.8130 0.8408 0.9224 0.9061 1.3807 1.7573 5]. See Figure C1 for further details. 
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Figure C.4 Dynamic simulations of MC2 by using parameter values in selected sample set 4. 
The parameter values used in this simulation are: Parain = [0.0038 0.0235 0.0177 0.0439 0.0238 0.0015 0.0046 
2.8345 0.1232 1.3067 0.5391 0.6339 0.5274 1.4802 1.9632 9]. See Figure C1 for further details. 
 
Figure C.5 Dynamic simulations of MC2 by using parameter values in selected sample set 5. 
The parameter values used in this simulation are: Parain = [0.0235 0.0958 0.0109 0.0904 0.0577 0.0160 0.0083 
0.4650 0.6545 1.0419 0.6188 0.5254 0.4659 1.7823 1.8502 10]. See Figure C1 for further details. 
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Figure C.6 Dynamic simulations of MC2 by using parameter values in selected sample set 6. 
The parameter values used in this simulation are: Parain = [0.0362 0.0379 0.0123 0.0365 0.0243 0.0327 0.0012 
0.5980 6.6175 1.8979 0.2865 0.6796 0.7615 1.7568 1.6002 10]. See Figure C1 for further details. 
 
Figure C.7 Dynamic simulations of MC2 by using parameter values in selected sample set 7.  
The parameter values used in this simulation are: Parain = [0.0176 0.0908 0.0232 0.0769 0.0972 0.0512 0.0027 
1.6793 1.5401 1.7832 0.2196 0.7376 0.6810 1.5133 1.6543 10]. See Figure C1 for further details. 
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Figure C.8 Dynamic simulations of MC2 by using parameter values in selected sample set 8. 
The parameter values used in this simulation are as the following: Parain = [0.0153 0.0344 0.0122 0.0456 0.0314 
0.0102 0.0414 0.9806 2.5609 1.6142 0.3707 0.7949 0.6931 1.5375 1.2294 8]. See Figure C1 for further details. 
 
Figure C.9 Dynamic simulations of MC2 by using parameter values in selected sample set 9. 
The parameter values used in this simulation are as the following: Parain = [0.0924 0.0373 0.0282 0.0747 0.0761 
0.0698 0.0388 0.4009 2.4353 1.9377 0.4880 0.8860 0.5403 1.2936 1.8561 8]. See Figure C1 for further details. 
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Figure C.10 Dynamic simulations of MC2 by using parameter values in selected sample set 10.  
The parameter values used in this simulation are: Parain = [0.0296 0.0128 0.0179 0.0769 0.0264 0.0191 0.0245 
3.7825 0.4957 0.6346 0.9127 0.6552 0.0139 1.9572 1.2572 10]. See Figure C1 for further details. 
 
Figure C.11 Dynamic simulations of MC2 by using parameter values in selected sample set 11. 
The parameter values used in this simulation are: Parain = [0.0741 0.0445 0.0107 0.0668 0.0748 0.0463 0.0661 
9.7272 0.1711 1.8628 0.4397 0.6193 0.7049 1.9886 1.3945 10]. See Figure C1 for further details. 
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Figure C.12 Dynamic simulations of MC2 by using parameter values in selected sample set 12.  
The parameter values used in this simulation are: Parain = [0.0452 0.0163 0.0100 0.0643 0.0270 0.0737 0.0455 
0.4358 0.1940 1.5931 0.1986 0.7182 0.5257 1.7633 1.3120 7]. See Figure C1 for further details. 
C.3 cSrc-Dependent EGFR Activation Module 
The pathway structure (shown in Figure 4.15 (a)) is mathematically expressed in the GMA 





EGFR ⋅−⋅−⋅= βα ,    (C.1) 
where the symbols with * indicate active signaling molecules, whose values are assumed to be at 
“1” in unstimulated control condition. α and β are rate constants with non-negative values, and g 
is the real-valued kinetic order. TEGFR represents the total amount of EGFR molecules in both 
active and inactive forms. 
 Under unstimulated control conditions, the whole Nox1 system dynamically operates at a 
stable state, and so does this cSrc-dependent EGFR signaling cascade. It requires not only the 
level of active EGFR stably staying at “1”, but also the change of active EGFR over time 
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(represented by its derivative) equalling zero. Thus, this requirement adds one linear constraint to 







EGFR ⋅−⋅−⋅−⋅= αα ,   (C.2) 
 Ultimately, there are three unknown parameters, namely α, g, and TEGFR, whose 
numerical values need to be determined. According to experimental evidence (represented by 
green circles in Figure 4.8), the level of active EGFR increases over 7 fold in the cells stimulated 
with AngII (100nM), suggesting that the total amount of EGFR (represented by TEGFR) should be 
at least 8. In order to simplify the later parameter estimation process, TEGFR is set to take the 
numerical value of 8 during the simulation. As for the other two parameters, α and g, we use the 
nonlinear optimization function in MATLAB to find optimal values. Since little prior 
information is available about the possible ranges or magnitudes of these two parameters, we 
start with a wide range of random initial guesses (size = 100) for these two parameters. This 
procedure led to several parameter candidates with almost equivalent performances.  The 
parameter values that are used to generate simulation results represented in Figure 4.15 (b) are: α 
= 1, g = 1.5.  
C.4 cSrc- and Ca2+-Dependent EGFR Activation Module 
The pathway structure depicted in Figure 4.16 (a) is mathematically expressed in the GMA 











+ βαα ,          
            (C.3) 
where α1, α2, and β are rate constants with non-negative values; g1 and g2 are real-valued kinetic 
orders. The levels of all active signaling molecules (denoted by symbols with *), including 
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EGFRactive, cSrcactive, and Ca2+, are again assumed to have values of “1” in unstimulated control 
conditions.  Considering the steady state requirement for this signaling cascade, Eq. (4.3) 















+ αααα  .  
            (C.4) 
 Totally, there are five unknown parameters, namely α1, α2, g1, g2, and TEGFR. Similar to 
the specifications in section C.3, the value of TEGFR is fixed at 8, and the values of other 
parameters are searched via nonlinear optimization function in MATLAB. Several candidate sets 
were found with quite similar performances. The parameter values used to generate the 
simulation result displayed in Figure 4.16 (b) are: α1 = 0.5, α2 = 0.5, g1 = 1.5, g2 = 3.5.                                                            
C.5 Integrated AngII-Induced Nox1 Activation with H2O2-Dependent Positive Feedback 
 Compared to Model Candidate 3 (detailed described in Table 4.4), the final integrated 
model with H2O2-induced positive feedback contains cSrcactive as a dependent variable rather 
than an independent variable, which adds two fluxes to the system. As a consequence, the 
integrated model with H2O2-dependent positive feedback is mathematically expressed in Eq. 
(C.5):  
finalfinal FNdt
dX ⋅= ,          (C.5) 
where X14×1 is the variable vector, consisting of dependent variables Nox1active, Nox1/p22phox, 
p47phox, p47phoxP, Rac1GDP, Rac1GTP, NoxA1, NoxA1P, O2.-, H2O2, PIP3, PI3Kactive, EGFRactive, 
and cSrcactive.  Nfinal is a 14×30 stoichiometric matrix, and Ffinal is the 30×1 flux vector. The 
explicit expression of both Nfinal and Ffinal are respectively given Eqs. (C.6) and (C.7), where 
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PKCactive, Nox4active, PIP2, and Ca2+ are considered as independent inputs; X1 to X14 are dependent 
system variables.  
 Ultimately, the final integrated system has 31 rate constants, 9 kinetic orders, and three 
other parameters (TPI3K, TEGFR, TcSrc). Among these parameters, only three parameters involved in 
H2O2-induced cSrc activation (γ30, g9, and TcSrc) are unknown and need to be numerically 
determined. Using the nonlinear optimization function in MATLAB with different initials, we 
found several parameter candidates with quite similar performances. The parameter values used 
to generate simulation results displayed in Figure 4.17, and Figure C.13 to C.23 are: γ30 = 0.001, 
g9 = 4.5, and TcSrc = 5. Other parameter values are either retained from the 12 selected samples in 
the second round of Monte-Carlo simulation (see Parain ) or directly obtained from the simulation 
setting of cSrc- and Ca2+-dependent EGFR activation (see section C.4): γ27 = 0.5, γ28 = 0.5, g7 = 





























































































































































































































                                                                                                         (C.7) 
 
Figure C.13 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 1. The partial parameter values used in this simulation are: Parain = [0.0052 0.0879 0.0196 0.0830 0.0930 0.0012 
0.0037 0.3393 0.7817 1.3660 0.0749 0.6380 0.7274 1.8914 6]. The values of other parameters are kept the same for 
Figure C.13 to C.23, and are defined in corresponding text in section C.5.  
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Figure C.14 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 2. The parameter values used in this simulation are: Parain = [0.0093 0.0286 0.0130 0.0807 0.0395 0.0037 
0.0018 0.5067 0.4351 0.9721 0.1349 0.6377 1.1940 1.7580 7].  
 
Figure C.15 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 4. The parameter values used in this simulation are: Parain = [0.0038 0.0235 0.0177 0.0439 0.0238 0.0015 
0.0046 2.8345 0.1232 1.3067 0.5391 0.6339 0.5274 1.4802 1.9632 9]. 
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Figure C.16 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 5. The parameter values used in this simulation are: Parain = [0.0235 0.0958 0.0109 0.0904 0.0577 0.0160 
0.0083 0.4650 0.6545 1.0419 0.6188 0.5254 0.4659 1.7823 1.8502 10]. 
 
Figure C.17 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 6. The parameter values used in this simulation are: Parain = [0.0362 0.0379 0.0123 0.0365 0.0243 0.0327 
0.0012 0.5980 6.6175 1.8979 0.2865 0.6796 0.7615 1.7568 1.6002 10]. 
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Figure C.18 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 7. The parameter values used in this simulation are: Parain = [0.0176 0.0908 0.0232 0.0769 0.0972 0.0512 
0.0027 1.6793 1.5401 1.7832 0.2196 0.7376 0.6810 1.5133 1.6543 10]. 
 
Figure C.19 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 8. The parameter values used in this simulation are: Parain = [0.0153 0.0344 0.0122 0.0456 0.0314 0.0102 
0.0414 0.9806 2.5609 1.6142 0.3707 0.7949 0.6931 1.5375 1.2294 8]. 
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Figure C.20 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 9. The parameter values used in this simulation are: Parain = [0.0924 0.0373 0.0282 0.0747 0.0761 0.0698 
0.0388 0.4009 2.4353 1.9377 0.4880 0.8860 0.5403 1.2936 1.8561 8]. 
 
Figure C.21 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 10. The parameter values used in this simulation are: Parain = [0.0296 0.0128 0.0179 0.0769 0.0264 0.0191 
0.0245 3.7825 0.4957 0.6346 0.9127 0.6552 0.0139 1.9572 1.2572 10]. 
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Figure C.22 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 11. The parameter values used in this simulation are: Parain = [0.0741 0.0445 0.0107 0.0668 0.0748 0.0463 
0.0661 9.7272 0.1711 1.8628 0.4397 0.6193 0.7049 1.9886 1.3945 10]. 
 
Figure C.23 Dynamic simulations of integrated model with H2O2-induced cSrc activation for selected sample 
set 12. The parameter values used in this simulation are: Parain = [0.0452 0.0163 0.0100 0.0643 0.0270 0.0737 
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